<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006616" GROUP_ID="ANAESTH" ID="817905051822185566" MERGED_FROM="" MODIFIED="2012-08-06 13:34:51 +0100" MODIFIED_BY="Jane Cracknell" REVIEW_NO="125" REVMAN_SUB_VERSION="5.1.7" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="3.2">
<COVER_SHEET MODIFIED="2012-08-06 13:34:51 +0100" MODIFIED_BY="Jane Cracknell">
<TITLE MODIFIED="2009-11-19 14:23:47 +0000" MODIFIED_BY="[Empty name]">N-acetylcysteine for sepsis and systemic inflammatory response in adults</TITLE>
<CONTACT MODIFIED="2012-08-06 13:34:51 +0100" MODIFIED_BY="Jane Cracknell"><PERSON ID="360B62A782E26AA20114382D5EAB71C9" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Tamas</FIRST_NAME><LAST_NAME>Szakmany</LAST_NAME><SUFFIX>MD, PhD, EDIC, DESA</SUFFIX><POSITION>Consultant in Anaesthesia and Intensive Care, Lead Clinician in Intensive Care</POSITION><EMAIL_1>szakmany@gmail.com</EMAIL_1><EMAIL_2>szakmany@yahoo.co.uk</EMAIL_2><ADDRESS><DEPARTMENT>Department of Anaesthesia</DEPARTMENT><ORGANISATION>Cwm Taf NHS Trust, Royal Glamorgan Hospital</ORGANISATION><CITY>Llantrisant</CITY><ZIP>CF72 8XR</ZIP><REGION>Wales</REGION><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2012-08-06 13:34:51 +0100" MODIFIED_BY="Jane Cracknell"><PERSON ID="360B62A782E26AA20114382D5EAB71C9" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Tamas</FIRST_NAME><LAST_NAME>Szakmany</LAST_NAME><SUFFIX>MD, PhD, EDIC, DESA</SUFFIX><POSITION>Consultant in Anaesthesia and Intensive Care, Lead Clinician in Intensive Care</POSITION><EMAIL_1>szakmany@gmail.com</EMAIL_1><EMAIL_2>szakmany@yahoo.co.uk</EMAIL_2><ADDRESS><DEPARTMENT>Department of Anaesthesia</DEPARTMENT><ORGANISATION>Cwm Taf NHS Trust, Royal Glamorgan Hospital</ORGANISATION><CITY>Llantrisant</CITY><ZIP>CF72 8XR</ZIP><REGION>Wales</REGION><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="2935834B82E26AA2004A583D4B1FB85B" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Balázs</FIRST_NAME><LAST_NAME>Hauser</LAST_NAME><EMAIL_1>bhauser1@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Semmelweis Egyetem</DEPARTMENT><ORGANISATION>Aneszteziológiai és Intenzív Terápiás Klinika</ORGANISATION><ADDRESS_1>Kútvölgyi u 4</ADDRESS_1><CITY>Budapest</CITY><ZIP>H-1125</ZIP><COUNTRY CODE="HU">Hungary</COUNTRY></ADDRESS></PERSON><PERSON ID="36126C3382E26AA20114382DD2DFB6E1" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Peter</FIRST_NAME><LAST_NAME>Radermacher</LAST_NAME><EMAIL_1>peter.radermacher@uni-ulm.de</EMAIL_1><ADDRESS><DEPARTMENT>Sektion Anästhesiologische Pathophysiologie und Verfahrensentwicklung</DEPARTMENT><ORGANISATION>Klinik für Anästhesiologie, Universitätsklinikum</ORGANISATION><ADDRESS_1>Parkstrasse 11</ADDRESS_1><CITY>Ulm</CITY><ZIP>89073</ZIP><COUNTRY CODE="DE">Germany</COUNTRY></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2012-07-30 10:23:36 +0100" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="2" MONTH="1" YEAR="2012"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="2" MONTH="1" YEAR="2012"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="4" MONTH="8" YEAR="2015"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2007"/>
<REVIEW_PUBLISHED ISSUE="" YEAR=""/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2007"/>
</DATES>
<WHATS_NEW MODIFIED="2012-03-27 23:51:07 +0100" MODIFIED_BY="[Empty name]"/>
<HISTORY/>
<SOURCES_OF_SUPPORT MODIFIED="2010-01-14 11:54:07 +0000" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2010-01-14 11:54:07 +0000" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2010-01-14 11:54:07 +0000" MODIFIED_BY="[Empty name]">
<NAME>Cwm Taf LHB, Directorate of Anaesthetics, Critical Care and Theatres</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>Departmental funding</P>
</DESCRIPTION>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2012-08-06 13:33:54 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2012-07-29 12:05:48 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2012-06-27 10:45:37 +0100" MODIFIED_BY="[Empty name]">Intravenous N-acetylcysteine compared to placebo for treatment of systemic inflammatory response syndrome and sepsis in seriously ill adults</TITLE>
<SUMMARY_BODY MODIFIED="2012-07-29 12:05:48 +0100" MODIFIED_BY="[Empty name]">
<P>Systemic inflammatory response syndrome (SIRS) is a complex response to an insult such as major surgery or trauma. It is called sepsis syndrome, or simply sepsis, when infection is present. The generalized inflammatory reaction involves activation of leukocytes and endothelial cells and the release of inflammatory mediators and toxic oxygen free radicals. Diffuse microthrombosis can result in localized tissue perfusion abnormalities and low oxygenation (hypoxia). Both SIRS and sepsis can be difficult to treat and are major causes of multiple organ failure and the death of patients in the intensive care unit. SIRS and sepsis both lead to a drop in the level of antioxidants normally present in the body.</P>
<P>N-acetylcysteine is an antioxidant with strong anti-inflammatory effects that is used in treating endotoxaemia and overdoses of acetaminophen. This Cochrane review of 41 randomized controlled trials with 2768 critically ill adult patients found no evidence to support the theory that N-acetylcysteine might reduce the risk of death in adults with SIRS or sepsis. Intravenous N-acetylcysteine did not affect the length of stay in the intensive care unit, duration of mechanical ventilation, duration of support for the cardiovascular system or incidence of new organ failure. There is currently insufficient evidence to support the use of N-acetylcysteine in SIRS or sepsis. We also found that when N-acetylcysteine was administered more than 24 hours after the development of clinical signs of SIRS or sepsis it may even be harmful, by causing cardiovascular depression.</P>
<P>Twenty of the trials used N-acetylcysteine in patients around the time of surgery, including cardiac, vascular and major abdominal surgery, and liver transplantation. Eight studies evaluated N-acetylcysteine in patients with severe sepsis or septic shock associated with the medical conditions acute respiratory distress syndrome (ARDS), multiple organ failure, liver failure, malaria or burns. The dosing of N-acetylcysteine, timing and duration of treatment, from a single intravenous dose to infusions up to seven days, varied. Twenty papers had a low risk of bias.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2012-07-29 12:11:05 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2012-07-29 12:11:05 +0100" MODIFIED_BY="[Empty name]">
<P>Death is common in systemic inflammatory response syndrome (SIRS) or sepsis-induced multisystem organ failure and it has been thought that antioxidants such as N-acetylcysteine could be beneficial.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2012-07-29 11:50:01 +0100" MODIFIED_BY="[Empty name]">
<P>We assessed the clinical effectiveness of intravenous N-acetylcysteine for the treatment of patients with SIRS or sepsis.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2012-07-29 11:52:42 +0100" MODIFIED_BY="Jane Cracknell">
<P>We searched the following databases: Cochrane Central Register of Clinical Trials (CENTRAL) (<I>The Cochrane Librar</I>y 2011, Issue 12); MEDLINE (January 1950 to January 2012); EMBASE (January 1980 to January 2012); CINAHL (1982 to January 2012); the NHS Trusts Clinical Trials Register and Current Controlled Trials (www.controlled-trials.com); LILACS; KoreaMED; MEDCARIB; INDMED; PANTELEIMON; Ingenta; ISI Web of Knowledge and the National Trials Register to identify all relevant randomized controlled trials available for review.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2010-01-08 11:33:33 +0000" MODIFIED_BY="[Empty name]">
<P>We included only randomized controlled trials (RCTs) in the meta-analysis.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2012-07-29 11:53:40 +0100" MODIFIED_BY="[Empty name]">
<P>We independently performed study selection, quality assessment and data extraction. We estimated risk ratios (RR) for dichotomous outcomes. We measured statistical heterogeneity using the I<SUP>2 </SUP>statistic.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2012-07-29 11:58:19 +0100" MODIFIED_BY="[Empty name]">
<P>We included 41 fully published studies (2768 patients). Mortality was similar in the N-acetylcysteine group and the placebo group (RR 1.06, 95% CI 0.79 to 1.42; I<SUP>2 </SUP>= 0%). Neither did N-acetylcysteine show any significant effect on length of stay, duration of mechanical ventilation or incidence of new organ failure. Early application of N-acetylcysteine to prevent the development of an oxidato-inflammatory response did not affect the outcome, nor did late application that is after 24 hours of developing symptoms. Late application was associated with cardiovascular instability.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2012-07-29 12:00:32 +0100" MODIFIED_BY="[Empty name]">
<P>Overall, this meta-analysis puts doubt on the safety and utility of intravenous N-acetylcysteine as an adjuvant therapy in SIRS and sepsis. At best, N-acetylcysteine is ineffective in reducing mortality and complications in this patient population. At worst, it can be harmful, especially when administered later than 24 hours after the onset of symptoms, by causing cardiovascular depression. Unless future RCTs provide evidence of treatment effect, clinicians should not routinely use intravenous N-acetylcysteine in SIRS or sepsis and academics should not promote its use.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2012-08-06 10:45:48 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2012-07-29 12:27:32 +0100" MODIFIED_BY="[Empty name]">
<P>There is an increasing incidence of systemic inflammatory response syndrome (SIRS) and sepsis, and consequent multiple organ failure, especially in the developed world. Despite recent advances in antibacterial and other therapies the mortality rate only shows a slow decline (<LINK REF="REF-Engel-2007" TYPE="REFERENCE">Engel 2007</LINK>).</P>
<CONDITION MODIFIED="2012-07-29 12:12:48 +0100" MODIFIED_BY="[Empty name]">
<P>Since the discovery of oxygen free radicals about 30 years ago there has been a growing interest in their role in inflammatory diseases (<LINK REF="REF-Crimi-2006" TYPE="REFERENCE">Crimi 2006</LINK>). Although the pathophysiology of systemic inflammatory response syndrome (SIRS) and sepsis is complex, and only partially understood, it has been proposed that following an insult, such as trauma, systemic infection or major surgery, the development of multiple organ failure is due to a generalized inflammatory reaction involving activation of leukocytes and endothelial cells and the release of inflammatory mediators and toxic oxygen free radicals of both intracellular and extracellular origin (<LINK REF="REF-Pinsky-2003" TYPE="REFERENCE">Pinsky 2003</LINK>). Another important mechanism of sepsis-induced organ failure is diffuse microthrombosis, resulting in locoregional abnormalities of tissue perfusion and tissue hypoxia. In patients affected by mild-to-moderate organ dysfunction there is an imbalance between oxidant and antioxidant forces, and it has been suggested that in multiple organ failure there is an overwhelming production of oxygen free radicals that results in tissue destruction (<LINK REF="REF-Goode-1995" TYPE="REFERENCE">Goode 1995</LINK>). Several studies have demonstrated decreased concentrations of plasma antioxidants in septic patients and those in multiple organ failure as they try to combat the increased production of free radicals (<LINK REF="REF-Cowley-1996" TYPE="REFERENCE">Cowley 1996</LINK>; <LINK REF="REF-Goode-1995" TYPE="REFERENCE">Goode 1995</LINK>; <LINK REF="REF-Ogilvie-1991" TYPE="REFERENCE">Ogilvie 1991</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2012-07-29 12:15:48 +0100" MODIFIED_BY="[Empty name]">
<P>Similar protection against free radical mediated injury to the endogenous mechanisms might be achieved by using exogenous agents such as N-acetylcysteine, which has been used clinically for nearly 40 years. Historically it has been administered for chronic bronchitis, cystic fibrosis and paracetamol intoxication (<LINK REF="REF-Kiefer-2000" TYPE="REFERENCE">Kiefer 2000</LINK>; <LINK REF="REF-Pinsky-2003" TYPE="REFERENCE">Pinsky 2003</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2012-07-29 12:27:32 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine acts as a powerful oxygen free radical scavenger and also replenishes depleted glutathione stores, enhancing the endogenous antioxidant defence (<LINK REF="REF-Aruoma-1989" TYPE="REFERENCE">Aruoma 1989</LINK>; <LINK REF="REF-Repine-1992" TYPE="REFERENCE">Repine 1992</LINK>). It also has a powerful anti-inflammatory effect when given as a pre- and post-treatment in endotoxaemia (<LINK REF="REF-Schmidt-1997" TYPE="REFERENCE">Schmidt 1997</LINK>; <LINK REF="REF-Schmidt-1998" TYPE="REFERENCE">Schmidt 1998</LINK>). In experimental animal studies N-acetylcysteine was administered before induction of sepsis with endotoxin infusion (<LINK REF="REF-Hsu-2004" TYPE="REFERENCE">Hsu 2004</LINK>; <LINK REF="REF-Zhang-1994a" TYPE="REFERENCE">Zhang 1994a</LINK>). These studies suggested that timing of the treatment was important. In previous in vitro and in vivo studies N-acetylcysteine treatment attenuated TNF and IL-8 production and enhanced oxygen extraction in septic shock, severe multiple organ failure and acute respiratory distress syndrome (ARDS) (<LINK REF="STD-Paterson-2003" TYPE="STUDY">Paterson 2003</LINK>; <LINK REF="REF-Peristeris-1992" TYPE="REFERENCE">Peristeris 1992</LINK>; <LINK REF="STD-Spapen-1998" TYPE="STUDY">Spapen 1998</LINK>). Many authors have proposed the use of exogenous agents such as N-acetylcysteine to prevent oxygen free radical damage in patients suffering from septic shock (<LINK REF="STD-Spies-1994" TYPE="STUDY">Spies 1994</LINK>; <LINK REF="REF-Zhang-1994b" TYPE="REFERENCE">Zhang 1994b</LINK>). Despite the theoretical advantages, the benefit of N-acetylcysteine remains controversial in critically ill patients (<LINK REF="REF-Henderson-1994" TYPE="REFERENCE">Henderson 1994</LINK>; <LINK REF="REF-Pinsky-2003" TYPE="REFERENCE">Pinsky 2003</LINK>). Molnar found that early treatment with N-acetylcysteine (within 24 hours of hospital admission) may improve mortality in a subgroup of patients from a heterogeneous intensive care population (<LINK REF="STD-Molnar-1999" TYPE="STUDY">Molnar 1999</LINK>). On the other hand, recent randomized placebo-controlled studies in patients with ARDS and early septic shock or SIRS found no significant differences in gas exchange, development of ARDS, inflammatory response and mortality in patients treated with N-acetylcysteine or placebo (<LINK REF="STD-Domenighetti-1997" TYPE="STUDY">Domenighetti 1997</LINK>; <LINK REF="STD-Spapen-2005" TYPE="STUDY">Spapen 2005</LINK>; <LINK REF="STD-Szakmany-2003" TYPE="STUDY">Szakmany 2003</LINK>). Furthermore, several papers reported conflicting and undesirable effects of N-acetylcysteine administration. Depressed cardiac performance was found in septic patients and impaired bacterial killing due to augmented neutrophil phagocytosis was reported in animals and humans (<LINK REF="STD-Heller-2001" TYPE="STUDY">Heller 2001</LINK>; <LINK REF="REF-Koch-1996" TYPE="REFERENCE">Koch 1996</LINK>; <LINK REF="STD-Peake-1996" TYPE="STUDY">Peake 1996</LINK>). Late administration of N-acetylcysteine was associated with an adverse outcome in experimental and clinical sepsis (<LINK REF="STD-Molnar-1999" TYPE="STUDY">Molnar 1999</LINK>; <LINK REF="REF-Vassilev-2004" TYPE="REFERENCE">Vassilev 2004</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2011-03-02 22:30:10 +0000" MODIFIED_BY="[Empty name]">
<P>Although many clinical trials have investigated its effect, the value of N-acetylcysteine administration in the critically ill has not been assessed in a systematic review.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2012-07-29 12:28:12 +0100" MODIFIED_BY="[Empty name]">
<P>Our aim was to critically appraise and summarize all randomized clinical trials involving intravenous N-acetylcysteine administration in adult patients suffering from sepsis and SIRS.</P>
<P>We wanted to answer the question: does N-acetylcysteine influence the outcome in sepsis or SIRS?</P>
<P>Our primary objective was to investigate whether intravenous N-acetylcysteine has any effect on the 30-day all-cause mortality.</P>
</OBJECTIVES>
<METHODS MODIFIED="2012-07-29 13:11:16 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2012-07-29 12:40:36 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2012-07-29 12:28:42 +0100" MODIFIED_BY="Jane Cracknell">
<P>We included only randomized controlled trials (RCTs) in the meta-analysis. No cross-over or quasi-randomization designs were allowed.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2012-07-29 12:33:46 +0100" MODIFIED_BY="[Empty name]">
<P>We included trials involving participants with SIRS and sepsis according to the Bone criteria (<LINK REF="REF-Bone-1992" TYPE="REFERENCE">Bone 1992</LINK>), regardless of the underlying cause. If the authors of the study did not specify that they used the Bone criteria, we have assessed the study to determine if the inclusion criteria were in line with the published SIRS or sepsis definition.</P>
<P>We only included trials conducted in adult patient populations. There are at least three important differences between adult and paediatric sepsis, which would make grouping of the data confusing. First, the causes of sepsis may be substantially different, with viral infections contributing a large proportion of the sepsis cases. Second, the risk for paediatric sepsis is almost exclusively in children with chronic comorbid medical conditions, such as chronic lung disease. Third, case-fatality rates are substantially lower in children than in adults, although the risk of death is similar between children and young adults.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2012-07-29 12:36:49 +0100" MODIFIED_BY="[Empty name]">
<P>We included studies where one of the groups was treated with intravenous N-acetylcysteine in bolus intravenous doses or as a continuous infusion, or a combination of the two. We included studies if intravenous N-acetylcysteine was compared with placebo or standard treatment. Placebo was considered if a similar composition and volume of fluid was administered without the active ingredient; standard treatment was considered if the patient received standard care without the administration of N-acetylcysteine.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2012-07-29 12:40:36 +0100" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2011-03-02 22:23:44 +0000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Our principal outcome measure was 30-day all-cause mortality.</LI>
<LI>Overall mortality: we used the longest follow-up data from each trial regardless of the period of follow up.</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2012-07-29 12:40:36 +0100" MODIFIED_BY="[Empty name]">
<P>1. Length of stay in the critical care unit.<BR/>2. Duration of mechanical ventilation.<BR/>3. Duration of inotropic support.<BR/>4. Incidence of new organ failures, such as:<BR/>a) acute renal failure;<BR/>b) ARDS;<BR/>c) liver failure;<BR/>d) circulatory failure;<BR/>5. quality of life;<BR/>6. cost.</P>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2012-07-29 12:45:38 +0100" MODIFIED_BY="[Empty name]">
<P>We used several techniques to identify published and ongoing studies for this review. We included all relevant published studies regardless of the language.</P>
<ELECTRONIC_SEARCHES MODIFIED="2012-07-29 12:44:28 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the following databases: Cochrane Central Register of Clinical Trials (CENTRAL) (<I>The Cochrane Librar</I>y 2011, Issue 12); MEDLINE (January 1950 to January 2012); EMBASE (January 1980 to January 2012); CINAHL (1982 to January 2012); the NHS Trusts Clinical Trials Register and Current Controlled Trials (<A HREF="http://www.controlled-trials.com">www.controlled-trials.com</A>); LILACS; KoreaMED; MEDCARIB; INDMED; PANTELEIMON; Ingenta; ISI Web of Knowledge and the National Trials Register to identify all relevant randomized controlled trials available for review. We used the SilverPlatter MEDLINE and the Ovid version of all other databases.</P>
<P>We searched MEDLINE using the strategy detailed in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>. We modified this search strategy as necessary and applied it to the CENTRAL (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>), CINAHL (<LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>) and EMBASE databases as well. We applied the search strategy detailed in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> to the LILACS, KoreaMED, MEDCARIB, INDMED, PANTELEIMON, CCT, Ingenta, ISI Web of Knowledge and National Trials Register databases.</P>
<P>We utilized the Cochrane highly sensitive RCT filter for MEDLINE from the <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<P>We identified relevant studies initially by title then by abstract and finally by full text. Two authors (TSZ and BH) independently performed the electronic searches.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2012-07-29 12:45:38 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the bibliographies of reports of randomized trials and any identified reviews.</P>
<P>We also searched for abstracts from conference proceedings published from 1994 to December 2011 in the <I>American Journal of Respiratory and Critical Care Medicine</I>, <I>Chest</I>, <I>Critical Care Medicine</I> and <I>Intensive Care Medicine</I>.</P>
<P>We contacted the authors of all identified trials to ask them about any other published or unpublished trials that may have been conducted.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2012-07-29 13:11:16 +0100" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2012-07-29 12:46:34 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="5">
<I>Selection of trials</I>
</HEADING>
<P>Two authors (BH, TSZ) independently reviewed the titles and abstracts identified from the searches. We obtained full copies of potentially relevant trials and assessed all full copies according to the parameters outlined in '<LINK TAG="SELECTION_CRITERIA" TYPE="SECTION">Criteria for considering studies for this review</LINK>'. Only eligible trials were considered for inclusion in the meta-analysis. The authors resolved any discrepancies by discussion, if necessary.</P>
</SUBSECTION>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2012-07-29 12:47:50 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="5">
<I>Data collection</I>
</HEADING>
<P>Two authors (BH, TSZ) independently extracted data using a form modified from one developed by the Cochrane Anaesthesia Review Group. We (as far as possible) extracted data on the basis of an intention-to-treat analysis. Two authors (BH and TSZ) entered all data independently into Review Manager (<LINK REF="REF-RevMan-5.1" TYPE="REFERENCE">RevMan 5.1</LINK>) after checking for differences.</P>
</SUBSECTION>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2012-07-29 12:51:48 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="5">
<I>Assessment of methodological quality</I>
</HEADING>
<P>We evaluated the validity and design characteristics of each trial. To draw conclusions about the overall risk of bias for an outcome it was necessary to evaluate the trials for major sources of bias, also defined as domains (random sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting, and other sources of bias). The Cochrane Collaboration&#8217;s recommended tool for assessing risk of bias is neither a scale nor a checklist, but rather the domain-based evaluation. Any assessment of the overall risk of bias involves consideration of the relative importance of the different domains (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).<BR/>
</P>
<P>We assessed the methodological quality of the included studies according to the Cochrane Collaboration's tool for assessing risk of bias.</P>
<P>We assessed the studies for bias based on the following criteria:</P>
<UL>
<LI>random sequence generation;</LI>
</UL>
<UL>
<LI>allocation concealment;</LI>
</UL>
<UL>
<LI>blinding of participants, personnel and outcome assessors;</LI>
</UL>
<UL>
<LI>incomplete outcome data;</LI>
</UL>
<UL>
<LI>selective reporting;</LI>
</UL>
<UL>
<LI>other bias.</LI>
</UL>
<P>We have generated a risk of bias tables for each included trial (<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>). </P>
<P>We defined the trials as having low risk of bias only if they adequately fulfilled the criteria listed in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I>. We performed summary assessments of the risk of bias for each important outcome (across domains) within and across studies. We applied a 'Risk of bias' graph (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>) and a 'Risk of bias' summary figure (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>).</P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2012-07-29 12:54:18 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="6">Dichotomous data</HEADING>
<P>We summarized dichotomous data using risks ratio (RR) as the summary estimate of treatment effect with 95% confidence interval (CI).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Continuous data </HEADING>
<P>We summarized continuous outcomes using the mean difference (MD). For data reported using different scales which cannot be converted to a uniform scale, we used the standardized mean difference (SMD). If the mean and SD of the continuous outcomes were not reported in the studies, we assigned the median as the mean if sample size was greater than 25 and estimated the SD from the range (that is, SD range 0.95/4 or interquartile range/1.35) as suggested by Hozo et al (<LINK REF="REF-Hozo-2005" TYPE="REFERENCE">Hozo 2005</LINK>). If sample size was less than 25 we used formulaes suggested by Hozo et al to calculate the mean (<LINK REF="REF-Hozo-2005" TYPE="REFERENCE">Hozo 2005</LINK>). If we could not calculate the mean and SD from the available data, we excluded the study from the analysis.</P>
</SUBSECTION>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2012-07-29 12:55:51 +0100" MODIFIED_BY="[Empty name]">
<P>In trials where more than two treatment arms were present, using a different dosage of N-acetylcysteine, we divided the control group into several parts so that the total numbers add up to the original size of the group.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2012-07-29 13:00:34 +0100" MODIFIED_BY="[Empty name]">
<P>We contacted all the first authors and contact persons of the trials with missing data in order to retrieve the relevant data.</P>
<P>Intention-to-treat analysis is recommended in order to minimize bias in design, follow up, and analysis of the efficacy of randomized clinical trials. It gives a pragmatic estimate of the benefit of a change in treatment policy rather than of the potential benefit in patients who receive treatment exactly as planned (<LINK REF="REF-Hollis-1999" TYPE="REFERENCE">Hollis 1999</LINK>). Full application of intention to treat is possible only when complete outcome data are available for all randomized participants. Despite the fact that about half of all published reports of randomized controlled trials state that Intention-to-treat analysis is used, handling of deviations from randomized allocation varies widely and many trials have missing data for the primary outcome variable. Methods used to deal with this are generally inadequate, potentially leading to bias (<LINK REF="REF-Hollis-1999" TYPE="REFERENCE">Hollis 1999</LINK>).</P>
<P>Performing an Intention-to-treat analysis in a systematic review is not straightforward in practice since review authors must decide how to handle outcome data that are missing in the contributing trials. No consensus exists about how missing data should be handled in intention-to-treat analyses, and different approaches may be appropriate in different situations (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>; <LINK REF="REF-Hollis-1999" TYPE="REFERENCE">Hollis 1999</LINK>). In the case of missing data we chose 'complete-case analysis' for our primary outcomes, which simply excludes from the analysis all participants with the outcome missing.</P>
<P>Selective outcome reporting occurs when non-significant results are selectively withheld from publication. It is defined as selection on the basis of the results of a subset of the original variables recorded for inclusion in the publication of trials. The most important types of selective outcome reporting are: selective omission of outcomes from reports; selective choice of data for an outcome; selective reporting of analyses using the same data; selective reporting of subsets of the data; and selective under-reporting of data (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). Statistical methods to detect within-study selective reporting are still in their infant stage. We chose to explore selective outcome reporting by comparing publications with their protocols, if the latter were available.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2012-07-29 13:01:54 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="6">Clinical heterogeneity</HEADING>
<P>We used the term 'clinical heterogeneity' to describe clinical differences in the studies to do with the participants, interventions and outcomes. We based the decision to pool studies on the absence of clinical heterogeneity. We assessed clinical heterogeneity by judgment. We based these judgments on patient demographics, clinical circumstances and the comparability of the interventions applied.</P>
</SUBSECTION>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2012-07-29 13:04:00 +0100" MODIFIED_BY="Jane Cracknell">
<P>If sufficient studies were identified we constructed funnel plots (trial effect versus standard error) to assess for possible publication bias, expressed by asymmetry (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>). In the case of asymmetry we chose to apply the Arcsine-Thompsen test, as proposed by Rücker (<LINK REF="REF-R_x00fc_cker-2008" TYPE="REFERENCE">Rücker 2008</LINK>).</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2012-07-29 13:05:58 +0100" MODIFIED_BY="[Empty name]">
<P>Patients admitted to the intensive care unit (ICU) are a heterogenous group in terms of admitting diagnosis, prognosis and resource use. This heterogeneity not only exist between individual patients in a single critical care unit but also in the case-mix of patients admitted to different units. Whilst acknowledging this heterogeneity we decided to pool all studies together and perform individual sensitivity analyses to evaluate if there was any difference between the groups.</P>
<P>We pooled data using either the random-effects model (REM) or fixed-effect model (FEM) depending on the presence or absence of statistical heterogeneity. Risk ratios (RR) were pooled using the Mantel-Hansen (M-H) method. If there were many &#8216;zeros&#8217; the Peto method was considered. The mean difference (MD) for continuous data was analysed using the inverse variance method. We used <LINK REF="REF-RevMan-5.1" TYPE="REFERENCE">RevMan 5.1</LINK> for all analyses.<I>
<BR/>
</I>
</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2012-07-29 13:10:13 +0100" MODIFIED_BY="Jane Cracknell">
<P>We performed stratified meta-analyses, using all available mortality data only, to investigate the influence of:<BR/>1. sepsis versus SIRS;<BR/>2. aetiology of critical illness (medical versus surgical studies);<BR/>3. delay of administration of N-acetylcysteine (less than 24 hours versus more than 24 hours from the first documented signs of SIRS or sepsis).<BR/>
</P>
<P>Conduct of the proposed subgroup analyses, defined a priori, was 'hypothesis generating'. We expected that all subgroup analyses would be underpowered and we viewed these as exploratory given their propensity to generate misleading conclusions (<LINK REF="REF-Oxman-1992" TYPE="REFERENCE">Oxman 1992</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="6">Statistical heterogeneity</HEADING>
<P>We conducted an evaluation of the heterogeneity of the data using the I<SUP>2</SUP> statistic (<LINK REF="REF-Higgins-2002" TYPE="REFERENCE">Higgins 2002</LINK>), which is a statistic that describes the proportion of variation in point estimates that is attributable to heterogeneity as opposed to sampling error. We decided a priori that in the case where the assumption of homogeneity was rejected for any endpoint (I<SUP>2</SUP> &gt; 50%) a random-effects model would be applied to estimate the variance component associated with between-study variation for that endpoint. According to this method, the variance for each individual study in the meta-analysis is the sum of within- and between-study components of the variance. We also decided a priori not to pool the data if the I<SUP>2</SUP> statistic indicated significant heterogeneity (I<SUP>2 </SUP>&gt; 80%).</P>
</SUBSECTION>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2012-07-29 13:11:16 +0100" MODIFIED_BY="[Empty name]">
<P>1. Comparing estimates of the pooled intervention effect in trials with low risk of bias to estimates from trials with high risk of bias (i.e. trials having at least one inadequate risk of bias component).</P>
<P>2. Comparing estimates of the pooled intervention effect in trials based on the different components of risk of bias (random sequence generation, allocation concealment, blinding).</P>
<P>We calculated RR with 95% CI, if possible, for our sensitivity and subgroup analyses based on our primary outcome measure (mortality).</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2012-07-30 10:23:56 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2012-07-29 13:20:54 +0100" MODIFIED_BY="Jane Cracknell">
<P>See: <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>; <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>
</P>
<P>We identified 6983 potential studies in the initial electronic search. One potential study was identified during a Google search. No additional studies were identified by contacting experts in the field or relevant pharmaceutical companies, or by searching personal reference databases of the authors or steering group. No additional studies were identified following screening of reference lists of potentially eligible studies and previously published systematic reviews (snowballing). See <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK> for our search results.</P>
<SEARCH_RESULTS MODIFIED="2012-03-27 23:47:38 +0100" MODIFIED_BY="[Empty name]">
<P>We identified 73 potentially eligible studies following screening of abstracts of potential studies (BH, TSZ). We found no ongoing trials. The two review authors (BH, TSZ) completely agreed on the selection of included studies. We obtained no additional information from the primary authors.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2012-07-29 13:19:12 +0100" MODIFIED_BY="Jane Cracknell">
<P>We included 41 fully published studies (including 2768 patients). A detailed summary of each included study, including patient characteristics and the N-acetylcysteine dosing regimens used, can be found in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>. The included studies were conducted between 1991 and 2009.</P>
<P>All studies used intravenous N-acetylcysteine but two studies used oral N-acetylcysteine preoperatively then intravenous N-acetylcysteine intraoperatively (<LINK REF="STD-El_x002d_Hamamsy-2007" TYPE="STUDY">El-Hamamsy 2007</LINK>; <LINK REF="STD-Macedo-2006" TYPE="STUDY">Macedo 2006</LINK>). Twenty studies evaluated the use of N-acetylcysteine perioperatively, 15 during cardiac surgery (<LINK REF="STD-Andersen-2005" TYPE="STUDY">Andersen 2005</LINK>; <LINK REF="STD-Burns-2005" TYPE="STUDY">Burns 2005</LINK>; <LINK REF="STD-De-Backer-1996" TYPE="STUDY">De Backer 1996</LINK>; <LINK REF="STD-El_x002d_Hamamsy-2007" TYPE="STUDY">El-Hamamsy 2007</LINK>; <LINK REF="STD-Eren-2003" TYPE="STUDY">Eren 2003</LINK>; <LINK REF="STD-Haase-2007" TYPE="STUDY">Haase 2007</LINK>; <LINK REF="STD-Orhan-2006" TYPE="STUDY">Orhan 2006</LINK>; <LINK REF="STD-Ozaydin-2008" TYPE="STUDY">Ozaydin 2008</LINK>; <LINK REF="STD-Peker-2008" TYPE="STUDY">Peker 2008</LINK>; <LINK REF="STD-Ristikankare-2006" TYPE="STUDY">Ristikankare 2006</LINK>; <LINK REF="STD-Sisillo-2008" TYPE="STUDY">Sisillo 2008</LINK>; <LINK REF="STD-Spies-1996" TYPE="STUDY">Spies 1996</LINK>; <LINK REF="STD-Sucu-2004" TYPE="STUDY">Sucu 2004</LINK>; <LINK REF="STD-Tossios-2003" TYPE="STUDY">Tossios 2003</LINK>; <LINK REF="STD-Wijeysundera-2007" TYPE="STUDY">Wijeysundera 2007</LINK>); three during liver transplantation (<LINK REF="STD-Bromley-1995" TYPE="STUDY">Bromley 1995</LINK>; <LINK REF="STD-Hilmi-2010" TYPE="STUDY">Hilmi 2010</LINK>; <LINK REF="STD-Steib-1998" TYPE="STUDY">Steib 1998</LINK>; <LINK REF="STD-Hilmi-2010" TYPE="STUDY">Hilmi 2010</LINK>); two in vascular surgery (<LINK REF="STD-Hynninen-2006" TYPE="STUDY">Hynninen 2006</LINK>; <LINK REF="STD-Macedo-2006" TYPE="STUDY">Macedo 2006</LINK>) and one after major abdominal surgery (<LINK REF="STD-Szakmany-2003" TYPE="STUDY">Szakmany 2003</LINK>). Eight studies used N-acetylcysteine in patients with severe sepsis or septic shock (<LINK REF="STD-Emet-2004" TYPE="STUDY">Emet 2004</LINK>; <LINK REF="STD-Ortolani-2000b" TYPE="STUDY">Ortolani 2000b</LINK>; <LINK REF="STD-Paterson-2003" TYPE="STUDY">Paterson 2003</LINK>; <LINK REF="STD-Peake-1996" TYPE="STUDY">Peake 1996</LINK>; <LINK REF="STD-Rank-2000" TYPE="STUDY">Rank 2000</LINK>; <LINK REF="STD-Spapen-1998" TYPE="STUDY">Spapen 1998</LINK>; <LINK REF="STD-Spapen-2005" TYPE="STUDY">Spapen 2005</LINK>; <LINK REF="STD-Spies-1994" TYPE="STUDY">Spies 1994</LINK>); five in ARDS (<LINK REF="STD-Bernard-1997" TYPE="STUDY">Bernard 1997</LINK>; <LINK REF="STD-Domenighetti-1997" TYPE="STUDY">Domenighetti 1997</LINK>; <LINK REF="STD-Jepsen-1992" TYPE="STUDY">Jepsen 1992</LINK>; <LINK REF="STD-Moradi-2009" TYPE="STUDY">Moradi 2009</LINK>; <LINK REF="STD-Suter-1994" TYPE="STUDY">Suter 1994</LINK>); two in multiple organ failure (<LINK REF="STD-Burns-2010" TYPE="STUDY">Burns 2010</LINK>; <LINK REF="STD-Molnar-1999" TYPE="STUDY">Molnar 1999</LINK>); three in fulminant liver failure (<LINK REF="STD-Keays-1991" TYPE="STUDY">Keays 1991</LINK>; <LINK REF="STD-Lee-2009" TYPE="STUDY">Lee 2009</LINK>; <LINK REF="STD-Walsh-1998" TYPE="STUDY">Walsh 1998</LINK>), one in malaria (<LINK REF="STD-Charunwatthana-2009" TYPE="STUDY">Charunwatthana 2009</LINK>) and one in burns (<LINK REF="STD-Csontos-2011" TYPE="STUDY">Csontos 2011</LINK>). There was a wide variety in the N-acetylcysteine dose regime used, which ranged from 25 mg/kg to 150 mg/kg. Timing and duration of N-acetylcysteine treatment varied considerably, from single bolus dose to infusions up to seven days. In one trial (<LINK REF="STD-Ortolani-2000b" TYPE="STUDY">Ortolani 2000b</LINK>) N-acetylcysteine was compared to rutin and placebo. We only report the data for the N-acetylcysteine and placebo groups from this trial. Three trials compared N-acetylcysteine with no treatment (<LINK REF="STD-Csontos-2011" TYPE="STUDY">Csontos 2011</LINK>; <LINK REF="STD-Macedo-2006" TYPE="STUDY">Macedo 2006</LINK>; <LINK REF="STD-Orhan-2006" TYPE="STUDY">Orhan 2006</LINK>). Other clinical outcome variables in line with our defined primary and secondary outcomes were inconsistently reported.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2012-07-29 13:20:54 +0100" MODIFIED_BY="[Empty name]">
<P>We excluded 32 potentially relevant publications (<LINK REF="STD-Adabag-2008" TYPE="STUDY">Adabag 2008</LINK>; <LINK REF="STD-Agusti-1997" TYPE="STUDY">Agusti 1997</LINK>; <LINK REF="STD-Barr-2008" TYPE="STUDY">Barr 2008</LINK>; <LINK REF="STD-Csontos-2011" TYPE="STUDY">Csontos 2011</LINK>; <LINK REF="STD-Csontos-2011b" TYPE="STUDY">Csontos 2011b</LINK>; <LINK REF="STD-De-Rosa-2000" TYPE="STUDY">De Rosa 2000</LINK>; <LINK REF="STD-Devlin-1997" TYPE="STUDY">Devlin 1997</LINK>; <LINK REF="STD-Fischer-2005" TYPE="STUDY">Fischer 2005</LINK>; <LINK REF="STD-Fraga-2011" TYPE="STUDY">Fraga 2011</LINK>; <LINK REF="STD-Haase-2008" TYPE="STUDY">Haase 2008</LINK>; <LINK REF="STD-Heller-2001" TYPE="STUDY">Heller 2001</LINK>; <LINK REF="STD-Jepsen-1989" TYPE="STUDY">Jepsen 1989</LINK>; <LINK REF="STD-Koksal-2008" TYPE="STUDY">Koksal 2008</LINK>; <LINK REF="STD-Komisarof-2007" TYPE="STUDY">Komisarof 2007</LINK>; <LINK REF="STD-Koramaz-2006" TYPE="STUDY">Koramaz 2006</LINK>; <LINK REF="STD-Kurian-2010" TYPE="STUDY">Kurian 2010</LINK>; <LINK REF="STD-Laurent-1996" TYPE="STUDY">Laurent 1996</LINK>; <LINK REF="STD-Lawlor-2007" TYPE="STUDY">Lawlor 2007</LINK>; <LINK REF="STD-Milewski-2006" TYPE="STUDY">Milewski 2006</LINK>; <LINK REF="STD-Molnar-1998" TYPE="STUDY">Molnar 1998</LINK>; <LINK REF="STD-Molnar-2003" TYPE="STUDY">Molnar 2003</LINK>; <LINK REF="STD-Najafi-2009" TYPE="STUDY">Najafi 2009</LINK>; <LINK REF="STD-Niemi-2006" TYPE="STUDY">Niemi 2006</LINK>; <LINK REF="STD-Ortolani-2000a" TYPE="STUDY">Ortolani 2000a</LINK>; <LINK REF="STD-Reinhart-1995" TYPE="STUDY">Reinhart 1995</LINK>; <LINK REF="STD-Sahib-2010" TYPE="STUDY">Sahib 2010</LINK>; <LINK REF="STD-Saricaoglu-2005" TYPE="STUDY">Saricaoglu 2005</LINK>; <LINK REF="STD-Siriwardena-2007" TYPE="STUDY">Siriwardena 2007</LINK>; <LINK REF="STD-Soltan_x002d_Sharifi-2007" TYPE="STUDY">Soltan-Sharifi 2007</LINK>; <LINK REF="STD-Spies-1993" TYPE="STUDY">Spies 1993</LINK>; <LINK REF="STD-Szakmany-2002" TYPE="STUDY">Szakmany 2002</LINK>; <LINK REF="STD-Wijeysundera-2009" TYPE="STUDY">Wijeysundera 2009</LINK>; <LINK REF="STD-Zingg-2007" TYPE="STUDY">Zingg 2007</LINK>). The reasons for their exclusion are summarized in <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2012-07-30 10:23:50 +0100" MODIFIED_BY="[Empty name]">
<P>We have identified 20 papers with low risk of bias. For a more detailed description of individual trial qualities, see the table <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>. The various bias domains are presented in the 'Risk of bias' graph and a 'Risk of bias' summary figure (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>; <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>).</P>
<ALLOCATION MODIFIED="2012-07-29 13:23:29 +0100" MODIFIED_BY="[Empty name]">
<P>Random sequence generation was adequately reported in 24 trials (<LINK REF="STD-Bernard-1997" TYPE="STUDY">Bernard 1997</LINK>; <LINK REF="STD-Burns-2005" TYPE="STUDY">Burns 2005</LINK>; <LINK REF="STD-Burns-2010" TYPE="STUDY">Burns 2010</LINK>; <LINK REF="STD-Charunwatthana-2009" TYPE="STUDY">Charunwatthana 2009</LINK>; <LINK REF="STD-Emet-2004" TYPE="STUDY">Emet 2004</LINK>; <LINK REF="STD-Haase-2007" TYPE="STUDY">Haase 2007</LINK>; <LINK REF="STD-Hilmi-2010" TYPE="STUDY">Hilmi 2010</LINK>; <LINK REF="STD-Hynninen-2006" TYPE="STUDY">Hynninen 2006</LINK>; <LINK REF="STD-Keays-1991" TYPE="STUDY">Keays 1991</LINK>; <LINK REF="STD-Lee-2009" TYPE="STUDY">Lee 2009</LINK>; <LINK REF="STD-Molnar-1999" TYPE="STUDY">Molnar 1999</LINK>; <LINK REF="STD-Ozaydin-2008" TYPE="STUDY">Ozaydin 2008</LINK>; <LINK REF="STD-Paterson-2003" TYPE="STUDY">Paterson 2003</LINK>; <LINK REF="STD-Peake-1996" TYPE="STUDY">Peake 1996</LINK>; <LINK REF="STD-Ristikankare-2006" TYPE="STUDY">Ristikankare 2006</LINK>; <LINK REF="STD-Sisillo-2008" TYPE="STUDY">Sisillo 2008</LINK>; <LINK REF="STD-Spapen-1998" TYPE="STUDY">Spapen 1998</LINK>; <LINK REF="STD-Spapen-2005" TYPE="STUDY">Spapen 2005</LINK>; <LINK REF="STD-Spies-1994" TYPE="STUDY">Spies 1994</LINK>; <LINK REF="STD-Spies-1996" TYPE="STUDY">Spies 1996</LINK>; <LINK REF="STD-Szakmany-2003" TYPE="STUDY">Szakmany 2003</LINK>; <LINK REF="STD-Tossios-2003" TYPE="STUDY">Tossios 2003</LINK>; <LINK REF="STD-Walsh-1998" TYPE="STUDY">Walsh 1998</LINK>; <LINK REF="STD-Wijeysundera-2007" TYPE="STUDY">Wijeysundera 2007</LINK>). Allocation concealment was adequately reported in 25 studies (<LINK REF="STD-Bernard-1997" TYPE="STUDY">Bernard 1997</LINK>; <LINK REF="STD-Burns-2005" TYPE="STUDY">Burns 2005</LINK>; <LINK REF="STD-Burns-2010" TYPE="STUDY">Burns 2010</LINK>; <LINK REF="STD-Charunwatthana-2009" TYPE="STUDY">Charunwatthana 2009</LINK>; <LINK REF="STD-Domenighetti-1997" TYPE="STUDY">Domenighetti 1997</LINK>; <LINK REF="STD-El_x002d_Hamamsy-2007" TYPE="STUDY">El-Hamamsy 2007</LINK>; <LINK REF="STD-Emet-2004" TYPE="STUDY">Emet 2004</LINK>; <LINK REF="STD-Haase-2007" TYPE="STUDY">Haase 2007</LINK>; <LINK REF="STD-Hilmi-2010" TYPE="STUDY">Hilmi 2010</LINK>; <LINK REF="STD-Hynninen-2006" TYPE="STUDY">Hynninen 2006</LINK>; <LINK REF="STD-Keays-1991" TYPE="STUDY">Keays 1991</LINK>; <LINK REF="STD-Lee-2009" TYPE="STUDY">Lee 2009</LINK>; <LINK REF="STD-Molnar-1999" TYPE="STUDY">Molnar 1999</LINK>; <LINK REF="STD-Ozaydin-2008" TYPE="STUDY">Ozaydin 2008</LINK>; <LINK REF="STD-Paterson-2003" TYPE="STUDY">Paterson 2003</LINK>; <LINK REF="STD-Peake-1996" TYPE="STUDY">Peake 1996</LINK>; <LINK REF="STD-Ristikankare-2006" TYPE="STUDY">Ristikankare 2006</LINK>; <LINK REF="STD-Spapen-1998" TYPE="STUDY">Spapen 1998</LINK>; <LINK REF="STD-Spapen-2005" TYPE="STUDY">Spapen 2005</LINK>; <LINK REF="STD-Spies-1994" TYPE="STUDY">Spies 1994</LINK>; <LINK REF="STD-Spies-1996" TYPE="STUDY">Spies 1996</LINK>; <LINK REF="STD-Suter-1994" TYPE="STUDY">Suter 1994</LINK>; <LINK REF="STD-Szakmany-2003" TYPE="STUDY">Szakmany 2003</LINK>; <LINK REF="STD-Tossios-2003" TYPE="STUDY">Tossios 2003</LINK>; <LINK REF="STD-Walsh-1998" TYPE="STUDY">Walsh 1998</LINK>; <LINK REF="STD-Wijeysundera-2007" TYPE="STUDY">Wijeysundera 2007</LINK>).</P>
</ALLOCATION>
<BLINDING MODIFIED="2012-07-30 10:23:50 +0100" MODIFIED_BY="[Empty name]">
<P>Thirty trials provided sufficient data to be categorized as double blinded (<LINK REF="STD-Bernard-1997" TYPE="STUDY">Bernard 1997</LINK>; <LINK REF="STD-Bromley-1995" TYPE="STUDY">Bromley 1995</LINK>; <LINK REF="STD-Burns-2005" TYPE="STUDY">Burns 2005</LINK>; <LINK REF="STD-Burns-2010" TYPE="STUDY">Burns 2010</LINK>; <LINK REF="STD-Charunwatthana-2009" TYPE="STUDY">Charunwatthana 2009</LINK>; <LINK REF="STD-Domenighetti-1997" TYPE="STUDY">Domenighetti 1997</LINK>; <LINK REF="STD-El_x002d_Hamamsy-2007" TYPE="STUDY">El-Hamamsy 2007</LINK>; <LINK REF="STD-Emet-2004" TYPE="STUDY">Emet 2004</LINK>; <LINK REF="STD-Eren-2003" TYPE="STUDY">Eren 2003</LINK>; <LINK REF="STD-Haase-2007" TYPE="STUDY">Haase 2007</LINK>; <LINK REF="STD-Hilmi-2010" TYPE="STUDY">Hilmi 2010</LINK>; <LINK REF="STD-Hynninen-2006" TYPE="STUDY">Hynninen 2006</LINK>; <LINK REF="STD-Jepsen-1992" TYPE="STUDY">Jepsen 1992</LINK>; <LINK REF="STD-Lee-2009" TYPE="STUDY">Lee 2009</LINK>; <LINK REF="STD-Molnar-1999" TYPE="STUDY">Molnar 1999</LINK>; <LINK REF="STD-Ozaydin-2008" TYPE="STUDY">Ozaydin 2008</LINK>; <LINK REF="STD-Paterson-2003" TYPE="STUDY">Paterson 2003</LINK>; <LINK REF="STD-Peake-1996" TYPE="STUDY">Peake 1996</LINK>; <LINK REF="STD-Peker-2008" TYPE="STUDY">Peker 2008</LINK>; <LINK REF="STD-Rank-2000" TYPE="STUDY">Rank 2000</LINK>; <LINK REF="STD-Ristikankare-2006" TYPE="STUDY">Ristikankare 2006</LINK>; <LINK REF="STD-Sisillo-2008" TYPE="STUDY">Sisillo 2008</LINK>; <LINK REF="STD-Spapen-1998" TYPE="STUDY">Spapen 1998</LINK>; <LINK REF="STD-Spapen-2005" TYPE="STUDY">Spapen 2005</LINK>; <LINK REF="STD-Spies-1994" TYPE="STUDY">Spies 1994</LINK>; <LINK REF="STD-Spies-1996" TYPE="STUDY">Spies 1996</LINK>; <LINK REF="STD-Suter-1994" TYPE="STUDY">Suter 1994</LINK>; <LINK REF="STD-Szakmany-2003" TYPE="STUDY">Szakmany 2003</LINK>; <LINK REF="STD-Tossios-2003" TYPE="STUDY">Tossios 2003</LINK>; <LINK REF="STD-Wijeysundera-2007" TYPE="STUDY">Wijeysundera 2007</LINK>). The remaining 11 trials were either open label or did not provided sufficient information about how double blinding was achieved (<LINK REF="STD-Andersen-2005" TYPE="STUDY">Andersen 2005</LINK>; <LINK REF="STD-Csontos-2011" TYPE="STUDY">Csontos 2011</LINK>; <LINK REF="STD-De-Backer-1996" TYPE="STUDY">De Backer 1996</LINK>; <LINK REF="STD-Keays-1991" TYPE="STUDY">Keays 1991</LINK>; <LINK REF="STD-Macedo-2006" TYPE="STUDY">Macedo 2006</LINK>; <LINK REF="STD-Moradi-2009" TYPE="STUDY">Moradi 2009</LINK>; <LINK REF="STD-Orhan-2006" TYPE="STUDY">Orhan 2006</LINK>; <LINK REF="STD-Ortolani-2000b" TYPE="STUDY">Ortolani 2000b</LINK>; <LINK REF="STD-Steib-1998" TYPE="STUDY">Steib 1998</LINK>; <LINK REF="STD-Sucu-2004" TYPE="STUDY">Sucu 2004</LINK>; <LINK REF="STD-Walsh-1998" TYPE="STUDY">Walsh 1998</LINK>).</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2012-07-29 13:25:41 +0100" MODIFIED_BY="[Empty name]">
<P>There was complete follow up in all trials except four for the primary outcome (<LINK REF="STD-De-Backer-1996" TYPE="STUDY">De Backer 1996</LINK>; <LINK REF="STD-Spapen-2005" TYPE="STUDY">Spapen 2005</LINK>; <LINK REF="STD-Spies-1996" TYPE="STUDY">Spies 1996</LINK>; <LINK REF="STD-Walsh-1998" TYPE="STUDY">Walsh 1998</LINK>). In these four trials the authors did not provide data on mortality nor on the length of follow up.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2012-07-29 13:27:34 +0100" MODIFIED_BY="[Empty name]">
<P>In one study we found evidence of the possibility of selective reporting. In this study the number of patients recruited to the treatment (17 patients) and placebo (10 patients) groups was very different. Furthermore three patients in the N-acetylcysteine group were excluded from the analysis, without reasonable explanation (<LINK REF="STD-Moradi-2009" TYPE="STUDY">Moradi 2009</LINK>). We were unable to retrieve the original protocols of the trials and thus were unable to examine selective outcome reporting, as described above. However, all but four trials provided data on our primary outcome of mortality (<LINK REF="STD-De-Backer-1996" TYPE="STUDY">De Backer 1996</LINK>; <LINK REF="STD-Spapen-2005" TYPE="STUDY">Spapen 2005</LINK>; <LINK REF="STD-Spies-1996" TYPE="STUDY">Spies 1996</LINK>; <LINK REF="STD-Walsh-1998" TYPE="STUDY">Walsh 1998</LINK>).</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2012-06-27 11:25:02 +0100" MODIFIED_BY="Jane Cracknell">
<P>The funnel plot of standard error versus risk ratio for 30-day mortality (<LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>) and the funnel plot for all reported mortality (<LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>) showed a symmetrical distribution that indicated no bias or publication bias. Since there was no asymmetry or heterogeneity in the funnel plot, we found no need to apply the Arcsine-Thompson test as proposed by Rücker (<LINK REF="REF-R_x00fc_cker-2008" TYPE="REFERENCE">Rücker 2008</LINK>).</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2012-07-30 10:23:56 +0100" MODIFIED_BY="[Empty name]">
<P>Eleven trials reported the primary outcome. Combining the data from these studies and applying complete-case analysis showed no statistically significant effect of N-acetylcysteine on 30-day all-cause mortality: 67/467 (14.35%) deaths in the N-acetylcysteine group compared with 63/463 (13.60%) deaths in the control group (RR 1.07, 95% CI 0.80 to 1.43; I<SUP>2 </SUP>= 0%) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). In combining the data from the 37 studies reporting mortality, using the longest reported follow-up data, mortality was similar: 223/1228 (18.16%) in the N-acetylcysteine group and 241/1233 (19.55%) in the placebo group (RR 0.94, 95% CI 0.81 to 1.09; I<SUP>2 </SUP>= 0%) (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="5">Sensitivity analysis - analysis of bias</HEADING>
<P>Comparing estimates of the pooled intervention effect based on the overall risk of bias (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>) (high risk of bias: 12 studies, 919 patients; low risk of bias: 17 studies, 1524 patients); on random sequence generation (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>) (adequate sequence generation: 20 studies, 1899 patients; inadequate or unclear sequence generation: 12 studies, 602 patients); on allocation concealment (<LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>) (adequate allocation concealment: 22 studies, 1835 patients; inadequate or unclear allocation concealment: 11 studies, 706 patients) or on blinding (<LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>) (adequate blinding: 25 studies, 2228 patients; inadequate or unclear blinding: 6 studies, 233 patients) did not result in any statistically significant finding in any of the subgroups examined.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Sensitivity analysis - analysis of follow-up time</HEADING>
<P>As the studies reported variable follow-up times we have pooled the trials in two groups, one reporting short follow-up time scales (less than 30 days) and one with a long follow-up time scale. We could not find any significant difference in reported mortality between patients in the N-acetylcysteine and placebo arms in any of these subgroups (<LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>) (short time scale: 14 studies, 1524 patients; long time scale: 18 studies, 957 patients).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Subgroup analysis - sepsis versus SIRS and medical versus surgical aetiology</HEADING>
<P>None of the stratified meta-analyses revealed any significant effect of N-acetylcysteine. It did not affect mortality in patients admitted to the ICU with sepsis or SIRS (<LINK REF="CMP-002.07" TYPE="ANALYSIS">Analysis 2.7</LINK>) (sepsis: eight studies, 369 patients; SIRS: nine studies, 527 patients), nor did it show any significant effect when we analysed the aetiology of the critical illness (<LINK REF="CMP-002.08" TYPE="ANALYSIS">Analysis 2.8</LINK>) (medical background: 16 studies, 926 patients; surgical background: 13 studies, 1478 patients).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Subgroup analysis - early versus late administration</HEADING>
<P>Application of N-acetylcysteine early to prevent the development of an oxidato-inflammatory response did not affect outcome, nor did late application that is after 24 hours of developing symptoms (<LINK REF="CMP-002.09" TYPE="ANALYSIS">Analysis 2.9</LINK>) (early administration: 24 studies, 2075 patients; late administration: eight studies, 362 patients). Three trials compared N-acetylcysteine to no treatment and there was no significant difference between these two groups (10 deaths/43 patients versus 10 deaths/49 patients, respectively) (<LINK REF="STD-Csontos-2011" TYPE="STUDY">Csontos 2011</LINK>; <LINK REF="STD-Macedo-2006" TYPE="STUDY">Macedo 2006</LINK>; <LINK REF="STD-Orhan-2006" TYPE="STUDY">Orhan 2006</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Secondary outcomes</HEADING>
<P>N-acetylcysteine did not show any significant effect on length of ICU stay, duration of mechanical ventilation or incidence of new organ failure (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>; <LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>; <LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>). When analysing length of stay there was significant heterogeneity that was not otherwise explained (I<SUP>2</SUP> = 83%, P &lt; 0.0001), therefore a summary estimate must be interpreted with great caution. Only five trials compared the duration of inotropic support, they reported that the difference was not significant between the N-acetylcysteine and control groups (<LINK REF="STD-Burns-2005" TYPE="STUDY">Burns 2005</LINK>; <LINK REF="STD-Haase-2007" TYPE="STUDY">Haase 2007</LINK>; <LINK REF="STD-Hynninen-2006" TYPE="STUDY">Hynninen 2006</LINK>; <LINK REF="STD-Molnar-1999" TYPE="STUDY">Molnar 1999</LINK>; <LINK REF="STD-Szakmany-2003" TYPE="STUDY">Szakmany 2003</LINK>). None of the trials reported healthcare costs and quality of life data.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2012-08-06 10:45:48 +0100" MODIFIED_BY="[Empty name]">
<P>In this systematic review of 41 trials with 2768 patients with sepsis and SIRS we found no benefits of N-acetylcysteine on survival (See <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>). The analysis on mortality showed no heterogeneity and was robust when performing different subgroup and sensitivity analyses. The sparse data on mortality are not promising but are not evidence of the absence of a beneficial effect; the data suggest that a potentially beneficial effect of N-acetylcysteine must be very modest and the actual point estimate on the 30-day all-cause mortality suggests harm (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>; <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>).</P>
<P>As the included studies reported the mortality over variable time periods, there was the possibility of over- or underestimating the mortality when pooling studies with long and short follow-up times. Therefore we have performed a subgroup analysis, which showed no significant difference between short-term, that is less than 30 days, and long-term, that is more than 30 days up to one year, reported mortality (<LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>).</P>
<P>Despite the well-defined inclusion criteria, there is considerable heterogeneity amongst the trials in terms of patient population, timing and dosage of N-acetylcysteine. We included 20 studies in which N-acetylcysteine was used to prevent the evolution of the oxido-inflammatory response, where patients developed SIRS during the operation. We also identified 21 studies where patients were treated with N-acetylcysteine after they had already developed symptoms of SIRS or sepsis. To address this heterogeneity we completed an a priory defined subgroup analysis. However, the analysis did not show any effect on mortality when patients with sepsis or with an established systemic inflammatory response were studied (<LINK REF="CMP-002.07" TYPE="ANALYSIS">Analysis 2.7</LINK>).</P>
<P>To assess the impact of N-acetycysteine on the various primary aetiologies, we have conducted subgroup analyses in patients admitted to the ICU with a 'medical' condition (16 studies of patients with conditions ranging from sepsis, multiorgan failure and ARDS to acute fulminant liver failure and burns) as opposed to a distinct surgical insult (13 studies, including patients undergoing cardiac, vascular and major abdominal surgery). None of these yielded significant results (<LINK REF="CMP-002.08" TYPE="ANALYSIS">Analysis 2.8</LINK>).</P>
<P>Early or late administration of N-acetylcysteine did not affect the outcome (<LINK REF="CMP-002.09" TYPE="ANALYSIS">Analysis 2.9</LINK>). Although all of the methodologically sound trials involving this patient population observed that late administration might be harmful (<LINK REF="STD-Molnar-1999" TYPE="STUDY">Molnar 1999</LINK>; <LINK REF="STD-Peake-1996" TYPE="STUDY">Peake 1996</LINK>; <LINK REF="STD-Spies-1994" TYPE="STUDY">Spies 1994</LINK>), our sensitivity analysis could not confirm this (<LINK REF="CMP-002.09" TYPE="ANALYSIS">Analysis 2.9</LINK>) (eight studies, 362 patients). Peake and colleagues (<LINK REF="STD-Peake-1996" TYPE="STUDY">Peake 1996</LINK>) and later Spapen et al (<LINK REF="STD-Spapen-2005" TYPE="STUDY">Spapen 2005</LINK>) also demonstrated that late administration of N-acetylcysteine in patients with septic shock caused depression of cardiovascular performance, as indicated by a decrease in cardiac output and the mean arterial pressure. The possibility for excess mortality was attributed to depressed cardiovascular function with a higher need of vasopressors. This finding was corroborated by reports showing that delayed administration also failed to improve tissue oxygenation and partial pressure of arterial oxygen over fraction of inspired oxygen (PaO<SUB>2</SUB>/FiO<SUB>2</SUB>) ratio (<LINK REF="STD-Agusti-1997" TYPE="STUDY">Agusti 1997</LINK>; <LINK REF="STD-Spapen-2005" TYPE="STUDY">Spapen 2005</LINK>). This could not be confirmed when analysing the secondary outcome measures, mainly because of the lack of reported data on length of inotropic support. However, it has been mentioned in various trials that the infusion of N-acetylcysteine caused temporary haemodynamic instability, but this was not quantified further (<LINK REF="STD-Emet-2004" TYPE="STUDY">Emet 2004</LINK>; <LINK REF="STD-Molnar-1999" TYPE="STUDY">Molnar 1999</LINK>; <LINK REF="STD-Peake-1996" TYPE="STUDY">Peake 1996</LINK>; <LINK REF="STD-Rank-2000" TYPE="STUDY">Rank 2000</LINK>; <LINK REF="STD-Spapen-2005" TYPE="STUDY">Spapen 2005</LINK>; <LINK REF="STD-Spies-1996" TYPE="STUDY">Spies 1996</LINK>).</P>
<P>Perhaps the failure to find a clinical role for therapies aimed at the reduction of oxygen free radicals is because the studies are based on the limited paradigm that oxygen free radicals only cause injury. An alternative view is that although oxygen free radicals are potentially highly toxic, redox reactions are also part of the basic chemical processes of life. Oxygen free radicals are an essential part of many metabolic pathways; they are part of the frameworkof basic energy producing processes. Organisms have had to evolve elaborate mechanisms to live with these reactive molecules and seem also to have evolved to use the reactive nature of these molecules for intracellular signal transduction (<LINK REF="REF-Magder-2006" TYPE="REFERENCE">Magder 2006</LINK>). Based on these results a key concept in dealing with oxygen free radicals must be to regulate but not eradicate them.</P>
<P>Early administration, on the other hand, whilst not showing a statistically significant effect did indicate a possible benefit (23 studies) (<LINK REF="CMP-002.09" TYPE="ANALYSIS">Analysis 2.9</LINK>). Similar signal was detected when only the high quality trials were analysed (data not shown). Early administration of N-acetylcysteine could beneficially affect the lipid peroxidation of cell membranes. It is becoming increasingly apparent that redox-sensitive signalling pathways, known to be important in initiating inflammatory-immune activation pathways, influence a broad array of cell signalling and gene pathways in the context of the transition metal milieu (<LINK REF="REF-Cross-2006" TYPE="REFERENCE">Cross 2006</LINK>). These can relate to antimicrobial host defence and to reparative and adaptive processes, sometimes involving production of anti-inflammatory cytokines and wound healing (<LINK REF="REF-Cross-2006" TYPE="REFERENCE">Cross 2006</LINK>).</P>
<P>The dose of N-acetylcysteine in the included trials showed great variability, from a single bolus of 50 mg/kg to continuous infusions delivering N-acetylcysteine in doses in the region of 15,000 to 20,000 mg/day. The rationale for the different regimens in different studies has not been clarified and so their clinical relevance is questionable. It is possible that the applied dose was either excessive or inadequate in some of the studies. The majority of the studies based their dosing regimens on the protocol for patients receiving treatment for acetaminophen poisoning (150 mg/kg). It has been suggested that the initial concentration of 150 mg/kg N-acetylcysteine should be modified since liver damage in acetaminophen poisoning was prevented just as effectively by the lowest as well as at the highest plasma concentrations of the drug (<LINK REF="REF-Prescott-1989" TYPE="REFERENCE">Prescott 1989</LINK>). The possible disadvantage of excessive doses could be the formation of toxic intermediate molecules during N-acetylcysteine metabolism, such as thiol and glutathionyl free radicals, glutathione disulfide and cysteine (<LINK REF="REF-Harman-1984" TYPE="REFERENCE">Harman 1984</LINK>).</P>
<P>The studies showed a great variability regarding the length of treatment, from one single bolus to six days of continuous treatment, with no evidence to support any of the applied methods. Interestingly, the most recent experimental data indicates that prolonged N-acetylcysteine was deleterious even in acetaminophen intoxication, for which N-acetylcysteine is normally the antidote (<LINK REF="REF-Yang-2009" TYPE="REFERENCE">Yang 2009</LINK>). Based on our data, we could not find any correlation between the dosage of N-acetylcysteine and outcome in this patient population.</P>
<SUMMARY_OF_RESULTS MODIFIED="2012-07-29 14:06:25 +0100" MODIFIED_BY="[Empty name]">
<P>In summary, we found that N-acetylcysteine is ineffective in reducing mortality and morbidity in SIRS and sepsis.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2012-07-29 14:09:14 +0100" MODIFIED_BY="[Empty name]">
<P>Our study pools data on the effect of intravenous N-acetylcysteine from 41 studies involving 2768 patients. The trials were identified following a detailed systematic search of the literature. Study inclusion criteria were tightly defined and the meta-analysis was rigorously conducted according to a predefined analysis plan addressing specific hypotheses. The meta-analysis combined data from a group of predominantly underpowered single centre studies. However, the included studies reflect international practice, from North America to the Middle East and Australasia, although the majority of included studies are from major teaching centres.</P>
<P>Although there was minimal heterogeneity among trial results on mortality, we are aware that we pooled clinical trials that are typical of critical care and perioperative medicine in terms of age, patients, settings, and treatment regimens. Thus, the validity of our meta-analysis may be criticized. However, all trials included critically ill patients where a common systemic inflammatory pathway was activated. Therefore, we think that there is a good biologic reason to perform a broad meta-analysis, which also considerably increases the generalizability and usefulness of the review (<LINK REF="REF-Goetzsche-2000" TYPE="REFERENCE">Goetzsche 2000</LINK>).</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2012-07-29 14:11:17 +0100" MODIFIED_BY="[Empty name]">
<P>The quality of the included studies varied and it was apparent from the result of the sensitivity analysis that internal flaws in the study design could result in significant bias. Only 20 out of 41 trials were scored as high quality and according to our power calculation the sample size of 1524 patients that was included in these trials is not enough to exclude malevolence. To ascertain the presence of a 2% relative risk reduction, according to our calculations 8548 patients would be needed in a well-designed, transparently reported multicentre trial to clear the doubts about the use of N-acetylcysteine in the critically ill.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2012-07-29 14:12:54 +0100" MODIFIED_BY="[Empty name]">
<P>Several possible sources of bias arise in this meta-analysis. First, selection bias is possible with every review. To avoid this, we searched for studies from several databases without language restrictions. Second, the possibility of publication bias cannot be excluded. Visual inspection of the Funnel plot also suggested that publication bias is unlikely. Third, flaws in the original study designs are a significant potential source of bias. The studies included in this review are typical of studies in critical care research in general in that the vast majority of studies are underpowered and single centre. The meta-analysis includes 2768 patients but the unit of analysis is the study (or study subgroup) and the sample size (41 studies) is relatively small. Although defined a priori, our stratified analysis (subgroup analysis) should be seen as hypothesis generating only. Fourth, while studies utilized different N-acetylcysteine doses and schedules, we were unable to assess this heterogeneity on outcomes, thus we cannot discern the optimal N-acetylcysteine dosing from our meta-analysis.<BR/>
</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2012-07-29 14:15:24 +0100" MODIFIED_BY="[Empty name]">
<P>This review represents the best up-to-date summary of the literature. We framed a tightly defined question and used explicit inclusion criteria for studies and a predefined analysis plan. Our primary result agrees with from those of recent reviews in this area, which have raised questions about the efficacy of N-acetylcysteine in preventing renal dysfunction, other morbidity or death in the perioperative period (<LINK REF="REF-Adabag-2009" TYPE="REFERENCE">Adabag 2009</LINK>; <LINK REF="REF-Baker-2009" TYPE="REFERENCE">Baker 2009</LINK>; <LINK REF="REF-Ho-2009" TYPE="REFERENCE">Ho 2009</LINK>; <LINK REF="REF-Naughton-2008" TYPE="REFERENCE">Naughton 2008</LINK>; <LINK REF="REF-Nigwekar-2009" TYPE="REFERENCE">Nigwekar 2009</LINK>).</P>
<P>Clinical application of N-acetylcysteine in sepsis has been questioned in two recent editorials in leading journals (<LINK REF="REF-Molnar-2008" TYPE="REFERENCE">Molnar 2008</LINK>; <LINK REF="REF-Spapen-2004" TYPE="REFERENCE">Spapen 2004</LINK>). These voiced similar concerns to ours regarding the efficacy and safety of the drug.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2012-07-29 14:17:26 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2012-07-29 14:16:36 +0100" MODIFIED_BY="[Empty name]">
<P>Overall, this meta-analysis puts doubt on the safety and utility of intravenous N-acetylcysteine as an adjuvant therapy in SIRS and sepsis. At best, N-acetylcysteine is ineffective in reducing mortality and complications in this patient population. At worst, it can be harmful, especially when administered later than 24 hours after the onset of symptoms, by causing cardiovascular depression. Unless future RCTs provide evidence of treatment effect, clinicians should not routinely use intravenous N-acetylcysteine in SIRS and sepsis and academics should not promote its use.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2012-07-29 14:17:26 +0100" MODIFIED_BY="[Empty name]">
<P>Many issues regarding the use of N-acetylcysteine in patients with SIRS and sepsis have received remarkably poor attention or remain unresolved. The pharmacokinetics and pharmacodynamics of the drug are virtually unknown. It remains to be determined whether and how N-acetylcysteine influences basic cellular processes such as bacterial clearance, neutrophil-endothelial cell interplay and apoptosis. More information is needed about possible drug interactions and toxic effects of N-acetylcysteine or its metabolites. Until we have a better understanding of these questions, intravenous N-acetylcysteine should only be used in adequately powered (and preferably multicentre) studies testing an explicitly framed hypothesis. These should be methodologically rigorous and blinded.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2012-08-06 13:33:54 +0100" MODIFIED_BY="[Empty name]">
<P>We would like to thank Harald Herkner (content editor), Marialena Trivella (statistical editor), William L. Baker, Mical Paul  (peer reviewers), Ann E. Fonfa (CARG consumer panel representative) for their help and editorial advice during the preparation of the systematic review. We would also like to thank Hywel Roberts, Harald Herkner, Mitchell J Schwaber, Mical Paul, Herbert Spapen, Karen Hovhannisyan, Marialena Trivella and Jane Cracknell for their help and editorial advice during the preparation of the protocol for the systematic review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2012-08-06 10:45:36 +0100" MODIFIED_BY="[Empty name]">
<P>Dr Tamas Szakmany: received a Clinical Research Fellowship from the Welsh Assembly Government and numerous travel grants and speaker fees from Edwards Lifesciences, Philips, GSK and B Braun. None of these funds were in relation to the work published here. He conducted clinical trials using N-acetylcysteine postoperatively (<LINK REF="STD-Szakmany-2003" TYPE="STUDY">Szakmany 2003</LINK>).</P>
<P>Dr Balázs Hauser: Grants pending; Young Investigator Award of the European Society of Intensive Care Medicine 2001: Experimental study with N-acetylcysteine in porcine endotoxaemia; Roman Herzog Research fellowship of the Alexander von Humboldt Stiftung and the Gemeinnützige Hertie Stiftung 2003 to 2005: Experimental studies in porcine endotoxaemia. He has no competing financial interest regarding this manuscript</P>
<P>Prof Peter Radermacher: Prof Radermacher's institution received a research grant from the Deutsche Forschungsgemeinschaft (DFG project Ra 396/3-2 entitled &#8220;ROS, iNOS, and HO-1 in endotoxic shock&#8221;) that allowed a research fellow from his institution to perform a study (<LINK REF="REF-Vassilev-2004" TYPE="REFERENCE">Vassilev 2004</LINK>) on N-acetylcysteine in porcine endotoxaemia.</P>
<P>Tamas Szakmany, Balázs Hauser and Peter Radermacher conducted animal studies using N-acetylcysteine.</P>
<P>None of the authors have received financial support from pharmaceutical companies marketing N-acetylcysteine.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2012-07-29 14:18:29 +0100" MODIFIED_BY="[Empty name]">
<P>Conceiving the review: Tamas Szakmany (TSZ)<BR/>Co-ordinating the review: TSZ<BR/>Undertaking manual searches: Balázs Hauser (BH), TSZ<BR/>Screening search results: BH, TSZ<BR/>Organizing retrieval of papers: BH<BR/>Screening retrieved papers against inclusion criteria: BH<BR/>Appraising quality of papers: TSZ, BH<BR/>Abstracting data from papers: TSZ, BH<BR/>Writing to authors of papers for additional information: TSZ<BR/>Providing additional data about papers: TSZ<BR/>Obtaining and screening data on unpublished studies: BH<BR/>Data management for the review: TSz<BR/>Entering data into Review Manager (<LINK REF="REF-RevMan-5.1" TYPE="REFERENCE">RevMan 5.1</LINK>): TSz, BH<BR/>RevMan statistical data: TSZ<BR/>Other statistical analysis not using RevMan: TSZ<BR/>Double entry of data: (data entered by person one: TSZ; data entered by person two: BH)<BR/>Interpretation of data: TSZ, BH, Peter Radermacher (PR)<BR/>Statistical inferences: TSZ<BR/>Writing the review: TSZ, BH, PR<BR/>Securing funding for the review: TSZ, BH, PR<BR/>Performing previous work that was the foundation of the present study: TSZ, BH, PR<BR/>Guarantor for the review (one author): TSZ<BR/>Person responsible for reading and checking review before submission: TSZ</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2012-07-29 14:24:13 +0100" MODIFIED_BY="Jane Cracknell">
<P>In the original protocol Martin Matejovic was one of the authors, however due to personal circumstances he could not contribute to the study any further. The authors are grateful for his contribution and help.</P>
<P>The authors decided to omit the planned subgroup analysis comparing bolus and continuous infusion administration of N-acetylcysteine.</P>
<P>The authors decided to introduce a further primary outcome variable: mortality in the longest reported follow-up period.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2009-11-23 11:58:03 +0000" MODIFIED_BY="[Empty name]">
<P> </P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2012-07-29 15:15:07 +0100" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2012-07-29 15:11:07 +0100" MODIFIED_BY="Jane Cracknell">
<INCLUDED_STUDIES MODIFIED="2012-07-29 15:01:33 +0100" MODIFIED_BY="Jane Cracknell">
<STUDY DATA_SOURCE="PUB" ID="STD-Andersen-2005" MODIFIED="2012-07-23 13:53:40 +0100" MODIFIED_BY="[Empty name]" NAME="Andersen 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-07-23 13:53:40 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Andersen LW, Thiis J, Kharazmi A, Rygg I</AU>
<TI>The role of N-acetylcystein administration on the oxidative response of neutrophils during cardiopulmonary bypass</TI>
<SO>Perfusion</SO>
<YR>2005</YR>
<VL>10</VL>
<PG>21-6</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:31:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1177/026765919501000105"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bernard-1997" MODIFIED="2009-11-20 11:33:45 +0000" MODIFIED_BY="[Empty name]" NAME="Bernard 1997" YEAR="1997">
<REFERENCE MODIFIED="2009-11-20 11:33:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bernard GR, Wheeler AP, Arons MM, Morris PE, Paz HL, Russell JA, et al</AU>
<TI>A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group</TI>
<SO>Chest</SO>
<YR>1997</YR>
<VL>112</VL>
<PG>164-72</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:31:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="9228372"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bromley-1995" MODIFIED="2010-01-16 15:39:53 +0000" MODIFIED_BY="[Empty name]" NAME="Bromley 1995" YEAR="1995">
<REFERENCE MODIFIED="2010-01-16 15:39:53 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bromley PN, Cottam SJ, Hilmi I, Tan KC, Heaton N, Ginsburg R, et al</AU>
<TI>Effects of intraoperative N-acetylcysteine in orthotopic liver transplantation</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>1995</YR>
<VL>75</VL>
<NO>3</NO>
<PG>352-4</PG>
<IDENTIFIERS MODIFIED="2010-01-12 13:41:30 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-12 13:41:30 +0000" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="7547057"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burns-2005" MODIFIED="2010-01-12 13:42:31 +0000" MODIFIED_BY="Jane Cracknell" NAME="Burns 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-01-12 13:42:31 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burns KE, Chu MW, Novick RJ, Fox SA, Gallo K, Martin CM, et al</AU>
<TI>Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial</TI>
<SO>JAMA</SO>
<YR>2005</YR>
<VL>294</VL>
<NO>3</NO>
<PG>342-50</PG>
<IDENTIFIERS MODIFIED="2010-01-12 13:42:31 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-12 13:42:31 +0000" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="16030279"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Burns-2010" MODIFIED="2012-07-29 14:56:41 +0100" MODIFIED_BY="[Empty name]" NAME="Burns 2010" YEAR="2002">
<REFERENCE MODIFIED="2012-07-29 14:56:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Burns KE, Priestap F, Martin C</AU>
<TI>N-acetylcysteine in critically ill patients undergoing contrast-enhanced computed tomography: a randomized trial</TI>
<SO>Clinical Nephrology</SO>
<YR>2010</YR>
<VL>74</VL>
<NO>4</NO>
<PG>323-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Charunwatthana-2009" MODIFIED="2010-01-16 15:40:11 +0000" MODIFIED_BY="[Empty name]" NAME="Charunwatthana 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-01-16 15:40:11 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Charunwatthana P, Abul Faiz M, Ruangveerayut R, Maude RJ, Rahman MR, Roberts LJ 2nd, et al</AU>
<TI>N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial</TI>
<SO>Critical Care Medicine</SO>
<YR>2009</YR>
<VL>37</VL>
<NO>2</NO>
<PG>516-22</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:31:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1097/CCM.0b013e3181958dfd"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Csontos-2011" MODIFIED="2012-03-27 23:55:00 +0100" MODIFIED_BY="[Empty name]" NAME="Csontos 2011" YEAR="2008">
<REFERENCE MODIFIED="2012-03-27 23:55:00 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Csontos C, Rezman B, Foldi V, Bogar L, Drenkovics L, Röth E, et al</AU>
<TI>Effect of N-acetylcysteine treatment on oxidative stress and inflammation after severe burn</TI>
<SO>Burns</SO>
<YR>2011</YR>
<VL>38</VL>
<NO>3</NO>
<PG>428-37</PG>
<IDENTIFIERS MODIFIED="2012-03-27 23:55:00 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-14 14:36:07 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="doi:10.1016/j.burns.2011.09.011"/>
<IDENTIFIER MODIFIED="2012-03-27 23:55:00 +0100" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="21978796"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-De-Backer-1996" MODIFIED="2010-01-16 15:53:05 +0000" MODIFIED_BY="[Empty name]" NAME="De Backer 1996" YEAR="1996">
<REFERENCE MODIFIED="2010-01-16 15:53:05 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>De Backer WA, Amsel B, Jorens PG, Bossaert L, Hiemstra PS, van Noort P, et al</AU>
<TI>N-acetylcysteine pretreatment of cardiac surgery patients influences plasma neutrophil elastase and neutrophil influx in bronchoalveolar lavage fluid</TI>
<SO>Intensive Care Medicine</SO>
<YR>1996</YR>
<VL>22</VL>
<NO>9</NO>
<PG>900-8</PG>
<IDENTIFIERS MODIFIED="2010-01-12 13:43:59 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-12 13:43:59 +0000" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="8905424"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Domenighetti-1997" MODIFIED="2011-12-15 12:03:07 +0000" MODIFIED_BY="[Empty name]" NAME="Domenighetti 1997" YEAR="1997">
<REFERENCE MODIFIED="2010-02-02 11:51:43 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Domenighetti G, Suter PM, Schaller MD, Ritz R, Perret C</AU>
<TI>Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study</TI>
<SO>Journal of Critical Care</SO>
<YR>1997</YR>
<VL>12</VL>
<NO>4</NO>
<PG>177-82</PG>
<IDENTIFIERS MODIFIED="2010-01-12 13:44:48 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-12 13:44:48 +0000" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="9459113 "/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-El_x002d_Hamamsy-2007" MODIFIED="2010-01-16 15:51:53 +0000" MODIFIED_BY="[Empty name]" NAME="El-Hamamsy 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-01-16 15:51:53 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>El-Hamamsy I, Stevens LM, Carrier M, Pellerin M, Bouchard D, Demers P, et al</AU>
<TI>Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial</TI>
<SO>The Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>2007</YR>
<VL>133</VL>
<PG>7-12</PG>
<IDENTIFIERS MODIFIED="2010-01-12 13:45:24 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-12 13:45:24 +0000" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="17198774"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Emet-2004" MODIFIED="2010-01-16 15:51:21 +0000" MODIFIED_BY="[Empty name]" NAME="Emet 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-01-16 15:51:21 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Emet S, Memis D, Pamukçu Z</AU>
<TI>The influence of N-acetyl-L-cystein infusion on cytokine levels and gastric intramucosal pH during severe sepsis</TI>
<SO>Critical Care</SO>
<YR>2004</YR>
<VL>8</VL>
<NO>4</NO>
<PG>229-30</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:31:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1186/cc2866"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eren-2003" MODIFIED="2010-02-02 11:51:43 +0000" MODIFIED_BY="Jane Cracknell" NAME="Eren 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-02-02 11:51:43 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eren N, Cakir O, Oruc A, Kaya Z, Erdinc L</AU>
<TI>Effects of N-acetylcysteine on pulmonary function in patients undergoing coronary artery bypass surgery with cardiopulmonary bypass</TI>
<SO>Perfusion</SO>
<YR>2003</YR>
<VL>18</VL>
<NO>6</NO>
<PG>345-50</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:31:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1191/0267659103pf696oa"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haase-2007" MODIFIED="2011-12-15 12:00:49 +0000" MODIFIED_BY="Jane Cracknell" NAME="Haase 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-01-16 15:52:08 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Haase M, Haase-Fielitz A, Bagshaw SM, Reade MC, Morgera S, Seevenayagam S, et al</AU>
<TI>Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients</TI>
<SO>Critical Care Medicine</SO>
<YR>2007</YR>
<VL>35</VL>
<NO>5</NO>
<PG>1324-31</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:31:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1097/01.CCM.0000261887.69976.12"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hilmi-2010" MODIFIED="2012-07-29 14:58:04 +0100" MODIFIED_BY="[Empty name]" NAME="Hilmi 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-07-29 14:58:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hilmi IA, Peng, Z, Planinsic RM, Damian D, Dai F, Tyurina YY, Kagan VE, Kellum JA</AU>
<TI>N-acetylcysteine does not prevent hepatorenal ischaemia&#8211;reperfusion injury in patients undergoing orthotopic liver transplantation</TI>
<SO>Nephrology, Dialysis, Transplantation</SO>
<YR>2010</YR>
<VL>25</VL>
<PG>2328-2333</PG>
<IDENTIFIERS MODIFIED="2011-12-14 07:55:51 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-14 07:55:51 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1093/ndt/gfq077"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-12-14 07:51:56 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-14 07:51:56 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1093/ndt/gfq077"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hynninen-2006" MODIFIED="2011-12-15 11:59:36 +0000" MODIFIED_BY="[Empty name]" NAME="Hynninen 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-01-16 15:52:36 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hynninen MS, Niemi TT, Pöyhiä R, Raininko EI, Salmenperä MT, Lepäntalo MJ, et al</AU>
<TI>N-acetylcysteine for the prevention of kidney injury in abdominal aortic surgery: a randomized, double-blind, placebo-controlled trial</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2006</YR>
<VL>102</VL>
<NO>6</NO>
<PG>1638-45</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:31:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1213/01.ANE.0000219590.79796.66"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jepsen-1992" MODIFIED="2010-01-16 15:40:30 +0000" MODIFIED_BY="[Empty name]" NAME="Jepsen 1992" YEAR="1992">
<REFERENCE MODIFIED="2010-01-16 15:40:30 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Jepsen S, Herlevsen P, Knudsen P, Bud MI, Klausen NO</AU>
<TI>Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study</TI>
<SO>Critical Care Medicine</SO>
<YR>1992</YR>
<VL>20</VL>
<NO>7</NO>
<PG>918-23</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:31:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="1617983"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Keays-1991" MODIFIED="2009-11-20 11:33:45 +0000" MODIFIED_BY="[Empty name]" NAME="Keays 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-11-20 11:33:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Keays R, Harrison PM, Wendon JA, Forbes A, Gove C, Alexander GJ, et al</AU>
<TI>Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial</TI>
<SO>BMJ</SO>
<YR>1991</YR>
<VL>303</VL>
<NO>6809</NO>
<PG>1026-9</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:31:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="1954453"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-2009" MODIFIED="2012-07-29 14:58:54 +0100" MODIFIED_BY="Jane Cracknell" NAME="Lee 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-07-29 14:58:54 +0100" MODIFIED_BY="Jane Cracknell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM et al</AU>
<TI>Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure</TI>
<SO>Gastroenterology</SO>
<YR>2009</YR>
<VL>137</VL>
<NO>3</NO>
<PG>856-64</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="10.1053/j.gastro.2009.06.006"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="10.1053/j.gastro.2009.06.006"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Macedo-2006" MODIFIED="2010-01-16 15:41:00 +0000" MODIFIED_BY="[Empty name]" NAME="Macedo 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-01-16 15:41:00 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Macedo E, Abdulkader R, Castro I, Sobrinho AC, Yu L, Vieira JM Jr</AU>
<TI>Lack of protection of N-acetylcysteine (NAC) in acute renal failure related to elective aortic aneurysm repair-a randomized controlled trial</TI>
<SO>Nephrology, Dialysis, Transplantation</SO>
<YR>2006</YR>
<VL>21</VL>
<NO>7</NO>
<PG>1863-9</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:31:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1093/ndt/gfl079"/>
<IDENTIFIER TYPE="PUBMED" VALUE="16522657"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Molnar-1999" MODIFIED="2011-12-15 11:58:35 +0000" MODIFIED_BY="[Empty name]" NAME="Molnar 1999" YEAR="1999">
<REFERENCE MODIFIED="2010-01-16 15:43:56 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Molnár Z, Shearer E, Lowe D</AU>
<TI>N-Acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study</TI>
<SO>Critical Care Medicine</SO>
<YR>1999</YR>
<VL>27</VL>
<NO>6</NO>
<PG>1100-4</PG>
<IDENTIFIERS MODIFIED="2009-11-19 14:50:39 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="10397212"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moradi-2009" MODIFIED="2011-12-15 11:57:47 +0000" MODIFIED_BY="[Empty name]" NAME="Moradi 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-01-16 15:41:50 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Moradi M, Mojtahedzadeh M, Mandegari A, Soltan-Sharifi MS, Najafi A, Khajavi MR, et al</AU>
<TI>The role of glutathione-S-transferase polymorphisms on clinical outcome of ALI/ARDS patient treated with N-acetylcysteine</TI>
<SO>Respiratory Medicine</SO>
<YR>2009</YR>
<VL>103</VL>
<NO>3</NO>
<PG>434-41</PG>
<IDENTIFIERS MODIFIED="2009-11-19 14:50:39 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="18993042"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Orhan-2006" MODIFIED="2010-01-16 15:43:43 +0000" MODIFIED_BY="[Empty name]" NAME="Orhan 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-01-16 15:43:43 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Orhan G, Yapici N, Yuksel M, Sargin M, Senay S, Yalcin AS, et al</AU>
<TI>Effects of N-acetylcysteine on myocardial ischemia&#8211;reperfusion injury in bypass surgery</TI>
<SO>Heart and Vessels</SO>
<YR>2006</YR>
<VL>21</VL>
<PG>42-7</PG>
<IDENTIFIERS MODIFIED="2010-01-12 13:51:02 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-12 13:51:02 +0000" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="16440148"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ortolani-2000b" MODIFIED="2011-02-23 12:51:36 +0000" MODIFIED_BY="[Empty name]" NAME="Ortolani 2000b" YEAR="2000">
<REFERENCE MODIFIED="2011-02-23 12:51:36 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ortolani O, Conti A, De Gaudio AR, Masoni M, Novelli G</AU>
<TI>Protective effects of N-acetylcysteine and rutin on the lipid peroxidation of the lung epithelium during the adult respiratory distress syndrome</TI>
<SO>Shock</SO>
<YR>2000</YR>
<VL>13</VL>
<NO>1</NO>
<PG>14-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="10638663"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ozaydin-2008" MODIFIED="2010-01-16 15:45:50 +0000" MODIFIED_BY="[Empty name]" NAME="Ozaydin 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-01-16 15:45:50 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ozaydin M, Peker O, Erdogan D, Kapan S, Turker Y, Varol E, et al</AU>
<TI>N-acetylcysteine for prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study</TI>
<SO>European Heart Journal</SO>
<YR>2008</YR>
<VL>29</VL>
<PG>625-31</PG>
<IDENTIFIERS MODIFIED="2009-11-19 14:50:39 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1093/eurheartj/ehn011"/>
<IDENTIFIER TYPE="PUBMED" VALUE="18263874"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Paterson-2003" MODIFIED="2010-01-16 15:46:04 +0000" MODIFIED_BY="[Empty name]" NAME="Paterson 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-01-16 15:46:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Paterson RL, Galley HF, Webster NR</AU>
<TI>The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis</TI>
<SO>Critical Care Medicine</SO>
<YR>2003</YR>
<VL>31</VL>
<NO>11</NO>
<PG>2474-8</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:31:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1097/01.CCM.0000089945.69588.18"/>
<IDENTIFIER TYPE="PUBMED" VALUE="14605526"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peake-1996" MODIFIED="2010-01-16 15:46:19 +0000" MODIFIED_BY="[Empty name]" NAME="Peake 1996" YEAR="1996">
<REFERENCE MODIFIED="2010-01-16 15:46:19 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Peake SL, Moran JL, Leppard PI</AU>
<TI>N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock</TI>
<SO>Critical Care Medicine</SO>
<YR>1996</YR>
<VL>24</VL>
<NO>8</NO>
<PG>1302-10</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:31:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="8706483"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peker-2008" MODIFIED="2010-01-16 15:46:48 +0000" MODIFIED_BY="[Empty name]" NAME="Peker 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-01-16 15:46:48 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Peker O, Peker T, Erdogan D, Ozaydin M, Kapan S, Sutcu R, et al</AU>
<TI>Effects of intravenous N-acetylcysteine on periprocedural myocardial injury after on-pump coronary artery by-pass grafting</TI>
<SO>The Journal of Cardiovascular Surgery</SO>
<YR>2008</YR>
<VL>49</VL>
<NO>4</NO>
<PG>527-31</PG>
<IDENTIFIERS MODIFIED="2009-11-19 14:50:39 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="18665117"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rank-2000" MODIFIED="2010-01-16 15:47:06 +0000" MODIFIED_BY="[Empty name]" NAME="Rank 2000" YEAR="2000">
<REFERENCE MODIFIED="2010-01-16 15:47:06 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Rank N, Michel C, Haertel C, Lenhart A, Welte M, Meier-Hellmann A, et al</AU>
<TI>N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study</TI>
<SO>Critical Care Medicine</SO>
<YR>2000</YR>
<VL>28</VL>
<NO>12</NO>
<PG>3799-807</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:31:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="11153617"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ristikankare-2006" MODIFIED="2010-01-16 15:47:25 +0000" MODIFIED_BY="[Empty name]" NAME="Ristikankare 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-01-16 15:47:25 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ristikankare A, Kuitunen T, Kuitunen A, Uotila L, Vento A, Suojaranta-Ylinen R, et al</AU>
<TI>Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>2006</YR>
<VL>97</VL>
<NO>5</NO>
<PG>611-6</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:31:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1093/bja/ael224"/>
<IDENTIFIER TYPE="PUBMED" VALUE="16914459"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sisillo-2008" MODIFIED="2010-01-16 15:47:49 +0000" MODIFIED_BY="[Empty name]" NAME="Sisillo 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-01-16 15:47:49 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sisillo E, Ceriani R, Bortone F, Juliano G, Salvi L, Veglia F, et al</AU>
<TI>N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial</TI>
<SO>Critical Care Medicine</SO>
<YR>2008</YR>
<VL>36</VL>
<NO>1</NO>
<PG>81-6</PG>
<IDENTIFIERS MODIFIED="2009-11-19 14:50:39 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="18090169"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Spapen-1998" MODIFIED="2009-11-20 11:33:45 +0000" MODIFIED_BY="[Empty name]" NAME="Spapen 1998" YEAR="1998">
<REFERENCE MODIFIED="2009-11-20 11:33:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Spapen H, Zhang H, Demanet C, Vleminckx W, Vincent JL, Huyghens L</AU>
<TI>Does N-acetyl-L-cysteine influence cytokine response during early human septic shock?</TI>
<SO>Chest</SO>
<YR>1998</YR>
<VL>113</VL>
<NO>6</NO>
<PG>1616-24</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:31:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="9631802"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Spapen-2005" MODIFIED="2010-01-19 22:27:03 +0000" MODIFIED_BY="[Empty name]" NAME="Spapen 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-01-19 22:27:03 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Spapen HD, Diltoer MW, Nguyen DN, Hendrickx I, Huyghens LP</AU>
<TI>Effects of N-acetylcysteine on microalbuminuria and organ failure in acute severe sepsis: results of a pilot study</TI>
<SO>Chest</SO>
<YR>2005</YR>
<VL>127</VL>
<NO>4</NO>
<PG>1413-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="15821223"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Spies-1994" MODIFIED="2011-12-15 11:55:34 +0000" MODIFIED_BY="Jane Cracknell" NAME="Spies 1994" YEAR="1994">
<REFERENCE MODIFIED="2010-01-16 15:48:31 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Spies CD, Reinhart K, Witt I, Meier-Hellmann A, Hannemann L, Bredle DL, et al</AU>
<TI>Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study</TI>
<SO>Critical Care Medicine</SO>
<YR>1994</YR>
<VL>22</VL>
<NO>11</NO>
<PG>1738-46</PG>
<IDENTIFIERS MODIFIED="2009-11-19 14:50:39 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="7956276"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Spies-1996" MODIFIED="2011-02-26 12:23:27 +0000" MODIFIED_BY="[Empty name]" NAME="Spies 1996" YEAR="1996">
<REFERENCE MODIFIED="2011-02-26 12:23:27 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Spies C, Giese C, Meier-Hellmann A, Specht M, Hannemann L, Schaffartzik W, et al</AU>
<TI>[The effect of prophylactically administered n-acetylcysteine on clinical indicators for tissue oxygenation during hyperoxic ventilation in cardiac risk patients]</TI>
<TO>Einflus der prophylaktischen gabe von N-Azetylzystein auf klinische indikatoren der gewebeoxygenierung unter hyperoxie bei kardialen rizikopatienten</TO>
<SO>Anaesthesist</SO>
<YR>1996</YR>
<VL>45</VL>
<NO>4</NO>
<PG>343-50</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="8702052"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Steib-1998" MODIFIED="2010-01-16 15:49:06 +0000" MODIFIED_BY="[Empty name]" NAME="Steib 1998" YEAR="1998">
<REFERENCE MODIFIED="2010-01-16 15:49:06 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Steib A, Freys G, Collin F, Launoy A, Mark G, Boudjema K</AU>
<TI>Does N-acetylcysteine improve hemodynamics and graft function in liver transplantation?</TI>
<SO>Liver Transplantation and Surgery</SO>
<YR>1998</YR>
<VL>4</VL>
<NO>2</NO>
<PG>152-7</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:31:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="9516568"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sucu-2004" MODIFIED="2010-02-02 11:51:43 +0000" MODIFIED_BY="Jane Cracknell" NAME="Sucu 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-02-02 11:51:43 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sucu N, Cinel I, Unlu A, Aytacoglu B, Tamer L, Kocak Z, et al</AU>
<TI>N-acetylcysteine for preventing pump-induced oxidoinflammatory response during cardiopulmonary bypass</TI>
<SO>Surgery Today</SO>
<YR>2004</YR>
<VL>34</VL>
<PG>237-42</PG>
<IDENTIFIERS MODIFIED="2009-11-19 14:50:39 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1007/s00595-003-2699-8"/>
<IDENTIFIER TYPE="PUBMED" VALUE="14999536"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Suter-1994" MODIFIED="2011-02-25 20:03:02 +0000" MODIFIED_BY="[Empty name]" NAME="Suter 1994" YEAR="1994">
<REFERENCE MODIFIED="2011-02-25 20:03:02 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Suter PM, Domenighetti G, Schaller MD, Laverrière MC, Ritz R, Perret C</AU>
<TI>N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study</TI>
<SO>Chest</SO>
<YR>1994</YR>
<VL>105</VL>
<NO>1</NO>
<PG>190-4</PG>
<IDENTIFIERS MODIFIED="2010-01-12 13:58:39 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-12 13:58:39 +0000" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="8275731 "/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Szakmany-2003" MODIFIED="2011-12-15 11:53:52 +0000" MODIFIED_BY="[Empty name]" NAME="Szakmany 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-02-02 11:51:43 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Szakmany T, Marton S, Molnar Z</AU>
<TI>Lack of effect of prophylactic N-acetylcysteine on postoperative organ dysfunction following major abdominal tumour surgery: a randomized, placebo-controlled, double-blinded clinical trial</TI>
<SO>Anaesthesia and Intensive Care</SO>
<YR>2003</YR>
<VL>31</VL>
<NO>3</NO>
<PG>267-71</PG>
<IDENTIFIERS MODIFIED="2009-11-19 14:50:39 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="12879670"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tossios-2003" MODIFIED="2011-12-15 11:52:42 +0000" MODIFIED_BY="[Empty name]" NAME="Tossios 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-01-16 15:50:53 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Tossios P, Bloch W, Huebner A, Raji MR, Dodos F, Klass O, et al</AU>
<TI>N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: results of a randomized, double-blind, placebo-controlled clinical trial</TI>
<SO>The Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>2003</YR>
<VL>126</VL>
<NO>5</NO>
<PG>1513-20</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:31:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1016/S0022-5223(03)00968-1"/>
<IDENTIFIER TYPE="PUBMED" VALUE="14666027"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Walsh-1998" MODIFIED="2011-02-26 12:26:34 +0000" MODIFIED_BY="[Empty name]" NAME="Walsh 1998" YEAR="1998">
<REFERENCE MODIFIED="2011-02-26 12:26:34 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Walsh TS, Hopton P, Philips BJ, Mackenzie SJ, Lee A</AU>
<TI>The effect of N-acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure</TI>
<SO>Hepatology</SO>
<YR>1998</YR>
<VL>27</VL>
<NO>5</NO>
<PG>1332-40</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="9581688"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wijeysundera-2007" MODIFIED="2012-07-29 15:01:33 +0100" MODIFIED_BY="[Empty name]" NAME="Wijeysundera 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-07-29 15:01:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wijeysundera DN, Beattie WS, Rao V, Granton JT, Chan CT</AU>
<TI>N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency</TI>
<SO>Canadian Journal of Anaesthesia</SO>
<YR>2007</YR>
<VL>54</VL>
<NO>11</NO>
<PG>872-81</PG>
<IDENTIFIERS MODIFIED="2009-11-19 14:50:39 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="17975231"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2012-07-29 15:11:07 +0100" MODIFIED_BY="Jane Cracknell">
<STUDY DATA_SOURCE="PUB" ID="STD-Adabag-2008" MODIFIED="2011-02-23 14:23:17 +0000" MODIFIED_BY="[Empty name]" NAME="Adabag 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-01-16 15:38:51 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Adabag AS, Ishani A, Koneswaran S, Johnson DJ, Kelly RF, Ward HB, et al</AU>
<TI>Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial</TI>
<SO>American Heart Journal</SO>
<YR>2008</YR>
<VL>155</VL>
<NO>6</NO>
<PG>1143-9</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:38:07 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1016/j.ahj.2008.01.013"/>
<IDENTIFIER TYPE="OTHER" VALUE="NCT00211653"/>
<IDENTIFIER TYPE="PUBMED" VALUE="18513531"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Agusti-1997" MODIFIED="2011-02-25 20:08:01 +0000" MODIFIED_BY="[Empty name]" NAME="Agusti 1997" YEAR="1997">
<REFERENCE MODIFIED="2010-01-16 15:38:30 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Agustí AG, Togores B, Ibañez J, Raurich JM, Maimó A, Bergada J, et al</AU>
<TI>Effects of N-acetylcysteine on tissue oxygenation in patients with multiple organ failure and evidence of tissue hypoxia</TI>
<SO>The European Respiratory Journal</SO>
<YR>1997</YR>
<VL>10</VL>
<NO>9</NO>
<PG>1962-6</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:38:07 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1183/09031936.97.10091962"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barr-2008" MODIFIED="2010-02-02 11:51:43 +0000" MODIFIED_BY="Jane Cracknell" NAME="Barr 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-02-02 11:51:43 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Barr LF, Kolodner K</AU>
<TI>N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery</TI>
<SO>Critical Care Medicine</SO>
<YR>2008</YR>
<VL>36</VL>
<NO>5</NO>
<PG>1427-35</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:38:07 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="18434903"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Csontos-2011b" MODIFIED="2012-07-29 15:02:04 +0100" MODIFIED_BY="[Empty name]" NAME="Csontos 2011b" YEAR="2008">
<REFERENCE MODIFIED="2012-07-29 15:02:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Csontos C, Rezman B, Foldi V, Bogar L, Bognar Z, Drenkovics L, Röth E, Weber G, Lantos J</AU>
<TI>Effect of N-acetylcysteine treatment on the expression of leukocyte surface markers after burn injury</TI>
<SO>Burns</SO>
<YR>2011</YR>
<VL>37</VL>
<NO>3</NO>
<PG>453-64</PG>
<IDENTIFIERS MODIFIED="2011-12-15 11:46:39 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-15 11:46:39 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/j.burns.2010.10.008"/>
<IDENTIFIER MODIFIED="2011-12-15 11:46:09 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="21131132"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-De-Rosa-2000" MODIFIED="2010-01-16 15:38:05 +0000" MODIFIED_BY="[Empty name]" NAME="De Rosa 2000" YEAR="2000">
<REFERENCE MODIFIED="2010-01-16 15:38:05 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>De Rosa SC, Zaretsky MD, Dubs JG, Roederer M, Anderson M, Green A, et al</AU>
<TI>N-acetylcysteine replenishes glutathione in HIV infection</TI>
<SO>European Journal of Clinical Investigation</SO>
<YR>2000</YR>
<VL>30</VL>
<NO>10</NO>
<PG>915-29</PG>
<IDENTIFIERS MODIFIED="2010-01-12 14:24:14 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-12 14:24:14 +0000" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="11029607"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Devlin-1997" MODIFIED="2012-07-29 15:02:23 +0100" MODIFIED_BY="[Empty name]" NAME="Devlin 1997" YEAR="1997">
<REFERENCE MODIFIED="2012-07-29 15:02:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Devlin J, Ellis AE, McPeake J, Heaton N, Wendon JA, Williams R</AU>
<TI>N-acetylcysteine improves indocyanine green extraction and oxygen transport during hepatic dysfunction</TI>
<SO>Critical Care Medicine</SO>
<YR>1997</YR>
<VL>25</VL>
<NO>2</NO>
<PG>236-42</PG>
<IDENTIFIERS MODIFIED="2010-01-12 14:24:52 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-12 14:24:52 +0000" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="9034257 "/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fischer-2005" MODIFIED="2012-02-01 15:18:04 +0000" MODIFIED_BY="[Empty name]" NAME="Fischer 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-02-01 15:18:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Fischer UM, Tossios P, Mehlhorn U</AU>
<TI>Renal protection by radical scavenging in cardiac surgery patients</TI>
<SO>Current Medical Research and Opinion</SO>
<YR>2005</YR>
<VL>21</VL>
<NO>8</NO>
<PG>1161-4</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="16083524"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fraga-2011" MODIFIED="2012-07-29 15:04:06 +0100" MODIFIED_BY="[Empty name]" NAME="Fraga 2011" YEAR="2009">
<REFERENCE MODIFIED="2012-07-29 15:04:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Fraga CM, Tomasi CD, Biff D, Topanotti MFL, Felisberto F, Vuolo F, et al</AU>
<TI>The effects of N-acetylcysteine and deferoxamine on plasma cytokine and oxidative damage parameters in critically ill patients with prolonged hypotension: A randomized controlled trial</TI>
<SO>Journal of Clinical Pharmacology</SO>
<YR>2011</YR>
<VL>Nov 1</VL>
<PG>Epub ahead of print</PG>
<IDENTIFIERS MODIFIED="2012-07-23 13:55:22 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-07-23 13:55:22 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="22045831"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2012-02-28 15:09:44 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-02-28 15:09:44 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE=""/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haase-2008" MODIFIED="2011-12-15 12:02:15 +0000" MODIFIED_BY="[Empty name]" NAME="Haase 2008" YEAR="2008">
<REFERENCE MODIFIED="2011-12-15 12:00:49 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Haase M, Haase-Fielitz A, Ratnaike S, Reade MC, Bagshaw SM, Morgera S, et al</AU>
<TI>N-Acetylcysteine does not artifactually lower plasma creatinine concentration</TI>
<SO>Nephrology, Dialysis, Transplantation </SO>
<YR>2008</YR>
<VL>23</VL>
<NO>5</NO>
<PG>1581-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="DOI" VALUE="10.1093/ndt/gfm818"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Heller-2001" MODIFIED="2011-02-25 20:12:01 +0000" MODIFIED_BY="[Empty name]" NAME="Heller 2001" YEAR="2001">
<REFERENCE MODIFIED="2011-02-25 20:12:01 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Heller AR, Groth G, Heller SC, Breitkreutz R, Nebe T, Quintel M, et al</AU>
<TI>N-acetylcysteine reduces respiratory burst but augments neutrophil phagocytosis in intensive care unit patients</TI>
<SO>Critical Care Medicine</SO>
<YR>2001</YR>
<VL>29</VL>
<NO>2</NO>
<PG>272-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="11246305"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jepsen-1989" MODIFIED="2010-01-16 15:35:59 +0000" MODIFIED_BY="[Empty name]" NAME="Jepsen 1989" YEAR="1989">
<REFERENCE MODIFIED="2010-01-16 15:35:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Jepsen S, Klaerke A, Nielsen PH, Nielsen ST, Simonsen O.</AU>
<TI>Systemic administration of N-acetylcysteine has no effect on postoperative lung function following elective upper laparotomy in lung healthy patients</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>1989</YR>
<VL>33</VL>
<NO>3</NO>
<PG>219-22</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:38:07 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="2658458"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Koksal-2008" MODIFIED="2012-07-29 15:05:43 +0100" MODIFIED_BY="[Empty name]" NAME="Koksal 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-07-29 15:05:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Köksal H, Rahman A, Burma O, Halifeoglu I, Bayar MK</AU>
<TI>The effects of low dose N-acetylcysteine (NAC) as an adjunct to cardioplegia in coronary artery bypass surgery</TI>
<SO>Anadolu Kardiyoloji Dergisi: AKD = The Anatolian Journal of Cardiology</SO>
<YR>2008</YR>
<VL>8</VL>
<NO>6</NO>
<PG>437-43</PG>
<IDENTIFIERS MODIFIED="2010-01-12 14:31:43 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-12 14:31:43 +0000" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="19103540"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Komisarof-2007" MODIFIED="2010-01-16 15:34:23 +0000" MODIFIED_BY="[Empty name]" NAME="Komisarof 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-01-16 15:34:23 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Komisarof JA, Gilkey GM, Peters DM, Koudelka CW, Meyer MM, Smith SM</AU>
<TI>N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON)</TI>
<SO>Critical Care Medicine</SO>
<YR>2007</YR>
<VL>35</VL>
<NO>2</NO>
<PG>435-41</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:38:07 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1097/01.CCM.0000253816.83011.DB"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Koramaz-2006" MODIFIED="2010-01-16 15:33:59 +0000" MODIFIED_BY="[Empty name]" NAME="Koramaz 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-01-16 15:33:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Koramaz I, Pulathan Z, Usta S, Karahan SC, Alver A, Yaris E, et al</AU>
<TI>Cardioprotective effect of cold-blood cardioplegia enriched with N-acetylcysteine during coronary artery bypass grafting</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>2006</YR>
<VL>81</VL>
<NO>2</NO>
<PG>613-8</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:38:07 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE="10.1016/j.athoracsur.2005.08.013"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kurian-2010" MODIFIED="2012-07-29 15:06:09 +0100" MODIFIED_BY="[Empty name]" NAME="Kurian 2010" YEAR="2003">
<REFERENCE MODIFIED="2012-07-29 15:06:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kurian GA, Paddikkala J</AU>
<TI>N-acetylcysteine and magnesium improve biochemical abnormalities associated with myocardial ischaemic reperfusion in South Indian patients undergoing coronary artery bypass grafting: a comparative analysis</TI>
<SO>Singapore Medical Journal</SO>
<YR>2010</YR>
<VL>51</VL>
<NO>5</NO>
<PG>381-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Laurent-1996" MODIFIED="2011-12-15 12:03:22 +0000" MODIFIED_BY="[Empty name]" NAME="Laurent 1996" YEAR="1996">
<REFERENCE MODIFIED="2011-12-15 12:03:07 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Laurent T, Markert M, Feihl F, Schaller MD, Perret C</AU>
<TI>Oxidant-antioxidant balance in granulocytes during ARDS. Effect of N-acetylcysteine</TI>
<SO>Chest</SO>
<YR>1996</YR>
<VL>106</VL>
<NO>1</NO>
<PG>163-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="8549180"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lawlor-2007" MODIFIED="2010-01-16 15:33:31 +0000" MODIFIED_BY="[Empty name]" NAME="Lawlor 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-01-16 15:33:31 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lawlor DK, Moist L, DeRose G, Harris KA, Lovell MB, Kribs SW, et al</AU>
<TI>Prevention of contrast-induced nephropathy in vascular surgery patients</TI>
<SO>Annals of Vascular Surgery</SO>
<YR>2007</YR>
<VL>21</VL>
<NO>5</NO>
<PG>593-7</PG>
<IDENTIFIERS MODIFIED="2010-01-12 14:33:20 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-12 14:33:20 +0000" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE=" 17823041"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Milewski-2006" MODIFIED="2010-01-16 15:33:14 +0000" MODIFIED_BY="[Empty name]" NAME="Milewski 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-01-16 15:33:14 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Milewski J, Rydzewska G, Degowska M, Kierzkiewicz M, Rydzewski A</AU>
<TI>N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis</TI>
<SO>World Journal of Gastroenterology : WJG</SO>
<YR>2006</YR>
<VL>12</VL>
<NO>23</NO>
<PG>3751-5</PG>
<IDENTIFIERS MODIFIED="2010-01-12 14:34:32 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-12 14:34:32 +0000" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="16773694"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Molnar-1998" MODIFIED="2011-12-15 11:58:57 +0000" MODIFIED_BY="[Empty name]" NAME="Molnar 1998" YEAR="1998">
<REFERENCE MODIFIED="2011-12-15 11:58:35 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Molnar Z, MacKinnon KL, Shearer E, Lowe D, Watson ID</AU>
<TI>The effect of N-acetylcysteine on total serum anti-oxidant potential and urinary albumin excretion in critically ill patients</TI>
<SO>Intensive Care Medicine</SO>
<YR>1998</YR>
<VL>24</VL>
<NO>3</NO>
<PG>230-5</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="9565804"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Molnar-2003" MODIFIED="2011-12-15 11:53:36 +0000" MODIFIED_BY="[Empty name]" NAME="Molnar 2003" YEAR="2003">
<REFERENCE MODIFIED="2011-12-15 11:53:14 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Molnar Z, Szakmany T, Koszegi T</AU>
<TI>Prophylactic N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomised, double-blinded, placebo-controlled clinical trial</TI>
<SO>Intensive Care Medicine</SO>
<YR>2003</YR>
<VL>29</VL>
<NO>5</NO>
<PG>749-55</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="12682719"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Najafi-2009" MODIFIED="2011-12-15 11:57:22 +0000" MODIFIED_BY="[Empty name]" NAME="Najafi 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-12-15 11:57:02 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Najafi A, MojtahedzadehM, Mahmoodpoor A, Aghamohammadi M, Ahmadi A, Nahreini S, et al</AU>
<TI>Effect of N-acetylcysteine on microalbuminuria in patients with acute respiratory distress syndrome</TI>
<SO>Archives of Medical Science</SO>
<YR>2009</YR>
<VL>5</VL>
<NO>3</NO>
<PG>408-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Niemi-2006" MODIFIED="2011-12-15 11:59:51 +0000" MODIFIED_BY="[Empty name]" NAME="Niemi 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-12-15 11:59:36 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Niemi TT, Munsterhjelm E, Pöyhiä R, Hynninen MS, Salmenperä MT</AU>
<TI>The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm</TI>
<SO>Blood Coagulation &amp; Fibrinolysis</SO>
<YR>2006</YR>
<VL>17</VL>
<NO>1</NO>
<PG>29-34</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="16607076 "/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ortolani-2000a" MODIFIED="2012-07-29 15:07:45 +0100" MODIFIED_BY="[Empty name]" NAME="Ortolani 2000a" YEAR="2000">
<REFERENCE MODIFIED="2012-07-29 15:07:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ortolani O, Conti A, De Gaudio AR, Moraldi E, Cantini Q, Novelli G</AU>
<TI>The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock</TI>
<SO>American Journal of Respiratory Critical Care Medicine</SO>
<YR>2000</YR>
<VL>161</VL>
<NO>6</NO>
<PG>1907-11</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="10852765"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reinhart-1995" MODIFIED="2011-12-15 11:55:17 +0000" MODIFIED_BY="[Empty name]" NAME="Reinhart 1995" YEAR="1995">
<REFERENCE MODIFIED="2011-12-15 11:54:54 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reinhart K, Spies CD, Meier-Hellmann A, Bredle DL, Hannemann L, Specht M, et al</AU>
<TI>N-acetylcysteine preserves oxygen consumption and gastric mucosal pH during hyperoxic ventilation</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>1995</YR>
<VL>151</VL>
<PG>773-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="7881669"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sahib-2010" MODIFIED="2012-07-29 15:09:04 +0100" MODIFIED_BY="[Empty name]" NAME="Sahib 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-07-29 15:09:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sahib AS, Al-Jawad FH, Alkaisy AA</AU>
<TI>Effect of antioxidants on the incidence of wound infection in burn patients</TI>
<SO>Annals of Burns and Fire Disasters</SO>
<YR>2010</YR>
<VL>23</VL>
<NO>4</NO>
<PG>199-205</PG>
<IDENTIFIERS MODIFIED="2011-12-15 09:42:17 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-15 09:42:17 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="21991225"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-12-15 09:39:34 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-15 09:39:34 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="PMC3188280"/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Saricaoglu-2005" MODIFIED="2010-01-16 15:30:52 +0000" MODIFIED_BY="[Empty name]" NAME="Saricaoglu 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-01-16 15:30:52 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Saricaoglu F, Dal D, Salman AE, Atay OA, Doral MN, Salman MA, et al</AU>
<TI>Effect of low-dose N-acetyl-cysteine infusion on tourniquet-induced ischaemia-reperfusion injury in arthroscopic knee surgery</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>2005</YR>
<VL>49</VL>
<NO>6</NO>
<PG>847-51</PG>
<IDENTIFIERS MODIFIED="2010-01-12 14:41:57 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-12 14:41:57 +0000" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE=" 15954970"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Siriwardena-2007" MODIFIED="2011-02-23 15:06:26 +0000" MODIFIED_BY="[Empty name]" NAME="Siriwardena 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-02-23 15:06:26 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Siriwardena AK, Mason JM, Balachandra S, Bagul A, Galloway S, Formela L, et al</AU>
<TI>Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis</TI>
<SO>Gut</SO>
<YR>2007</YR>
<VL>56</VL>
<NO>10</NO>
<PG>1439-44</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="17356040"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Soltan_x002d_Sharifi-2007" MODIFIED="2011-12-15 11:58:09 +0000" MODIFIED_BY="[Empty name]" NAME="Soltan-Sharifi 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-12-15 11:57:47 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Soltan-Sharifi MS, Mojtahedzadeh M, Najafi A, Reza Khajavi M, Reza Rouini M, Moradi M, et al</AU>
<TI>Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing intracellular glutathione, and extracellular thiol molecules and anti-oxidant power: evidence for underlying toxicological mechanisms</TI>
<SO>Human &amp; Experimental Toxicology</SO>
<YR>2007</YR>
<VL>26</VL>
<NO>9</NO>
<PG>697-703</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="17984140"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Spies-1993" MODIFIED="2012-07-29 15:10:24 +0100" MODIFIED_BY="[Empty name]" NAME="Spies 1993" YEAR="1993">
<REFERENCE MODIFIED="2012-07-29 15:10:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Spies C, Reinhart K, Witt I, Walensky C, Hannemann L, Specht M, et al</AU>
<TI>Influence of N-acetylcysteine on O2 consumption and gastric intramucosal pH in septic patients</TI>
<SO>Critical Care Medicine</SO>
<YR>1993</YR>
<VL>21 Suppl 4</VL>
<PG>183</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Szakmany-2002" MODIFIED="2011-12-15 11:54:07 +0000" MODIFIED_BY="[Empty name]" NAME="Szakmany 2002" YEAR="2002">
<REFERENCE MODIFIED="2011-12-15 11:53:52 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Szakmány T, Tóth I, Márton S, Molnár Z</AU>
<TI>[Effect of prophylactic N-acetylcysteine on postoperative organ dysfunction and inflammatory markers after major abdominal surgery for cancer. Prospective, randomized, double-blind, placebo-controlled clinical trial]</TI>
<TO>Profilaktikus N-acetylcysteine kezeles hatasa a posztoperativ szervdiszfunkciora es gyulladasos markerek szintjere kiterjesztett hasi tumorsebeszeti beavatkozasok utan. Prospektiv, randomizalt, kettos-vak, placebo kontrolalt klinikai tanulmany</TO>
<SO>Magyar Sebészet</SO>
<YR>2002</YR>
<VL>55</VL>
<NO>6</NO>
<PG>369-74</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="12616822 "/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wijeysundera-2009" MODIFIED="2011-12-15 11:52:24 +0000" MODIFIED_BY="[Empty name]" NAME="Wijeysundera 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-12-15 11:51:43 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wijeysundera DN, Karkouti K, Rao V, Granton JT, Chan CT, Raban R, et al</AU>
<TI>N-acetylcysteine is associated with increased blood loss and blood product utilization during cardiac surgery</TI>
<SO>Critical Care Medicine</SO>
<YR>2009</YR>
<VL>37</VL>
<NO>6</NO>
<PG>1929-34</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="19384218"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zingg-2007" MODIFIED="2012-07-29 15:11:07 +0100" MODIFIED_BY="Jane Cracknell" NAME="Zingg 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-07-29 15:11:07 +0100" MODIFIED_BY="Jane Cracknell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Zingg U, Hofer CK, Seifert B, Metzger U, Zollinger A.</AU>
<TI>High dose N-acetylcysteine to prevent pulmonary complications in partial or total transthoracic esophagectomy: results of a prospective observational study</TI>
<SO>Diseases of the Esophagus</SO>
<YR>2007</YR>
<VL>20</VL>
<NO>5</NO>
<PG>399-405</PG>
<IDENTIFIERS MODIFIED="2011-02-25 18:38:15 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-02-25 18:38:15 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17760653"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-02-25 18:35:47 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-02-25 18:35:47 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1111/j.1442-2050.2007.00690.x"/>
</IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2012-07-29 15:15:07 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2012-07-29 15:15:07 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Adabag-2009" MODIFIED="2012-07-29 15:11:24 +0100" MODIFIED_BY="[Empty name]" NAME="Adabag 2009" TYPE="JOURNAL_ARTICLE">
<AU>Adabag AS, Ishani A, Bloomfield HE, Ngo AK, Wilt TJ</AU>
<TI>Efficacy of N-acetylcysteine in preventing renal injury after heart surgery: a systematic review of randomized trials</TI>
<SO>European Heart Journal</SO>
<YR>2009</YR>
<VL>30</VL>
<NO>15</NO>
<PG>1910-7</PG>
<IDENTIFIERS MODIFIED="2010-01-14 20:09:36 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-01-14 20:09:36 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19282300"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Aruoma-1989" MODIFIED="2010-01-13 13:28:06 +0000" MODIFIED_BY="Jane Cracknell" NAME="Aruoma 1989" TYPE="JOURNAL_ARTICLE">
<AU>Aruoma OI, Halliwell B, Hoey BM, Butler J</AU>
<TI>The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid</TI>
<SO>Free Radical Biology &amp; Medicine</SO>
<YR>1989</YR>
<VL>6</VL>
<PG>593-7</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:40:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="MEDLINE" VALUE="2546864"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Baker-2009" MODIFIED="2012-07-29 15:11:41 +0100" MODIFIED_BY="[Empty name]" NAME="Baker 2009" TYPE="JOURNAL_ARTICLE">
<AU>Baker WL, Anglade MW, Baker EL, White CM, Kluger J, Coleman CI</AU>
<TI>Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis</TI>
<SO>European Journal of Cardiothoracic Surgery</SO>
<YR>2009</YR>
<VL>35</VL>
<NO>3</NO>
<PG>521-7</PG>
<IDENTIFIERS MODIFIED="2010-01-14 20:14:09 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-01-14 20:14:09 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19147369"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bone-1992" MODIFIED="2010-01-13 13:28:18 +0000" MODIFIED_BY="Jane Cracknell" NAME="Bone 1992" TYPE="JOURNAL_ARTICLE">
<AU>Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al</AU>
<TI>Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine</TI>
<SO>Chest</SO>
<YR>1992</YR>
<VL>101</VL>
<PG>1644-55</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:40:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="MEDLINE" VALUE="1303622"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cowley-1996" MODIFIED="2010-02-02 11:52:21 +0000" MODIFIED_BY="Jane Cracknell" NAME="Cowley 1996" TYPE="JOURNAL_ARTICLE">
<AU>Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Menon DK</AU>
<TI>Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors</TI>
<SO>Critical Care Medicine</SO>
<YR>1996</YR>
<VL>24</VL>
<PG>1179-83</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:40:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="MEDLINE" VALUE="8674332"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Crimi-2006" MODIFIED="2012-07-29 15:12:10 +0100" MODIFIED_BY="[Empty name]" NAME="Crimi 2006" TYPE="JOURNAL_ARTICLE">
<AU>Crimi E, Sica V, Williams-Ignarro S, Zhang H, Slutsky AS, Ignarro LJ, Napoli C</AU>
<TI>The role of oxidative stress in adult critical care</TI>
<SO>Free Radical Biology &amp; Medicine</SO>
<YR>2006</YR>
<VL>40</VL>
<NO>3</NO>
<PG>398-406</PG>
<IDENTIFIERS MODIFIED="2010-01-14 10:53:07 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-01-14 10:53:07 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/j.freeradbiomed.2005.10.054"/>
<IDENTIFIER MODIFIED="2010-01-14 10:49:11 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16443154"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cross-2006" MODIFIED="2010-01-15 14:01:13 +0000" MODIFIED_BY="[Empty name]" NAME="Cross 2006" TYPE="JOURNAL_ARTICLE">
<AU>Cross CE, van Asbeck BS, Halliwell B</AU>
<TI>More antioxidants in sepsis: still paved with uncertainties</TI>
<SO>Critical Care Medicine</SO>
<YR>2006</YR>
<VL>34</VL>
<NO>2</NO>
<PG>569-571</PG>
<IDENTIFIERS MODIFIED="2010-01-15 14:01:13 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-01-15 14:01:13 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16424756"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2010-01-13 13:28:54 +0000" MODIFIED_BY="Jane Cracknell" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey-Smith G, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple, graphic test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<PG>629-34</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:40:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="MEDLINE" VALUE="9310563"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Engel-2007" MODIFIED="2010-01-16 15:29:40 +0000" MODIFIED_BY="[Empty name]" NAME="Engel 2007" TYPE="JOURNAL_ARTICLE">
<AU>Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jaschinski U, John S, Mayer K, Oppert M, Olthoff D, Quintel M, Ragaller M, Rossaint R, Stuber F, Weiler N, Welte T, Bogatsch H, Hartog C, Loeffler M, Reinhart K.</AU>
<TI>Epidemiology of sepsis in Germany: results from a national prospective multicenter study</TI>
<SO>Intensive Care Medicine</SO>
<YR>2007</YR>
<VL>33</VL>
<NO>4</NO>
<PG>606-18</PG>
<IDENTIFIERS MODIFIED="2010-01-14 10:43:01 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-01-14 10:43:01 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1007/s00134-006-0517-7"/>
<IDENTIFIER MODIFIED="2010-01-14 10:35:26 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17323051"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Goetzsche-2000" MODIFIED="2012-07-29 15:12:40 +0100" MODIFIED_BY="Jane Cracknell" NAME="Goetzsche 2000" TYPE="JOURNAL_ARTICLE">
<AU>Gotzsche PC</AU>
<TI>Why we need a broad perspective on meta-analysis.It may be crucially important for patients</TI>
<SO>BMJ</SO>
<YR>2000</YR>
<VL>321</VL>
<NO>7261</NO>
<PG>585-6</PG>
<IDENTIFIERS MODIFIED="2011-03-02 20:40:16 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-03-02 20:40:16 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10977820"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Goode-1995" MODIFIED="2011-03-08 15:35:01 +0000" MODIFIED_BY="Jane Cracknell" NAME="Goode 1995" TYPE="JOURNAL_ARTICLE">
<AU>Goode HF, Cowley HC, Walker BE, Howdle PD, Webster NR</AU>
<TI>Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction</TI>
<SO>Critical Care Medicine</SO>
<YR>1995</YR>
<VL>23</VL>
<PG>646-51</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:40:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="MEDLINE" VALUE="7712754"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Harman-1984" MODIFIED="2010-01-16 15:26:43 +0000" MODIFIED_BY="[Empty name]" NAME="Harman 1984" TYPE="JOURNAL_ARTICLE">
<AU>Harman LS, Mottley C, Mason RP</AU>
<TI>Free radical metabolites of L-cysteine oxidation</TI>
<SO>The Journal of Biological Chemistry</SO>
<YR>1984</YR>
<VL>259</VL>
<PG>5606-11</PG>
<IDENTIFIERS MODIFIED="2010-01-12 14:57:41 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2010-01-12 14:57:41 +0000" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="6325443 "/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Henderson-1994" MODIFIED="2010-01-13 13:29:27 +0000" MODIFIED_BY="Jane Cracknell" NAME="Henderson 1994" TYPE="JOURNAL_ARTICLE">
<AU>Henderson A, Hayes P</AU>
<TI>Acetylcysteine as a cytoprotective antioxidant in patients with severe sepsis: potential new use for an old drug</TI>
<SO>The Annals of Pharmacotherapy</SO>
<YR>1994</YR>
<VL>28</VL>
<PG>1086-8</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:40:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="MEDLINE" VALUE="7803886"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2002" MODIFIED="2010-01-16 15:27:14 +0000" MODIFIED_BY="[Empty name]" NAME="Higgins 2002" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG</AU>
<TI>Quantifying heterogeneity in a meta-analysis</TI>
<SO>Statist Med</SO>
<YR>2002</YR>
<VL>21</VL>
<PG>1539-58</PG>
<IDENTIFIERS MODIFIED="2010-01-07 12:16:58 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-01-07 12:16:58 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/sim.1186"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2012-03-27 23:47:38 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="BOOK">
<AU>Higgins JPT, Green S (editors)</AU>
<SO>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]</SO>
<YR>2011</YR>
<PB>The Cochrane Collaboration</PB>
<CY>Available from http://www.cochrane-handbook.org</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ho-2009" MODIFIED="2010-01-14 20:03:39 +0000" MODIFIED_BY="[Empty name]" NAME="Ho 2009" TYPE="JOURNAL_ARTICLE">
<AU>Ho KM, Morgan DJ</AU>
<TI>Meta-analysis of N-acetylcysteine to prevent acute renal failure after major surgery</TI>
<SO>American Journal of Kidney Diseases</SO>
<YR>2009</YR>
<VL>53</VL>
<NO>1</NO>
<PG>33-40</PG>
<IDENTIFIERS MODIFIED="2010-01-14 20:03:39 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-01-14 20:03:11 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1053/j.ajkd.2008.05.019"/>
<IDENTIFIER MODIFIED="2010-01-14 20:03:39 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="18649982"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hollis-1999" MODIFIED="2011-03-08 15:35:01 +0000" MODIFIED_BY="Jane Cracknell" NAME="Hollis 1999" TYPE="JOURNAL_ARTICLE">
<AU>Hollis S, Campbell F</AU>
<TI>What is meant by intention to treat analysis? Survey of published randomised controlled trials</TI>
<SO>BMJ</SO>
<YR>1999</YR>
<VL>319</VL>
<NO>7211</NO>
<PG>670-4</PG>
<IDENTIFIERS MODIFIED="2011-02-27 20:40:44 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-02-27 20:40:44 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="10480822"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hozo-2005" MODIFIED="2012-07-29 15:13:13 +0100" MODIFIED_BY="[Empty name]" NAME="Hozo 2005" TYPE="JOURNAL_ARTICLE">
<AU>Hozo SP, Djulbegovic B, Hozo I</AU>
<TI>Estimating the mean and variance from the median, range, and the size of a sample</TI>
<SO>BMC Medical Research Methodology</SO>
<YR>2005</YR>
<VL>5</VL>
<PG>13-23</PG>
<IDENTIFIERS MODIFIED="2011-06-14 16:08:28 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-06-14 16:08:28 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1186/1471-2288-5-13"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hsu-2004" MODIFIED="2010-01-13 13:29:45 +0000" MODIFIED_BY="Jane Cracknell" NAME="Hsu 2004" TYPE="JOURNAL_ARTICLE">
<AU>Hsu BG, Yang FL, Lee RP, Peng TC, Harn HJ, Chen HI</AU>
<TI>N-acetylcysteine ameliorates lipopolysaccharide-induced organ damage in conscious rats</TI>
<SO>Journal of Biomedical Science</SO>
<YR>2004</YR>
<VL>11</VL>
<PG>152-62</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:40:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="MEDLINE" VALUE="14966365"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kiefer-2000" MODIFIED="2010-01-13 13:30:04 +0000" MODIFIED_BY="Jane Cracknell" NAME="Kiefer 2000" TYPE="JOURNAL_ARTICLE">
<AU>Kiefer P, Vogt J, Radermacher P</AU>
<TI>From mucolytic to antioxidant and liver protection: new aspects in the intensive care unit career of N-acetylcysteine</TI>
<SO>Critical Care Medicine</SO>
<YR>2000</YR>
<VL>28</VL>
<PG>3935-6</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:40:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="MEDLINE" VALUE="11153640"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Koch-1996" MODIFIED="2010-01-13 13:30:20 +0000" MODIFIED_BY="Jane Cracknell" NAME="Koch 1996" TYPE="JOURNAL_ARTICLE">
<AU>Koch T, Heller S, Heissler S, Breil I, Schiefer HG, van Ackern K, et al</AU>
<TI>Effects of N-acetylcysteine on bacterial clearance</TI>
<SO>European Journal of Clinical Investigation</SO>
<YR>1996</YR>
<VL>26</VL>
<PG>884-92</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:40:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="MEDLINE" VALUE="8911862"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Magder-2006" MODIFIED="2010-01-15 08:07:43 +0000" MODIFIED_BY="[Empty name]" NAME="Magder 2006" TYPE="JOURNAL_ARTICLE">
<AU>Magder S</AU>
<TI>Reactive oxygen species: toxic molecules or spark of life?</TI>
<SO>Critical Care</SO>
<YR>2006</YR>
<VL>10</VL>
<NO>1</NO>
<PG>208</PG>
<IDENTIFIERS MODIFIED="2010-01-15 08:07:43 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-01-15 08:07:43 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1186/cc3992"/>
<IDENTIFIER MODIFIED="2010-01-15 07:28:03 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16469133"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Molnar-2008" MODIFIED="2012-07-29 15:13:48 +0100" MODIFIED_BY="[Empty name]" NAME="Molnar 2008" TYPE="JOURNAL_ARTICLE">
<AU>Molnár Z</AU>
<TI>N-acetylcysteine as the magic bullet: too good to be true</TI>
<SO>Critical Care Medicine</SO>
<YR>2008</YR>
<VL>36</VL>
<NO>2</NO>
<PG>645-6</PG>
<IDENTIFIERS MODIFIED="2010-01-14 16:25:27 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-01-14 16:25:27 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="18216629"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Naughton-2008" MODIFIED="2010-01-16 15:29:11 +0000" MODIFIED_BY="[Empty name]" NAME="Naughton 2008" TYPE="JOURNAL_ARTICLE">
<AU>Naughton F, Wijeysundera D, Karkouti K, Tait G, Beattie WS</AU>
<TI>N-acetylcysteine to reduce renal failure after cardiac surgery: a systematic review and meta-analysis</TI>
<SO>Canadian Journal of Anaesthesia</SO>
<YR>2008</YR>
<VL>55</VL>
<NO>12</NO>
<PG>827-35</PG>
<IDENTIFIERS MODIFIED="2010-01-14 20:11:52 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-01-14 20:11:52 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19050086"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Nigwekar-2009" MODIFIED="2010-01-16 15:29:18 +0000" MODIFIED_BY="[Empty name]" NAME="Nigwekar 2009" TYPE="JOURNAL_ARTICLE">
<AU>Nigwekar SU, Kandula P</AU>
<TI>N-acetylcysteine in cardiovascular-surgery-associated renal failure: a meta-analysis</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>2009</YR>
<VL>87</VL>
<NO>1</NO>
<PG>139-47</PG>
<IDENTIFIERS MODIFIED="2010-01-14 20:16:13 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-01-14 20:16:13 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19101287"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ogilvie-1991" MODIFIED="2011-03-08 15:35:01 +0000" MODIFIED_BY="Jane Cracknell" NAME="Ogilvie 1991" TYPE="JOURNAL_ARTICLE">
<AU>Ogilvie AC, Groeneveld AB, Straub JP, Thijs LG</AU>
<TI>Plasma lipid peroxides and antioxidants in human septic shock</TI>
<SO>Intensive Care Medicine</SO>
<YR>1991</YR>
<VL>17</VL>
<PG>40-4</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:40:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="MEDLINE" VALUE="1645378"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Oxman-1992" MODIFIED="2010-01-13 13:31:21 +0000" MODIFIED_BY="Jane Cracknell" NAME="Oxman 1992" TYPE="JOURNAL_ARTICLE">
<AU>Oxman AD, Guyatt GH</AU>
<TI>A consumer's guide to subgroup analyses</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1992</YR>
<VL>116</VL>
<PG>78-84</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:40:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="MEDLINE" VALUE="1530753"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Peristeris-1992" MODIFIED="2010-01-13 13:31:36 +0000" MODIFIED_BY="Jane Cracknell" NAME="Peristeris 1992" TYPE="JOURNAL_ARTICLE">
<AU>Peristeris P, Clark BD, Gatti S, Faggioni R, Mantovani A, Mengozzi M, et al</AU>
<TI>N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production</TI>
<SO>Cellular Immunology</SO>
<YR>1992</YR>
<VL>140</VL>
<PG>390-9</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:40:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="MEDLINE" VALUE="1544168"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Pinsky-2003" MODIFIED="2011-03-08 15:35:01 +0000" MODIFIED_BY="Jane Cracknell" NAME="Pinsky 2003" TYPE="JOURNAL_ARTICLE">
<AU>Pinsky MR</AU>
<TI>Antioxidant therapy for severe sepsis: promise and perspective</TI>
<SO>Critical Care Medicine</SO>
<YR>2003</YR>
<VL>31</VL>
<PG>2697-8</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:40:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="MEDLINE" VALUE="14605544"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Prescott-1989" MODIFIED="2010-01-16 15:28:12 +0000" MODIFIED_BY="[Empty name]" NAME="Prescott 1989" TYPE="JOURNAL_ARTICLE">
<AU>Prescott LF, Donovan JW, Jarvie DR, Proudfoot AT</AU>
<TI>The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage.</TI>
<SO>European Journal of Clinical Pharmacology</SO>
<YR>1989</YR>
<VL>37</VL>
<NO>5</NO>
<PG>501-6</PG>
<IDENTIFIERS MODIFIED="2010-01-07 12:40:30 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-01-07 12:40:30 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="2598989"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Repine-1992" MODIFIED="2010-01-13 13:32:08 +0000" MODIFIED_BY="Jane Cracknell" NAME="Repine 1992" TYPE="JOURNAL_ARTICLE">
<AU>Repine JE</AU>
<TI>Scientific perspectives on adult respiratory distress syndrome</TI>
<SO>Lancet</SO>
<YR>1992</YR>
<VL>339</VL>
<PG>466-9</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:40:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="MEDLINE" VALUE="1346826"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-RevMan-5.1" MODIFIED="2012-03-27 23:47:38 +0100" MODIFIED_BY="[Empty name]" NAME="RevMan 5.1" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2011</YR>
<EN>5.1</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-R_x00fc_cker-2008" MODIFIED="2011-03-08 15:35:01 +0000" MODIFIED_BY="Jane Cracknell" NAME="Rücker 2008" TYPE="JOURNAL_ARTICLE">
<AU>Rücker G, Schwarzer G, Carpenter J</AU>
<TI>Arcsine test for publication bias in meta-analyses with binary outcomes</TI>
<SO>Statistics in Medicine</SO>
<YR>2008</YR>
<VL>27</VL>
<NO>5</NO>
<PG>746-63</PG>
<IDENTIFIERS MODIFIED="2011-02-27 20:47:20 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-02-27 20:47:20 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17592831"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Schmidt-1997" MODIFIED="2010-02-02 11:51:43 +0000" MODIFIED_BY="Jane Cracknell" NAME="Schmidt 1997" TYPE="JOURNAL_ARTICLE">
<AU>Schmidt H, Schmidt W, Müller T, Böhrer H, Gebhard MM, Martin E</AU>
<TI>N-acetylcysteine attenuates endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo</TI>
<SO>Critical Care Medicine</SO>
<YR>1997</YR>
<VL>25</VL>
<PG>558-63</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:40:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="MEDLINE" VALUE="9187607"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Schmidt-1998" MODIFIED="2010-01-13 13:32:38 +0000" MODIFIED_BY="Jane Cracknell" NAME="Schmidt 1998" TYPE="JOURNAL_ARTICLE">
<AU>Schmidt W, Walther A, Gebhard MM, Martin E, Schmidt H</AU>
<TI>Influence of N-acetylcysteine treatment on endotoxin-induced microcirculatory disturbances</TI>
<SO>Intensive Care Medicine</SO>
<YR>1998</YR>
<VL>24</VL>
<NO>9</NO>
<PG>967-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Spapen-2004" MODIFIED="2012-07-29 15:14:36 +0100" MODIFIED_BY="[Empty name]" NAME="Spapen 2004" TYPE="JOURNAL_ARTICLE">
<AU>Spapen H</AU>
<TI>N-acetylcysteine in clinical sepsis: a difficult marriage</TI>
<SO>Critical Care</SO>
<YR>2004</YR>
<VL>8</VL>
<NO>4</NO>
<PG>229-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vassilev-2004" MODIFIED="2012-07-29 15:15:07 +0100" MODIFIED_BY="[Empty name]" NAME="Vassilev 2004" TYPE="JOURNAL_ARTICLE">
<AU>Vassilev D, Hauser B, Bracht H, Iványi Z, Schoaff M, Asfar P, et al</AU>
<TI>Systemic, pulmonary, and hepatosplanchnic effects of N-acetylcysteine during long-term porcine endotoxemia</TI>
<SO>Critical Care Medicine</SO>
<YR>2004</YR>
<VL>32</VL>
<NO>2</NO>
<PG>525-32</PG>
<IDENTIFIERS MODIFIED="2010-01-14 21:26:28 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-01-14 21:26:28 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="14758174"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Yang-2009" MODIFIED="2010-01-14 21:18:06 +0000" MODIFIED_BY="[Empty name]" NAME="Yang 2009" TYPE="JOURNAL_ARTICLE">
<AU>Yang R, Miki K, He X, Killeen ME, Fink MP</AU>
<TI>Prolonged treatment with N-acetylcystine delays liver recovery from acetaminophen hepatotoxicity</TI>
<SO>Critical Care</SO>
<YR>2009</YR>
<VL>13</VL>
<NO>2</NO>
<PG>R55</PG>
<IDENTIFIERS MODIFIED="2010-01-14 21:18:06 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-01-14 21:18:06 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1186/cc7782"/>
<IDENTIFIER MODIFIED="2010-01-14 21:17:53 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19358737"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Zhang-1994a" MODIFIED="2010-01-13 13:46:58 +0000" MODIFIED_BY="Jane Cracknell" NAME="Zhang 1994a" TYPE="JOURNAL_ARTICLE">
<AU>Zhang H, Spapen H, Benlabed M, Nguyen DN, Buurman WA, Vincent JL</AU>
<TI>Pentoxifylline improves the tissue oxygen extraction capabilities during endotoxic shock</TI>
<SO>Shock</SO>
<YR>1994</YR>
<VL>2</VL>
<PG>90-7</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:40:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="MEDLINE" VALUE="7728587"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Zhang-1994b" MODIFIED="2010-01-13 13:36:07 +0000" MODIFIED_BY="Jane Cracknell" NAME="Zhang 1994b" TYPE="JOURNAL_ARTICLE">
<AU>Zhang H, Spapen H, Nguyen DN, Benlabed M, Buurman WA, Vincent JL</AU>
<TI>Protective effects of N-acetyl-L-cysteine in endotoxemia</TI>
<SO>The American Journal of Physiology</SO>
<YR>1994</YR>
<VL>266</VL>
<PG>H1746-54</PG>
<IDENTIFIERS MODIFIED="2009-11-20 11:40:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="MEDLINE" VALUE="8203575"/>
</IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES MODIFIED="2010-01-13 13:51:09 +0000" MODIFIED_BY="Jane Cracknell"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2012-08-06 10:45:48 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2012-08-06 10:45:48 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2012-07-29 14:24:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Andersen-2005">
<CHAR_METHODS MODIFIED="2012-07-29 14:24:28 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 13:20:32 +0000" MODIFIED_BY="[Empty name]">
<P>Cardiac surgery, high risk</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:24:45 +0100" MODIFIED_BY="[Empty name]">
<P>iv N-acetylcysteine 100mg/kg bolus on induction then 20mg/kg/hr during surgery versus placebo (not specified)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:24:53 +0100" MODIFIED_BY="[Empty name]">
<P>Inflammatory response, mortality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-11-23 12:29:10 +0000" MODIFIED_BY="[Empty name]">
<P>No side effects</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:26:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bernard-1997">
<CHAR_METHODS MODIFIED="2012-07-29 14:26:32 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 12:32:56 +0000" MODIFIED_BY="[Empty name]">
<P>ARDS</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:25:46 +0100" MODIFIED_BY="[Empty name]">
<P>iv N-acetylcysteine 210 mg daily for 10 days versus placebo (5% dextrose)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-03-02 22:26:26 +0000" MODIFIED_BY="[Empty name]">
<P>30-day mortality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:26:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bromley-1995">
<CHAR_METHODS MODIFIED="2012-07-29 14:26:38 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 12:44:17 +0000" MODIFIED_BY="[Empty name]">
<P>Orthotopic liver transplantation</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:26:57 +0100" MODIFIED_BY="[Empty name]">
<P>iv N-acetylcysteine 150 mg/kg bolus then 12.5mg/kg/hr for 4 hrs then 6.25 mg/kg/hr until the end of surgery versus placebo (not specified)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-03-02 22:26:27 +0000" MODIFIED_BY="[Empty name]">
<P>haemodynamic variables, 30-day mortality, morbidity</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:27:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Burns-2005">
<CHAR_METHODS MODIFIED="2012-07-29 14:27:37 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, quadruple blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 12:52:36 +0000" MODIFIED_BY="[Empty name]">
<P>Cardiac surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:27:50 +0100" MODIFIED_BY="[Empty name]">
<P>iv N-acetylcysteine 4 times 600mg in 24 hours, two intraoperatively two postoperatively versus placebo (5% dextrose)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-11-23 13:17:17 +0000" MODIFIED_BY="[Empty name]">
<P>renal function, mortality, morbidity</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:28:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Burns-2010">
<CHAR_METHODS MODIFIED="2011-12-14 07:14:53 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-12-14 07:15:13 +0000" MODIFIED_BY="[Empty name]">
<P>Critically ill patients undergoing contrast enhanced CT</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:28:40 +0100" MODIFIED_BY="[Empty name]">
<P>iv N-acetylcysteine 5000mg before CT, 2500mg 6 hours and 12 hours after CT versus placebo (dextrose 5%)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-12-14 07:17:05 +0000" MODIFIED_BY="[Empty name]">
<P>increase in creatinine by 50 micromol/L by day 5, ICU length of stay</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-12-14 07:23:39 +0000" MODIFIED_BY="[Empty name]">
<P>No adverse reactions</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:30:58 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Charunwatthana-2009">
<CHAR_METHODS MODIFIED="2010-01-15 14:35:45 +0000" MODIFIED_BY="[Empty name]">
<P>Randomized double blinded trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-29 14:30:44 +0100" MODIFIED_BY="[Empty name]">
<P>Severe malaria</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:30:58 +0100" MODIFIED_BY="[Empty name]">
<P>iv N-acetylcysteine 150mg/kg bolus, 50mg/kg for 4 hrs then 100mg/kg for 16 hrs versus placebo (dextrose 5%)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-08 14:41:32 +0000" MODIFIED_BY="[Empty name]">
<P>lactate clearance, mortality, morbidity</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:31:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Csontos-2011">
<CHAR_METHODS MODIFIED="2011-12-14 14:41:00 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-12-14 14:39:57 +0000" MODIFIED_BY="[Empty name]">
<P>Patients with severe burns</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:31:22 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine 150mg/kg bolus and 12mg/kg/hr for 5 days versus standard treatment (no placebo)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:31:27 +0100" MODIFIED_BY="[Empty name]">
<P>oxidative stress, inflammatory markers, oedema formation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:32:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-De-Backer-1996">
<CHAR_METHODS MODIFIED="2012-07-29 14:31:58 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 13:20:24 +0000" MODIFIED_BY="[Empty name]">
<P>Cardiac surgery, low risk</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:32:09 +0100" MODIFIED_BY="[Empty name]">
<P>iv N-acetylcysteine 72mg/kg bolus preoperatively then 72 mg/kg for 12 hrs versus placebo (0.9% NaCl)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-11-23 13:23:11 +0000" MODIFIED_BY="[Empty name]">
<P>inflammatory mediators in BAL</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:32:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Domenighetti-1997">
<CHAR_METHODS MODIFIED="2012-07-29 14:32:33 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 13:24:10 +0000" MODIFIED_BY="[Empty name]">
<P>ARDS</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:32:39 +0100" MODIFIED_BY="[Empty name]">
<P>iv N-acetylcysteine 190 mg/kg/day for 3 days versus placebo (not specified)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-11-23 13:26:37 +0000" MODIFIED_BY="[Empty name]">
<P>mortality, morbidity, adverse events</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:33:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-El_x002d_Hamamsy-2007">
<CHAR_METHODS MODIFIED="2012-07-29 14:33:03 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-04 11:28:31 +0000" MODIFIED_BY="[Empty name]">
<P>Cardiac surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:33:29 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine oral 600 mg preoperatively then 150 mg/kg iv bolus on incision versus placebo (5% dextrose)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-04 11:31:03 +0000" MODIFIED_BY="[Empty name]">
<P>mortality, organ dysfunction</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:34:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Emet-2004">
<CHAR_METHODS MODIFIED="2012-07-29 14:33:54 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-29 14:34:00 +0100" MODIFIED_BY="[Empty name]">
<P>Severe sepsis</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:34:08 +0100" MODIFIED_BY="[Empty name]">
<P>iv N-acetylcysteine 150 mg/kg bolus then 12 mg/kg/hr for 6 hrs versus placebo (dextrose 5%)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-11-23 13:34:29 +0000" MODIFIED_BY="[Empty name]">
<P>Gastric tonometry, inflammatory response, mortality, length of mechanical ventilation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:34:48 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Eren-2003">
<CHAR_METHODS MODIFIED="2012-07-29 14:34:34 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 13:45:27 +0000" MODIFIED_BY="[Empty name]">
<P>Cardiac surgery (low risk)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:34:42 +0100" MODIFIED_BY="[Empty name]">
<P>iv N-acetylcysteine 100 mg/kg bolus on induction and 40 mg/kg/day for 24 hrs versus placebo (0.9% NaCl)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:34:48 +0100" MODIFIED_BY="[Empty name]">
<P>haemodynamics, oxygenation, time for extubation, lipid peroxidation, mortality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:35:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Haase-2007">
<CHAR_METHODS MODIFIED="2012-07-29 14:35:34 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, multi blind, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 13:50:31 +0000" MODIFIED_BY="[Empty name]">
<P>Cardiac surgery (high risk for postoperative renal failure)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:35:46 +0100" MODIFIED_BY="[Empty name]">
<P>iv N-acetylcysteine 150mg/kg bolus on induction, 50mg/kg for 4 hrs then 100mg/kg for 16 hrs versus placebo (dextrose 5%)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-16 15:21:46 +0000" MODIFIED_BY="[Empty name]">
<P>Absolute change in serum creatinine from baseline, morbidity, LOS, mortality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:36:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hilmi-2010">
<CHAR_METHODS MODIFIED="2012-07-29 14:36:08 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled double blinded clinical trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-12-14 07:56:51 +0000" MODIFIED_BY="[Empty name]">
<P>Patients undergoing orthotopic liver transplantation</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:36:17 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine 140mg/kg bolus at the start of surgery, 70mg/kg every 4 hours for a total of 12 doses versus placebo (5% dextrose)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:36:24 +0100" MODIFIED_BY="[Empty name]">
<P>incidence of post-transplantation acute kidney injury, liver graft performance</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:36:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hynninen-2006">
<CHAR_METHODS MODIFIED="2012-07-29 14:36:36 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 13:59:43 +0000" MODIFIED_BY="[Empty name]">
<P>Vascular surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:36:50 +0100" MODIFIED_BY="[Empty name]">
<P>iv N-acetylcysteine 150 mg/kg bolus on induction then 150 mg/kg for 24 hrs versus placebo (dextrose 5%)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:36:54 +0100" MODIFIED_BY="[Empty name]">
<P>renal dysfunction</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:37:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jepsen-1992">
<CHAR_METHODS MODIFIED="2012-07-29 14:37:12 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 14:16:58 +0000" MODIFIED_BY="[Empty name]">
<P>ARDS</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:37:16 +0100" MODIFIED_BY="[Empty name]">
<P>iv N-acetylcysteine 150 mg/kg bolus and 20 mg/kg/hr for 7 days versus placebo (not stated)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:37:20 +0100" MODIFIED_BY="[Empty name]">
<P>resolution of ARDS</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:38:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Keays-1991">
<CHAR_METHODS MODIFIED="2012-07-29 14:37:50 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 14:21:05 +0000" MODIFIED_BY="[Empty name]">
<P>Patients with fulminant liver failure</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:38:01 +0100" MODIFIED_BY="[Empty name]">
<P>iv N-acetylcysteine 150mg/kg bolus on induction, 50mg/kg for 4 hrs then 100mg/kg for 16 hrs versus placebo (dextrose 5%) until recovery from encephalopathy or death</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:38:08 +0100" MODIFIED_BY="[Empty name]">
<P>mortality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:38:55 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lee-2009">
<CHAR_METHODS MODIFIED="2012-07-29 14:38:29 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-03-02 22:32:18 +0000" MODIFIED_BY="[Empty name]">
<P>Liver failure patients waiting for liver transplantation</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:38:42 +0100" MODIFIED_BY="[Empty name]">
<P>iv N-acetylcysteine 150 mg/kg/h over 1 hour, followed by 12.5 mg/kg/h for 4 hours, then continuous infusions of 6.25 mg/kg N-acetylcysteine for the remaining 67 hours versus placebo (5% dextrose)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:38:55 +0100" MODIFIED_BY="[Empty name]">
<P>21-day mortality, transplant-free survival</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:41:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Macedo-2006">
<CHAR_METHODS MODIFIED="2012-07-29 14:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 14:29:42 +0000" MODIFIED_BY="[Empty name]">
<P>Vascular surgery patients</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:39:28 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine 2400 mg oral before surgery then 1200 mg iv for 48 hrs postop versus no treatment</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:41:11 +0100" MODIFIED_BY="[Empty name]">
<P>occurrence of acute renal failure</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:41:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Molnar-1999">
<CHAR_METHODS MODIFIED="2012-07-29 14:39:54 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 14:37:55 +0000" MODIFIED_BY="[Empty name]">
<P>Ventilated patients with two or more organ failures</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:40:07 +0100" MODIFIED_BY="[Empty name]">
<P>iv N-acetylcysteine 150 mg/kg bolus then 12 mg/kg/hr for 3 to 5 days versus placebo (dextrose 5%)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:41:00 +0100" MODIFIED_BY="[Empty name]">
<P>mortality, resolution of organ dysfunction</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-11-23 14:37:55 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:40:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Moradi-2009">
<CHAR_METHODS MODIFIED="2012-07-29 14:40:26 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, single blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 14:40:47 +0000" MODIFIED_BY="[Empty name]">
<P>ARDS</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:40:33 +0100" MODIFIED_BY="[Empty name]">
<P>iv N-acetylcysteine 150 mg/kg bolus then 50 mg/kg/day for 3 days versus placebo (dextrose 5%)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:40:38 +0100" MODIFIED_BY="[Empty name]">
<P>mortality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:41:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Orhan-2006">
<CHAR_METHODS MODIFIED="2012-07-29 14:41:39 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 15:01:04 +0000" MODIFIED_BY="[Empty name]">
<P>Cardiac surgery (low risk)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-03-02 22:27:10 +0000" MODIFIED_BY="[Empty name]">
<P>iv N-acetylcysteine 50 mg/kg bolus on induction vs no treatment</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:41:44 +0100" MODIFIED_BY="[Empty name]">
<P>oxidative stress levels</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-08-06 10:45:48 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ortolani-2000b">
<CHAR_METHODS MODIFIED="2011-03-02 22:47:50 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-03-02 22:32:22 +0000" MODIFIED_BY="[Empty name]">
<P>ARDS patients</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:42:07 +0100" MODIFIED_BY="[Empty name]">
<P>iv N-acetylcysteine 50 mg/kg bolus 8 hourly for 9 days versus placebo (5% dextrose). Third group received 50 mg/kg N-acetylcysteine plus rutin 5mg/kg, but this data is not included</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-08-06 10:45:48 +0100" MODIFIED_BY="[Empty name]">
<P>lipid peroxidation, glutathione levels</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-07-29 14:42:38 +0100" MODIFIED_BY="[Empty name]">
<P>Only iv N-acetylcysteine and placebo group data are analysed</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:44:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ozaydin-2008">
<CHAR_METHODS MODIFIED="2012-07-29 14:44:12 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 15:25:38 +0000" MODIFIED_BY="[Empty name]">
<P>Cardiac surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:44:17 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine 50 mg/kg bolus preoperatively then 50 mg/kg/day for 48 hrs versus placebo (0.9% NaCl)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:44:25 +0100" MODIFIED_BY="[Empty name]">
<P>incidence of postoperative AF</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:44:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Paterson-2003">
<CHAR_METHODS MODIFIED="2012-07-29 14:44:42 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 15:29:53 +0000" MODIFIED_BY="[Empty name]">
<P>Patients with sepsis</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:44:49 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine 150mg/kg bolus then, 50mg/kg for 4 hrs then 50mg/kg for 16 hrs versus placebo (0.9% NaCl) for 72 hrs</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-11-23 15:29:21 +0000" MODIFIED_BY="[Empty name]">
<P>NF-kB activation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:45:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Peake-1996">
<CHAR_METHODS MODIFIED="2012-07-29 14:45:18 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 15:33:23 +0000" MODIFIED_BY="[Empty name]">
<P>Septic shock patients</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:45:34 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine 150mg/kg bolus then 50mg/kg for 4 hrs then 100mg/kg for 44 hrs versus placebo (dextrose 5%)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:45:40 +0100" MODIFIED_BY="[Empty name]">
<P>improvement in haemodynamic variables, resolution of organ failure</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:46:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Peker-2008">
<CHAR_METHODS MODIFIED="2012-07-29 14:46:04 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 15:36:09 +0000" MODIFIED_BY="[Empty name]">
<P>Cardiac surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:46:10 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine 50 mg/kg bolus preoperatively then 50 mg/kg/day for 48 hrs versus placebo (0.9% NaCl)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-11-23 15:38:52 +0000" MODIFIED_BY="[Empty name]">
<P>markers of myocardial injury</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:46:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rank-2000">
<CHAR_METHODS MODIFIED="2012-07-29 14:46:37 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-29 14:46:43 +0100" MODIFIED_BY="[Empty name]">
<P>Septic shock</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:46:51 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine 150 mg/kg bolus then 12.5 mg/kg/hr versus placebo (dextrose 5%) for 90 minutes</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:46:57 +0100" MODIFIED_BY="[Empty name]">
<P>liver blood flow and liver function</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:47:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ristikankare-2006">
<CHAR_METHODS MODIFIED="2012-07-29 14:47:13 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 16:24:16 +0000" MODIFIED_BY="[Empty name]">
<P>Cardiac surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:47:19 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine 150mg/kg bolus on induction, 50mg/kg for 4 hrs then 100mg/kg for 16 hrs versus placebo (0.9% NaCl)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:47:23 +0100" MODIFIED_BY="[Empty name]">
<P>renal function</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:47:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sisillo-2008">
<CHAR_METHODS MODIFIED="2012-07-29 14:47:38 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 16:34:28 +0000" MODIFIED_BY="[Empty name]">
<P>Cardiac surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:47:44 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine 1200 mg bolus before induction then 1200 mg 12 hourly for 36 hrs versus placebo (0.9% NaCl)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:47:50 +0100" MODIFIED_BY="[Empty name]">
<P>occurrence of acute renal failure</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:48:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Spapen-1998">
<CHAR_METHODS MODIFIED="2012-07-29 14:48:07 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 16:56:51 +0000" MODIFIED_BY="[Empty name]">
<P>Septic shock patients</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:48:18 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine 150 mg/kg bolus then 50 mg/kg over 4 hours versus placebo (dextrose 5%)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:48:23 +0100" MODIFIED_BY="[Empty name]">
<P>haemodynamic and oxygen transport variables, inflammatory markers</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:48:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Spapen-2005">
<CHAR_METHODS MODIFIED="2012-07-29 14:48:43 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-04 10:50:53 +0000" MODIFIED_BY="[Empty name]">
<P>Severe sepsis</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:48:53 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine50 mg/kg/4 hrs followed by 100 mg/kg/24 hrs for 44 hrs versus placebo (5% dextrose)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-04 10:55:59 +0000" MODIFIED_BY="[Empty name]">
<P>microalbuminuria, organ dysfunction scores</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:49:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Spies-1994">
<CHAR_METHODS MODIFIED="2012-07-29 14:49:09 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 17:21:39 +0000" MODIFIED_BY="[Empty name]">
<P>Septic shock patients</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:49:17 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine 150 mg/kg bolus then 12.5 mg/kg/hr for 90 minutes versus placebo (dextrose 5%)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:49:22 +0100" MODIFIED_BY="[Empty name]">
<P>oxygen consumption, haemodynamic variables</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:49:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Spies-1996">
<CHAR_METHODS MODIFIED="2012-07-29 14:49:45 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-01-04 10:56:46 +0000" MODIFIED_BY="[Empty name]">
<P>High risk cardiac surgery patients</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:49:53 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine 150 mg/kg bolus versus placebo (dextrose 5%)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-08 16:39:26 +0000" MODIFIED_BY="Jane Cracknell">
<P>VO<SUB>2</SUB>, tissue oxygenation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-01-16 15:21:47 +0000" MODIFIED_BY="[Empty name]">
<P>No mortality or other clinical outcome</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:50:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Steib-1998">
<CHAR_METHODS MODIFIED="2012-07-29 14:50:25 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 17:28:36 +0000" MODIFIED_BY="[Empty name]">
<P>Liver transplant patients</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:50:34 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine 150mg/kg bolus then, 50mg/kg for 4 hrs then 100mg/kg for 16 hrs versus placebo (dextrose 5%)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:50:39 +0100" MODIFIED_BY="[Empty name]">
<P>intraoperative haemodynamics and postoperative graft function</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:51:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sucu-2004">
<CHAR_METHODS MODIFIED="2012-07-29 14:51:04 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 17:35:15 +0000" MODIFIED_BY="[Empty name]">
<P>Cardiac surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:51:14 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine 50 mg/kg on induction than daily for 3 days versus placebo (0.9% saline)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-16 15:21:47 +0000" MODIFIED_BY="[Empty name]">
<P>Antioxidant capacity</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:51:35 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Suter-1994">
<CHAR_METHODS MODIFIED="2012-07-29 14:51:26 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 17:39:22 +0000" MODIFIED_BY="[Empty name]">
<P>ALI/ARDS</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:51:31 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine 40 mg/kg/day for 3 days versus placebo (not stated)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:51:35 +0100" MODIFIED_BY="[Empty name]">
<P>development of ARDS, mortality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:52:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Szakmany-2003">
<CHAR_METHODS MODIFIED="2012-07-29 14:51:50 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 17:43:03 +0000" MODIFIED_BY="[Empty name]">
<P>Major abdominal surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:51:59 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine 150 mg/kg bolus on induction then 12 mg/kg/hr intraoperatively versus placebo (dextrose 5%)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:52:04 +0100" MODIFIED_BY="[Empty name]">
<P>organ dysfunction, mortality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-11-23 17:42:49 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:52:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tossios-2003">
<CHAR_METHODS MODIFIED="2012-07-29 14:52:20 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 17:46:17 +0000" MODIFIED_BY="[Empty name]">
<P>Cardiac surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:52:25 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine 100 mg/kg bolus on induction then 12 mg/kg/hr intraoperatively versus placebo (0.9% NaCl)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:52:31 +0100" MODIFIED_BY="[Empty name]">
<P>antioxidant levels</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:53:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Walsh-1998">
<CHAR_METHODS MODIFIED="2011-03-02 22:27:26 +0000" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-03-02 22:32:26 +0000" MODIFIED_BY="[Empty name]">
<P>Fulminant liver failure patients</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:52:58 +0100" MODIFIED_BY="[Empty name]">
<P>iv N-acetycysteine 150 mg/kg body over 15 minutes, followed by 50 mg/kg over 4 hours, followed by 100mg/kg over 16 hours versus placebo (5% dextrose)<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:53:03 +0100" MODIFIED_BY="[Empty name]">
<P>haemodynamic variables, N-acetycysteine levels</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-29 14:53:43 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wijeysundera-2007">
<CHAR_METHODS MODIFIED="2012-07-29 14:53:22 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized, double blinded, placebo-controlled trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-23 17:56:40 +0000" MODIFIED_BY="[Empty name]">
<P>Cardiac surgery with moderate renal insufficiency</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-29 14:53:43 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine 100 mg/kg on induction then 20 mg/kg/hr for 4 hrs versus placebo (dextrose 5%)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-29 14:53:31 +0100" MODIFIED_BY="[Empty name]">
<P>renal impairment</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2012-07-29 14:55:31 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2009-11-23 18:00:53 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Adabag-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-23 18:00:53 +0000" MODIFIED_BY="[Empty name]">
<P>Oral N-acetylcysteine</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-23 18:01:11 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Agusti-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-23 18:01:11 +0000" MODIFIED_BY="[Empty name]">
<P>Cross-over design</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-23 18:01:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Barr-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-23 18:01:31 +0000" MODIFIED_BY="[Empty name]">
<P>Oral N-acetylcysteine</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-15 11:46:52 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Csontos-2011b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-15 11:46:52 +0000" MODIFIED_BY="[Empty name]">
<P>Duplicate publication</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-03-02 22:27:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-De-Rosa-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-03-02 22:27:31 +0000" MODIFIED_BY="[Empty name]">
<P>Oral N-acetylcysteine </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-23 18:02:08 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Devlin-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-23 18:02:08 +0000" MODIFIED_BY="[Empty name]">
<P>Non-RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-15 12:06:05 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fischer-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-15 12:06:05 +0000" MODIFIED_BY="[Empty name]">
<P>Duplicate publication</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-02-28 15:11:19 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fraga-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-02-28 15:11:19 +0000" MODIFIED_BY="[Empty name]">
<P>i.v. N-acetylcysteine and deferoxamine combination</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-15 12:06:07 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Haase-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-15 12:06:07 +0000" MODIFIED_BY="[Empty name]">
<P>Duplicate publication</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-29 14:54:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Heller-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-29 14:54:14 +0100" MODIFIED_BY="[Empty name]">
<P>i.v. N-acetylcysteine regime versus different N-acetylcysteine regime (not placebo)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-23 18:03:01 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jepsen-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-23 18:03:01 +0000" MODIFIED_BY="[Empty name]">
<P>Oral N-acetylcysteine</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-23 18:03:28 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Koksal-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-23 18:03:28 +0000" MODIFIED_BY="[Empty name]">
<P>Non-intravenous N-acetylcysteine</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-23 18:03:43 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Komisarof-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-23 18:03:43 +0000" MODIFIED_BY="[Empty name]">
<P>Oral N-acetylcysteine</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-23 18:03:53 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Koramaz-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-23 18:03:53 +0000" MODIFIED_BY="[Empty name]">
<P>Oral N-acetylcysteine</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-14 07:42:45 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kurian-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-14 07:42:45 +0000" MODIFIED_BY="[Empty name]">
<P>Non-intravenous N-acetylcysteine</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-15 12:06:10 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Laurent-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-15 12:06:10 +0000" MODIFIED_BY="[Empty name]">
<P>Duplicate publication</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-23 18:04:06 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lawlor-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-23 18:04:06 +0000" MODIFIED_BY="[Empty name]">
<P>Oral N-acetylcysteine</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-23 18:04:49 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Milewski-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-23 18:04:49 +0000" MODIFIED_BY="[Empty name]">
<P>Oral N-acetylcysteine</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-15 12:06:13 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Molnar-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-15 12:06:13 +0000" MODIFIED_BY="[Empty name]">
<P>Duplicate publication</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-15 12:06:15 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Molnar-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-15 12:06:15 +0000" MODIFIED_BY="[Empty name]">
<P>Duplicate publication</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-15 12:06:26 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Najafi-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-15 12:06:26 +0000" MODIFIED_BY="[Empty name]">
<P>Duplicate publication</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-15 12:06:28 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Niemi-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-15 12:06:28 +0000" MODIFIED_BY="[Empty name]">
<P>Duplicate publication</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-29 14:55:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ortolani-2000a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-29 14:55:31 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine and glutathione (GSH) in treatment arm</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-15 12:06:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Reinhart-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-15 12:06:31 +0000" MODIFIED_BY="[Empty name]">
<P>Duplicate publication</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-15 09:42:56 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sahib-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-15 09:42:56 +0000" MODIFIED_BY="[Empty name]">
<P>Non-randomized trial, oral N-acetylcysteine</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-03-02 22:32:26 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Saricaoglu-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-03-02 22:32:26 +0000" MODIFIED_BY="[Empty name]">
<P>No clinical outcome data </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-29 14:54:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Siriwardena-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-29 14:54:39 +0100" MODIFIED_BY="[Empty name]">
<P>N-acetylcysteine, selenium and vitamin C in treatment arm</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-15 12:06:35 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Soltan_x002d_Sharifi-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-15 12:06:35 +0000" MODIFIED_BY="[Empty name]">
<P>Duplicate publication</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-15 12:06:37 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Spies-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-15 12:06:37 +0000" MODIFIED_BY="[Empty name]">
<P>Duplicate publication</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-15 12:06:40 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Szakmany-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-15 12:06:40 +0000" MODIFIED_BY="[Empty name]">
<P>Duplicate publication</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-15 12:06:42 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wijeysundera-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-15 12:06:42 +0000" MODIFIED_BY="[Empty name]">
<P>Duplicate publication</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-03-02 22:27:33 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zingg-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-03-02 22:27:33 +0000" MODIFIED_BY="[Empty name]">
<P>Non-randomized trial (before-after design)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2012-07-29 14:53:56 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2012-07-29 14:53:51 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-14 12:18:10 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Andersen-2005">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:26:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bernard-1997">
<DESCRIPTION>
<P>Computer permuted block generation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:27:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bromley-1995">
<DESCRIPTION>
<P>Only stated "randomized".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:28:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Burns-2005">
<DESCRIPTION>
<P>Computer generated permuted blocks strategy.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:30:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Burns-2010">
<DESCRIPTION>
<P>Computer generated random number tables.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:31:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Charunwatthana-2009">
<DESCRIPTION>
<P>Computer allocated blocks.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:31:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Csontos-2011">
<DESCRIPTION>
<P>Only states randomised controlled trial, but no method given for randomization.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:32:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-De-Backer-1996">
<DESCRIPTION>
<P>Only stated: "randomized".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:32:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Domenighetti-1997">
<DESCRIPTION>
<P>Only states: "randomized".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:33:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-El_x002d_Hamamsy-2007">
<DESCRIPTION>
<P>Only states: "randomized".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:34:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Emet-2004">
<DESCRIPTION>
<P>Computer generated blocks.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:35:10 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Eren-2003">
<DESCRIPTION>
<P>States: The decision of which procedure should be performed was made independently by the surgeon.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:35:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Haase-2007">
<DESCRIPTION>
<P>Computer random number generator with permuted blocks.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:36:28 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hilmi-2010">
<DESCRIPTION>
<P>Random number generation in blocks.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:36:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hynninen-2006">
<DESCRIPTION>
<P>Random number generation in blocks.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:37:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jepsen-1992">
<DESCRIPTION>
<P>Only stated: patients were randomized.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:38:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Keays-1991">
<DESCRIPTION>
<P>Random number generation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:39:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-2009">
<DESCRIPTION>
<P>Computer generated random numbers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:39:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Macedo-2006">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:40:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Molnar-1999">
<DESCRIPTION>
<P>Random number generation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:40:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moradi-2009">
<DESCRIPTION>
<P>Only stated; "simple randomization".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-14 12:22:40 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Orhan-2006">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:44:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ortolani-2000b">
<DESCRIPTION>
<P>States "patients were randomly assigned" but no method described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:44:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ozaydin-2008">
<DESCRIPTION>
<P>Computer generated random numbers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:45:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Paterson-2003">
<DESCRIPTION>
<P>Random number table.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:45:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peake-1996">
<DESCRIPTION>
<P>Random number generation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:46:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peker-2008">
<DESCRIPTION>
<P>Only stated: patients were randomized.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:47:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rank-2000">
<DESCRIPTION>
<P>Only states: "patients were randomly assigned".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:47:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ristikankare-2006">
<DESCRIPTION>
<P>Random number generation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:47:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sisillo-2008">
<DESCRIPTION>
<P>Computer generated random numbers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:48:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spapen-1998">
<DESCRIPTION>
<P>Computer generated permuted blocks.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:48:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spapen-2005">
<DESCRIPTION>
<P>Computer generated permuted blocks.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:49:28 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spies-1994">
<DESCRIPTION>
<P>Computer generated random numbers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:50:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spies-1996">
<DESCRIPTION>
<P>Computer generated random numbers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:50:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Steib-1998">
<DESCRIPTION>
<P>Not-stated, only says "(patients) were allocated randomly to be administered either NAC or, ... placebo".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-14 12:30:19 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sucu-2004">
<DESCRIPTION>
<P>Method of allocation sequence generation not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:51:38 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Suter-1994">
<DESCRIPTION>
<P>Only states: "patients were randomized".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:52:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Szakmany-2003">
<DESCRIPTION>
<P>Computer generated random numbers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:52:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tossios-2003">
<DESCRIPTION>
<P>Computer generated random numbers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:53:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Walsh-1998">
<DESCRIPTION>
<P>Random number generation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:53:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wijeysundera-2007">
<DESCRIPTION>
<P>Computer generated random tables.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2012-07-29 14:53:53 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-14 12:18:04 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Andersen-2005">
<DESCRIPTION>
<P>Method of allocation to treatment group not clearly stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:26:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bernard-1997">
<DESCRIPTION>
<P>Ready made concealed bags supplied by pharmacy.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:27:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bromley-1995">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:28:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Burns-2005">
<DESCRIPTION>
<P>Centrally prepared premixed and preprepared bags.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:30:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Burns-2010">
<DESCRIPTION>
<P>Study medication centrally prepared and supplied in identical bags.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:31:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Charunwatthana-2009">
<DESCRIPTION>
<P>Identical ampoules supplied centrally.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:31:44 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Csontos-2011">
<DESCRIPTION>
<P>N-acetylcysteine was compared to standard treatment (no placebo).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:32:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-De-Backer-1996">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:32:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Domenighetti-1997">
<DESCRIPTION>
<P>Similar vials.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:33:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El_x002d_Hamamsy-2007">
<DESCRIPTION>
<P>Similar preparation for N-acetylcysteine and placebo.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:34:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Emet-2004">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:35:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Eren-2003">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:35:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Haase-2007">
<DESCRIPTION>
<P>Central randomization, premixed bags were used.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:36:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hilmi-2010">
<DESCRIPTION>
<P>Central randomization, premixed bags were used.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:36:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hynninen-2006">
<DESCRIPTION>
<P>Central randomization, premixed bags.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:37:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jepsen-1992">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:38:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Keays-1991">
<DESCRIPTION>
<P>Sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:39:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-2009">
<DESCRIPTION>
<P>Central allocation, premixed bags prepared by pharmacy.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:39:39 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Macedo-2006">
<DESCRIPTION>
<P>N-acetylcysteine versus no treatment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:40:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Molnar-1999">
<DESCRIPTION>
<P>Sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:40:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moradi-2009">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-02 22:27:10 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Orhan-2006">
<DESCRIPTION>
<P>Method of allocation to treatment group not clearly stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:44:05 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ortolani-2000b">
<DESCRIPTION>
<P>No data.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:44:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ozaydin-2008">
<DESCRIPTION>
<P>Sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:45:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Paterson-2003">
<DESCRIPTION>
<P>Sealed envelope, premixed infusion.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:45:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peake-1996">
<DESCRIPTION>
<P>Sealed envelope, premixed bag of infusion by pharmacist.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:46:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peker-2008">
<DESCRIPTION>
<P>Not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:47:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rank-2000">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:47:28 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ristikankare-2006">
<DESCRIPTION>
<P>Hospital pharmacy prepared the study infusions.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:48:02 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sisillo-2008">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:48:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spapen-1998">
<DESCRIPTION>
<P>Infusions prepared by hospital pharmacy.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:48:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spapen-2005">
<DESCRIPTION>
<P>Infusions prepared by hospital pharmacy.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:49:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spies-1994">
<DESCRIPTION>
<P>Sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:50:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spies-1996">
<DESCRIPTION>
<P>Sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-14 12:29:13 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Steib-1998">
<DESCRIPTION>
<P>Method of allocation to treatment group not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-14 12:30:19 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sucu-2004">
<DESCRIPTION>
<P>Method of allocation to treatment group not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:51:40 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Suter-1994">
<DESCRIPTION>
<P>Similar vials for treatment and placebo.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:52:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Szakmany-2003">
<DESCRIPTION>
<P>Sealed envelopes, pre-prepared infusions.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:52:43 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Tossios-2003">
<DESCRIPTION>
<P>Identical appearance glass vials, supplied by pharmacy.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:53:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Walsh-1998">
<DESCRIPTION>
<P>Sealed envelopes, matching infusion bags.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-29 14:53:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wijeysundera-2007">
<DESCRIPTION>
<P>Central randomization and preparation of drugs by independent pharmacist.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2012-07-29 14:53:56 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-01-14 12:18:43 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Andersen-2005">
<DESCRIPTION>
<P>Blinding of treatment: not stated.<BR/>Blinding of assessor: not stated.<BR/>Blinding of data analysis: not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:26:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bernard-1997">
<DESCRIPTION>
<P>Investigators, medical and nursing team and patients were blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:27:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bromley-1995">
<DESCRIPTION>
<P>Stated: "double-blind".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:28:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Burns-2005">
<DESCRIPTION>
<P>Stated in manuscript: Patients, health care clinicians, and individuals participating in the data collection and data analysis were blinded to treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:30:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Burns-2010">
<DESCRIPTION>
<P>Patients, medical and nursing staff were blinded to the intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:31:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Charunwatthana-2009">
<DESCRIPTION>
<P>Doctors, nurses and patients were masked for the treatment allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:31:51 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Csontos-2011">
<DESCRIPTION>
<P>No blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:32:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-De-Backer-1996">
<DESCRIPTION>
<P>Only stated: "double-blinded fashion".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:32:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Domenighetti-1997">
<DESCRIPTION>
<P>Researchers, medical, nursing staff and patients blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:33:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El_x002d_Hamamsy-2007">
<DESCRIPTION>
<P>States: "double-blinded".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:34:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Emet-2004">
<DESCRIPTION>
<P>Drug solution and infusion was administered to all patients by a nurse without any knowledge about the study protocol. Patients and medical staff was blinded to the treatment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:35:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Eren-2003">
<DESCRIPTION>
<P>Medical, nursing staff and patients.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:35:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Haase-2007">
<DESCRIPTION>
<P>Patients and all staff were blinded to the treatment allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:36:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hilmi-2010">
<DESCRIPTION>
<P>Patients and all staff were blinded to the treatment allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:37:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hynninen-2006">
<DESCRIPTION>
<P>Patients and staff.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:37:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jepsen-1992">
<DESCRIPTION>
<P>Patients and staff were blinded for treatment allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-01-14 12:19:38 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Keays-1991">
<DESCRIPTION>
<P>Blinding of treatment: no.<BR/>Blinding of assessor: not stated.<BR/>Blinding of data analysis: not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:39:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-2009">
<DESCRIPTION>
<P>Patients, staff and investigators blinded for treatment intervention.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:39:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Macedo-2006">
<DESCRIPTION>
<P>Stated "double-blinded" but compared N-acetylcysteine versus no treatment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:40:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Molnar-1999">
<DESCRIPTION>
<P>Patients, medical and nursing staff were blinded for treatment allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-01-14 12:20:45 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Moradi-2009">
<DESCRIPTION>
<P>Blinding of treatment: patients only.<BR/>Blinding of assessor: no.<BR/>Blinding of data analysis: not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:41:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Orhan-2006">
<DESCRIPTION>
<P>Stated double blind, but investigated N-acetylcysteine versus no treatment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:44:07 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ortolani-2000b">
<DESCRIPTION>
<P>Non-blinded trial.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:44:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ozaydin-2008">
<DESCRIPTION>
<P>Patients and investigators were blinded for treatment assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:45:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Paterson-2003">
<DESCRIPTION>
<P>Patients and investigators were blinded for the treatment allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:45:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peake-1996">
<DESCRIPTION>
<P>Patients and investigators blinded for treatment allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:46:28 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peker-2008">
<DESCRIPTION>
<P>Patients, medical staff and investigators blinded for treatment allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:47:05 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rank-2000">
<DESCRIPTION>
<P>Patients and investigators were blinded for treatment allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:47:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ristikankare-2006">
<DESCRIPTION>
<P>Patients, staff and investigators were blinded for treatment allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:47:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sisillo-2008">
<DESCRIPTION>
<P>Patients and investigators were blinded for treatment allocations.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:48:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spapen-1998">
<DESCRIPTION>
<P>Patients and investigators were blinded for treatment allocations.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:49:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spapen-2005">
<DESCRIPTION>
<P>Patients and investigators were blinded for treatment allocations.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:49:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spies-1994">
<DESCRIPTION>
<P>Patients and investigators were blinded for treatment allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:50:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spies-1996">
<DESCRIPTION>
<P>Patients and investigators were blinded for treatment allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:50:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Steib-1998">
<DESCRIPTION>
<P>Blinding of treatment: not stated.<BR/>Blinding of assessor: not stated.<BR/>Blinding of data analysis: not stated.</P>
<P>Probably not, as no indication of blinding in the manuscript.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-01-14 12:30:19 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sucu-2004">
<DESCRIPTION>
<P>Blinding of treatment: not stated.<BR/>Blinding of assessor: not stated.<BR/>Blinding of data analysis: not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:51:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Suter-1994">
<DESCRIPTION>
<P>Patients and investigators were blinded for treatment allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:52:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Szakmany-2003">
<DESCRIPTION>
<P>Patients, staff and investigators were blinded for treatment allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:52:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tossios-2003">
<DESCRIPTION>
<P>Patients, staff and investigators were blinded for treatment allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:53:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Walsh-1998">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-07-29 14:53:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wijeysundera-2007">
<DESCRIPTION>
<P>Patients, clinicians and data-collectors were blinded to treatment allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2011-12-14 14:47:36 +0000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 13:39:38 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Andersen-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 13:39:56 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bernard-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 13:40:20 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bromley-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 13:40:34 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Burns-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-12-14 07:23:06 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Burns-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 13:40:47 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Charunwatthana-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-12-14 14:47:36 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Csontos-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 13:41:00 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-De-Backer-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 13:41:18 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Domenighetti-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-04 11:28:05 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El_x002d_Hamamsy-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-25 11:52:52 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Emet-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 13:47:55 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Eren-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 13:53:38 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Haase-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-12-14 08:02:05 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hilmi-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 14:03:22 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hynninen-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 14:18:35 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jepsen-1992">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 14:22:58 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Keays-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-25 20:54:42 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 14:32:23 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Macedo-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 14:38:28 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Molnar-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 14:45:13 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moradi-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 15:05:30 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Orhan-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-23 13:09:54 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ortolani-2000b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 15:27:55 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ozaydin-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 15:31:35 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Paterson-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 15:34:49 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peake-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 15:39:02 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peker-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 16:22:46 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rank-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 16:25:59 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ristikankare-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 16:35:57 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sisillo-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-25 18:02:09 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spapen-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-04 10:56:16 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spapen-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 17:22:39 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spies-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-04 11:04:56 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spies-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 17:31:23 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Steib-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-14 12:30:19 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sucu-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 17:42:37 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Suter-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-25 20:58:31 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Szakmany-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-14 12:30:43 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tossios-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-26 12:32:22 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Walsh-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 17:58:00 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wijeysundera-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2011-12-14 14:47:41 +0000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 13:39:41 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Andersen-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 13:40:00 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bernard-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 13:40:23 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bromley-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 13:40:37 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Burns-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-12-14 07:23:22 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Burns-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 13:40:50 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Charunwatthana-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-12-14 14:47:41 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Csontos-2011">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 13:41:02 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-De-Backer-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 13:41:28 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Domenighetti-1997">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-04 11:28:07 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El_x002d_Hamamsy-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-25 11:52:52 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Emet-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 13:47:58 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Eren-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 13:53:41 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Haase-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-12-14 08:02:08 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hilmi-2010">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 14:03:24 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hynninen-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 14:18:37 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jepsen-1992">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 14:23:01 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Keays-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-25 20:54:45 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 14:33:10 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Macedo-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 14:38:30 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Molnar-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 14:45:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moradi-2009">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 15:05:33 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Orhan-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-23 13:09:56 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ortolani-2000b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 15:27:58 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ozaydin-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 15:31:37 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Paterson-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 15:34:52 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peake-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 15:39:05 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peker-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 16:22:48 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rank-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 16:26:01 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ristikankare-2006">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 16:35:59 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sisillo-2008">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-25 18:01:54 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spapen-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-04 10:56:19 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spapen-2005">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 17:22:41 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spies-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-04 11:04:58 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Spies-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 17:31:26 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Steib-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-14 12:30:19 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sucu-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 17:42:39 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Suter-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-25 18:14:45 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Szakmany-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-01-14 12:30:43 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tossios-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-26 12:32:24 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Walsh-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-23 17:58:02 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wijeysundera-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2012-07-29 14:56:01 +0100" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2012-07-29 14:56:01 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2010-01-08 12:05:29 +0000" MODIFIED_BY="[Empty name]">Summary of findings</TITLE>
<TABLE COLS="7" ROWS="10">
<TR>
<TD COLSPAN="7">
<P>
<B>N-acetylcysteine compared with placebo for SIRS or sepsis</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population: Adult patients</B> with SIRS or sepsis</P>
<P>
<B>Settings: Intensive care unit</B>
</P>
<P>
<B>Intervention: N-acetylcysteine</B>
</P>
<P>
<B>Comparison: Placebo</B>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="CENTER" ROWSPAN="3" VALIGN="MIDDLE">
<P>Outcomes</P>
</TH>
<TH ALIGN="CENTER" COLSPAN="2" VALIGN="MIDDLE">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="CENTER" ROWSPAN="3" VALIGN="MIDDLE">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="CENTER" ROWSPAN="3" VALIGN="MIDDLE">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="CENTER" ROWSPAN="3" VALIGN="MIDDLE">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="CENTER" ROWSPAN="3" VALIGN="MIDDLE">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="CENTER" VALIGN="MIDDLE">
<P>Assumed risk</P>
</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="CENTER" VALIGN="MIDDLE">
<P>Placebo</P>
</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE">
<P>N-acetylcysetine</P>
</TH>
</TR>
<TR>
<TD ALIGN="CENTER" VALIGN="MIDDLE">
<P>Mortality</P>
<P>30-day</P>
</TD>
<TD ROWSPAN="1" VALIGN="MIDDLE">
<P>136 per 1000</P>
</TD>
<TD ROWSPAN="1" VALIGN="MIDDLE">
<P>144 per 1000<BR/>(100 to 185)</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE">
<P>RR 1.07 (0.80 to 1.43)</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE">
<P>930<BR/>(11)</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE">
<P/>
<P>+++O<BR/>moderate</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="CENTER">
<P>
<B>Length of stay on the intensive care unit (days)</B>
</P>
</TD>
<TD ALIGN="CENTER">
<P>The mean <B>Length of stay on the intensive care unit</B> ranged across control groups from<BR/>1 to 33 days</P>
</TD>
<TD ALIGN="CENTER">
<P>The mean difference (95%CI) <B>Length of stay on the intensive care unit</B> in the intervention groups was<BR/>-0.22 (-0.86 to 0.43)</P>
</TD>
<TD>
<P/>
</TD>
<TD ALIGN="CENTER">
<P>
<BR/>1309<BR/>(19)</P>
</TD>
<TD ALIGN="CENTER">
<P/>
<P>+++O<BR/>moderate</P>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="CENTER">
<P>Duration of mechanical ventilation</P>
<P>(days)</P>
</TD>
<TD ALIGN="CENTER">
<P>The mean Duration of mechanical ventilation ranged across control groups from 1 to 25 days<BR/>
</P>
</TD>
<TD ALIGN="CENTER">
<P>The mean difference (95% CI) Duration of mechanical ventilation in the intervention groups was<BR/>-0.00 (-0.04 to 0.04)</P>
</TD>
<TD>
<P/>
</TD>
<TD ALIGN="CENTER">
<P>
<BR/>423<BR/>(9)</P>
</TD>
<TD ALIGN="CENTER">
<P/>
<P>+++O<BR/>moderate</P>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="CENTER" VALIGN="MIDDLE">
<P>Incidence of new organ failure</P>
</TD>
<TD ROWSPAN="1" VALIGN="MIDDLE">
<P>158 per 1000</P>
</TD>
<TD ROWSPAN="1" VALIGN="MIDDLE">
<P>165 per 1000<BR/>(123 to 241)</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE">
<P>RR 1.01 (0.80 to 1.27)</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE">
<P>1224<BR/>(12)</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE">
<P/>
<P>+++O<BR/>moderate</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<BR/>CI: Confidence interval; RR: Risk ratio; GRADE: GRADE Working Group grades of evidence (see explanations)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality (++++):</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality (+++O):</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality (++OO):</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality (+OOO):</B> We are very uncertain about the estimate.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2010-01-08 13:45:26 +0000" MODIFIED_BY="[Empty name]"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2012-08-06 10:45:48 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2012-07-29 15:16:14 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>N-acetylcysteine versus placebo - primary outcome</NAME>
<DICH_OUTCOME CHI2="7.742443044951992" CI_END="1.4290015512099292" CI_START="0.8028277274590898" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0710938651179838" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="63" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.15503270022662236" LOG_CI_START="-0.09537763658996962" LOG_EFFECT_SIZE="0.029827531818326355" METHOD="MH" MODIFIED="2012-03-05 15:11:18 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6539784725303064" P_Q="1.0" P_Z="0.6405565977869052" Q="0.0" RANDOM="NO" SCALE="683.97" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="467" TOTAL_2="463" WEIGHT="100.00000000000001" Z="0.46692072583617555">
<NAME>30-day all-cause Mortality</NAME>
<GROUP_LABEL_1>N-acetylcysteine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.278946616108553" CI_START="0.3498080525081715" EFFECT_SIZE="0.8928571428571429" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.35773415203381126" LOG_CI_START="-0.45617019737417447" LOG_EFFECT_SIZE="-0.049218022670181584" MODIFIED="2010-01-04 16:12:39 +0000" MODIFIED_BY="[Empty name]" ORDER="89" O_E="0.0" SE="0.47809144373375756" STUDY_ID="STD-Bernard-1997" TOTAL_1="14" TOTAL_2="15" VAR="0.22857142857142865" WEIGHT="9.003907196489601"/>
<DICH_DATA CI_END="5.355895422334702" CI_START="0.3319291430456687" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7288320885142859" LOG_CI_START="-0.4789546152976862" LOG_EFFECT_SIZE="0.12493873660829992" MODIFIED="2010-01-04 15:55:49 +0000" MODIFIED_BY="[Empty name]" ORDER="90" O_E="0.0" SE="0.7094598884597586" STUDY_ID="STD-Bromley-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.5033333333333332" WEIGHT="4.662737655324972"/>
<DICH_DATA CI_END="132.1011207444225" CI_START="0.37092796581794973" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1209065021796567" LOG_CI_START="-0.43071042215114297" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2010-01-04 15:57:44 +0000" MODIFIED_BY="[Empty name]" ORDER="95" O_E="0.0" SE="1.4988324120593923" STUDY_ID="STD-El_x002d_Hamamsy-2007" TOTAL_1="50" TOTAL_2="50" VAR="2.246498599439776" WEIGHT="0.777122942554162"/>
<DICH_DATA CI_END="2.454270482634857" CI_START="0.7435122882479992" EFFECT_SIZE="1.3508442776735459" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="13" LOG_CI_END="0.38992242417845724" LOG_CI_START="-0.1287118493690649" LOG_EFFECT_SIZE="0.13060528740469618" MODIFIED="2010-01-04 16:12:49 +0000" MODIFIED_BY="[Empty name]" ORDER="106" O_E="0.0" SE="0.3046483395628732" STUDY_ID="STD-Molnar-1999" TOTAL_1="41" TOTAL_2="45" VAR="0.09281061079841568" WEIGHT="19.26541992471481"/>
<DICH_DATA CI_END="1.6261635848009508" CI_START="0.3137470832586035" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.21116423154273745" LOG_CI_START="-0.5034203028992135" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2012-02-16 14:35:51 +0000" MODIFIED_BY="[Empty name]" ORDER="307" O_E="0.0" SE="0.4197504927816955" STUDY_ID="STD-Ortolani-2000b" TOTAL_1="12" TOTAL_2="12" VAR="0.17619047619047623" WEIGHT="10.879721195758268"/>
<DICH_DATA CI_END="4.007329751896776" CI_START="0.00964621359876602" EFFECT_SIZE="0.19661016949152543" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6028550807748148" LOG_CI_START="-2.0156431256052665" LOG_EFFECT_SIZE="-0.7063940224152256" MODIFIED="2010-01-04 15:56:00 +0000" MODIFIED_BY="[Empty name]" ORDER="111" O_E="0.0" SE="1.538118808202826" STUDY_ID="STD-Ozaydin-2008" TOTAL_1="58" TOTAL_2="57" VAR="2.3658094681472823" WEIGHT="3.918825094931244"/>
<DICH_DATA CI_END="4.407079247591173" CI_START="0.3328969156973013" EFFECT_SIZE="1.2112403100775193" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6441508600134609" LOG_CI_START="-0.4776902285797333" LOG_EFFECT_SIZE="0.08323031571686385" MODIFIED="2010-01-04 15:55:41 +0000" MODIFIED_BY="[Empty name]" ORDER="118" O_E="0.0" SE="0.6589750086425917" STUDY_ID="STD-Sisillo-2008" TOTAL_1="129" TOTAL_2="125" VAR="0.43424806201550387" WEIGHT="6.314888793038545"/>
<DICH_DATA CI_END="2.0605010693751504" CI_START="0.5775695350592529" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.3139728442542525" LOG_CI_START="-0.23839572247545296" LOG_EFFECT_SIZE="0.037788560889399754" MODIFIED="2010-01-04 16:13:59 +0000" MODIFIED_BY="[Empty name]" ORDER="122" O_E="0.0" SE="0.32446403036553206" STUDY_ID="STD-Spies-1994" TOTAL_1="29" TOTAL_2="29" VAR="0.10527690700104493" WEIGHT="17.096704736191565"/>
<DICH_DATA CI_END="129.92776744614594" CI_START="0.3771326250203609" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1137019760147355" LOG_CI_START="-0.423505895986222" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2010-01-14 11:36:56 +0000" MODIFIED_BY="[Empty name]" ORDER="124" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Steib-1998" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="0.777122942554162"/>
<DICH_DATA CI_END="1.4473847741421566" CI_START="0.27804053753675506" EFFECT_SIZE="0.634375" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.16058399972514328" LOG_CI_START="-0.5558918805385293" LOG_EFFECT_SIZE="-0.19765394040669304" MODIFIED="2010-01-04 16:14:33 +0000" MODIFIED_BY="[Empty name]" ORDER="126" O_E="0.0" SE="0.4208614786796877" STUDY_ID="STD-Suter-1994" TOTAL_1="32" TOTAL_2="29" VAR="0.17712438423645321" WEIGHT="16.30684207326766"/>
<DICH_DATA CI_END="2.5703939747908535" CI_START="0.3726664127879707" EFFECT_SIZE="0.9787234042553191" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.40999969452363927" LOG_CI_START="-0.428679747031926" LOG_EFFECT_SIZE="-0.009340026254143404" MODIFIED="2010-01-04 15:55:37 +0000" MODIFIED_BY="[Empty name]" ORDER="127" O_E="0.0" SE="0.49264445549992975" STUDY_ID="STD-Szakmany-2003" TOTAL_1="47" TOTAL_2="46" VAR="0.24269855953482228" WEIGHT="10.996707445175025"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2012-08-06 10:45:48 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>N-acetylcysteine versus placebo - sensitivity and subgroup analysis</NAME>
<DICH_OUTCOME CHI2="28.178866790127685" CI_END="1.0854401327634595" CI_START="0.8100499318714529" CI_STUDY="95" CI_TOTAL="95" DF="30" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9376890239282857" ESTIMABLE="YES" EVENTS_1="223" EVENTS_2="241" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.035605875024454635" LOG_CI_START="-0.09148821017334013" LOG_EFFECT_SIZE="-0.027941167574442764" METHOD="MH" MODIFIED="2012-08-06 10:45:48 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5609587458902374" P_Q="1.0" P_Z="0.388807633598216" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="31" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1228" TOTAL_2="1233" WEIGHT="100.00000000000003" Z="0.8617817587132909">
<NAME>Mortality (all reported timescales)</NAME>
<GROUP_LABEL_1>N-acetylcysteine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.278946616108553" CI_START="0.3498080525081715" EFFECT_SIZE="0.8928571428571429" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.35773415203381126" LOG_CI_START="-0.45617019737417447" LOG_EFFECT_SIZE="-0.049218022670181584" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="254" O_E="0.0" SE="0.47809144373375756" STUDY_ID="STD-Bernard-1997" TOTAL_1="14" TOTAL_2="15" VAR="0.22857142857142865" WEIGHT="2.3883394100394324"/>
<DICH_DATA CI_END="5.355895422334702" CI_START="0.3319291430456687" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7288320885142859" LOG_CI_START="-0.4789546152976862" LOG_EFFECT_SIZE="0.12493873660829992" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="231" O_E="0.0" SE="0.7094598884597586" STUDY_ID="STD-Bromley-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.5033333333333332" WEIGHT="1.2368186230561347"/>
<DICH_DATA CI_END="4.532109560681806" CI_START="0.34011897737665486" EFFECT_SIZE="1.241554054054054" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6563004000934802" LOG_CI_START="-0.46836913537093017" LOG_EFFECT_SIZE="0.09396563236127509" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="232" O_E="0.0" SE="0.6606364523357819" STUDY_ID="STD-Burns-2005" TOTAL_1="148" TOTAL_2="147" VAR="0.4364405221548079" WEIGHT="1.65468163807736"/>
<DICH_DATA CI_END="1.5402163575984629" CI_START="0.2885597482794114" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.1875817314281723" LOG_CI_START="-0.539764249539535" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="265" O_E="0.0" SE="0.4272466296411038" STUDY_ID="STD-Burns-2010" TOTAL_1="21" TOTAL_2="21" VAR="0.18253968253968256" WEIGHT="3.710455869168404"/>
<DICH_DATA CI_END="1.921993645698558" CI_START="0.6845724737859185" EFFECT_SIZE="1.1470588235294117" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="17" LOG_CI_END="0.2837519475143089" LOG_CI_START="-0.1645805675458208" LOG_EFFECT_SIZE="0.059585689984244045" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="233" O_E="0.0" SE="0.2633527386280618" STUDY_ID="STD-Charunwatthana-2009" TOTAL_1="56" TOTAL_2="52" VAR="0.06935466494290023" WEIGHT="7.268218081169384"/>
<DICH_DATA CI_END="1.892323407364669" CI_START="0.23486706485515438" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.2769953614690809" LOG_CI_START="-0.6291778795804434" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="274" O_E="0.0" SE="0.5322906474223771" STUDY_ID="STD-Csontos-2011" TOTAL_1="15" TOTAL_2="15" VAR="0.2833333333333333" WEIGHT="2.4736372461122693"/>
<DICH_DATA CI_END="3.373800796086585" CI_START="0.48012162206574754" EFFECT_SIZE="1.2727272727272727" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5281194363697701" LOG_CI_START="-0.3186487353297442" LOG_EFFECT_SIZE="0.10473535052001297" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="235" O_E="0.0" SE="0.49739581562634544" STUDY_ID="STD-Domenighetti-1997" TOTAL_1="22" TOTAL_2="20" VAR="0.2474025974025974" WEIGHT="2.159524579939283"/>
<DICH_DATA CI_END="132.1011207444225" CI_START="0.37092796581794973" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1209065021796567" LOG_CI_START="-0.43071042215114297" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="256" O_E="0.0" SE="1.4988324120593923" STUDY_ID="STD-El_x002d_Hamamsy-2007" TOTAL_1="50" TOTAL_2="50" VAR="2.246498599439776" WEIGHT="0.20613643717602245"/>
<DICH_DATA CI_END="1.9904147370272371" CI_START="0.3566906252675075" EFFECT_SIZE="0.8425925925925926" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.2989435785382142" LOG_CI_START="-0.4477083048699264" LOG_EFFECT_SIZE="-0.07438236316585613" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="236" O_E="0.0" SE="0.4385870123003728" STUDY_ID="STD-Emet-2004" TOTAL_1="27" TOTAL_2="26" VAR="0.19235856735856735" WEIGHT="3.360412862643083"/>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363438" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.4771212547196625" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="238" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Haase-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.6184093115280673"/>
<DICH_DATA CI_END="2.690131744379176" CI_START="0.555298885868718" EFFECT_SIZE="1.2222222222222223" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="9" LOG_CI_END="0.4297735493168515" LOG_CI_START="-0.2554731978790511" LOG_EFFECT_SIZE="0.0871501757189002" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="268" O_E="0.0" SE="0.4025173313289777" STUDY_ID="STD-Hilmi-2010" TOTAL_1="50" TOTAL_2="50" VAR="0.16202020202020204" WEIGHT="3.710455869168404"/>
<DICH_DATA CI_END="73.21457045001645" CI_START="0.13005106216612491" EFFECT_SIZE="3.085714285714286" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.864597518713366" LOG_CI_START="-0.8858860964400181" LOG_EFFECT_SIZE="0.4893557111366741" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="239" O_E="0.0" SE="1.6156476906545747" STUDY_ID="STD-Hynninen-2006" TOTAL_1="34" TOTAL_2="35" VAR="2.6103174603174604" WEIGHT="0.2032331070749517"/>
<DICH_DATA CI_END="1.6963845355930864" CI_START="0.6654778007660358" EFFECT_SIZE="1.0625" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" LOG_CI_END="0.22952430473485386" LOG_CI_START="-0.1768664272901555" LOG_EFFECT_SIZE="0.026328938722349145" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="240" O_E="0.0" SE="0.23871592765805774" STUDY_ID="STD-Jepsen-1992" TOTAL_1="32" TOTAL_2="34" VAR="0.05698529411764706" WEIGHT="6.796255868106437"/>
<DICH_DATA CI_END="0.9937985996092608" CI_START="0.42513644129315287" EFFECT_SIZE="0.65" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="20" LOG_CI_END="-0.00270161956714033" LOG_CI_START="-0.3714716671471485" LOG_EFFECT_SIZE="-0.1870866433571444" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="241" O_E="0.0" SE="0.21661735138967264" STUDY_ID="STD-Keays-1991" TOTAL_1="25" TOTAL_2="25" VAR="0.04692307692307691" WEIGHT="8.245457487040898"/>
<DICH_DATA CI_END="1.3672012569998246" CI_START="0.5655516368553801" EFFECT_SIZE="0.8793309438470729" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="31" LOG_CI_END="0.13583244900161887" LOG_CI_START="-0.24752773631314112" LOG_EFFECT_SIZE="-0.05584764365576113" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="242" O_E="0.0" SE="0.22518767051741245" STUDY_ID="STD-Lee-2009" TOTAL_1="81" TOTAL_2="92" VAR="0.050709486953058706" WEIGHT="11.967828757202136"/>
<DICH_DATA CI_END="6.055139337673937" CI_START="0.660595863601809" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.7821241413496992" LOG_CI_START="-0.18006415002173679" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="243" O_E="0.0" SE="0.565194165260439" STUDY_ID="STD-Macedo-2006" TOTAL_1="18" TOTAL_2="24" VAR="0.31944444444444436" WEIGHT="1.4135069977784396"/>
<DICH_DATA CI_END="2.454270482634857" CI_START="0.7435122882479992" EFFECT_SIZE="1.3508442776735459" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="13" LOG_CI_END="0.38992242417845724" LOG_CI_START="-0.1287118493690649" LOG_EFFECT_SIZE="0.13060528740469618" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="257" O_E="0.0" SE="0.3046483395628732" STUDY_ID="STD-Molnar-1999" TOTAL_1="41" TOTAL_2="45" VAR="0.09281061079841568" WEIGHT="5.110266093712557"/>
<DICH_DATA CI_END="0.9960030761728802" CI_START="0.21642626378031393" EFFECT_SIZE="0.4642857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="-0.0017393202481444689" LOG_CI_START="-0.6646900378226205" LOG_EFFECT_SIZE="-0.33321467903538243" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="244" O_E="0.0" SE="0.38942053316222514" STUDY_ID="STD-Moradi-2009" TOTAL_1="14" TOTAL_2="13" VAR="0.1516483516483517" WEIGHT="4.275422400687873"/>
<DICH_DATA CI_END="1.6261635848009508" CI_START="0.3137470832586035" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.21116423154273745" LOG_CI_START="-0.5034203028992135" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="301" O_E="0.0" SE="0.4197504927816955" STUDY_ID="STD-Ortolani-2000b" TOTAL_1="12" TOTAL_2="12" VAR="0.17619047619047623" WEIGHT="2.8859101204643145"/>
<DICH_DATA CI_END="4.007329751896776" CI_START="0.00964621359876602" EFFECT_SIZE="0.19661016949152543" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6028550807748148" LOG_CI_START="-2.0156431256052665" LOG_EFFECT_SIZE="-0.7063940224152256" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="258" O_E="0.0" SE="1.538118808202826" STUDY_ID="STD-Ozaydin-2008" TOTAL_1="58" TOTAL_2="57" VAR="2.3658094681472823" WEIGHT="1.039491435332079"/>
<DICH_DATA CI_END="2.1315266092423184" CI_START="0.3002542859305412" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.3286907585993715" LOG_CI_START="-0.5225107846154844" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="250" O_E="0.0" SE="0.49999999999999994" STUDY_ID="STD-Paterson-2003" TOTAL_1="10" TOTAL_2="10" VAR="0.24999999999999997" WEIGHT="2.0613643717602246"/>
<DICH_DATA CI_END="3.4594443824994294" CI_START="0.9365665817292654" EFFECT_SIZE="1.8" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.5390063528415914" LOG_CI_START="-0.02846134263497925" LOG_EFFECT_SIZE="0.25527250510330607" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="253" O_E="0.0" SE="0.3333333333333333" STUDY_ID="STD-Peake-1996" TOTAL_1="10" TOTAL_2="10" VAR="0.1111111111111111" WEIGHT="2.0613643717602246"/>
<DICH_DATA CI_END="1.3470381291495137" CI_START="0.37875994048868034" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.129379889000542" LOG_CI_START="-0.421635960357018" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="248" O_E="0.0" SE="0.3236694374850749" STUDY_ID="STD-Rank-2000" TOTAL_1="30" TOTAL_2="30" VAR="0.10476190476190478" WEIGHT="5.771820240928629"/>
<DICH_DATA CI_END="5.426771668614656" CI_START="0.0485244342329168" EFFECT_SIZE="0.5131578947368421" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7345415490261662" LOG_CI_START="-1.3140395195347503" LOG_EFFECT_SIZE="-0.2897489852542921" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="249" O_E="0.0" SE="1.2033466603125178" STUDY_ID="STD-Ristikankare-2006" TOTAL_1="38" TOTAL_2="39" VAR="1.4480431848852902" WEIGHT="0.8138373623572834"/>
<DICH_DATA CI_END="4.407079247591173" CI_START="0.3328969156973013" EFFECT_SIZE="1.2112403100775193" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6441508600134609" LOG_CI_START="-0.4776902285797333" LOG_EFFECT_SIZE="0.08323031571686385" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="259" O_E="0.0" SE="0.6589750086425917" STUDY_ID="STD-Sisillo-2008" TOTAL_1="129" TOTAL_2="125" VAR="0.43424806201550387" WEIGHT="1.6750614422492534"/>
<DICH_DATA CI_END="2.8660736990473508" CI_START="0.3785909081141594" EFFECT_SIZE="1.0416666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.45728735377872365" LOG_CI_START="-0.42182981985786044" LOG_EFFECT_SIZE="0.017728766960431616" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="251" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Spapen-1998" TOTAL_1="12" TOTAL_2="10" VAR="0.2666666666666667" WEIGHT="1.7990089062634684"/>
<DICH_DATA CI_END="2.0605010693751504" CI_START="0.5775695350592529" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.3139728442542525" LOG_CI_START="-0.23839572247545296" LOG_EFFECT_SIZE="0.037788560889399754" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="260" O_E="0.0" SE="0.32446403036553206" STUDY_ID="STD-Spies-1994" TOTAL_1="29" TOTAL_2="29" VAR="0.10527690700104493" WEIGHT="4.535001617872494"/>
<DICH_DATA CI_END="129.92776744614594" CI_START="0.3771326250203609" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1137019760147355" LOG_CI_START="-0.423505895986222" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="261" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Steib-1998" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="0.20613643717602245"/>
<DICH_DATA CI_END="1.4473847741421566" CI_START="0.27804053753675506" EFFECT_SIZE="0.634375" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.16058399972514328" LOG_CI_START="-0.5558918805385293" LOG_EFFECT_SIZE="-0.19765394040669304" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="262" O_E="0.0" SE="0.4208614786796877" STUDY_ID="STD-Suter-1994" TOTAL_1="32" TOTAL_2="29" VAR="0.17712438423645321" WEIGHT="4.325485894841126"/>
<DICH_DATA CI_END="2.5703939747908535" CI_START="0.3726664127879707" EFFECT_SIZE="0.9787234042553191" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.40999969452363927" LOG_CI_START="-0.428679747031926" LOG_EFFECT_SIZE="-0.009340026254143404" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="263" O_E="0.0" SE="0.49264445549992975" STUDY_ID="STD-Szakmany-2003" TOTAL_1="47" TOTAL_2="46" VAR="0.24269855953482228" WEIGHT="2.91694141208221"/>
<DICH_DATA CI_END="1.1367318594230087" CI_START="0.003822476117610868" EFFECT_SIZE="0.06591760299625468" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.055658032228059366" LOG_CI_START="-2.41765521932891" LOG_EFFECT_SIZE="-1.1809985935504255" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="247" O_E="0.0" SE="1.4528364470626132" STUDY_ID="STD-Wijeysundera-2007" TOTAL_1="88" TOTAL_2="87" VAR="2.1107337419135175" WEIGHT="3.109515747231525"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="28.17886679012768" CI_END="1.0854401327634597" CI_START="0.810049931871453" CI_STUDY="95" CI_TOTAL="95" DF="30" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9376890239282859" ESTIMABLE="YES" EVENTS_1="223" EVENTS_2="241" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.03560587502445472" LOG_CI_START="-0.09148821017334006" LOG_EFFECT_SIZE="-0.02794116757444266" METHOD="MH" MODIFIED="2012-08-06 10:45:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5609587458902375" P_Q="0.5402160433163115" P_Z="0.3888076335982178" Q="0.3751400497141678" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="31" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1228" TOTAL_2="1233" WEIGHT="100.00000000000001" Z="0.8617817587132877">
<NAME>Mortality - Overall risk of bias</NAME>
<GROUP_LABEL_1>N-acetylcysteine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="14.075174398335323" CI_END="1.1024066989711303" CI_START="0.7197923679382392" DF="13" EFFECT_SIZE="0.8907883745780518" ESTIMABLE="YES" EVENTS_1="96" EVENTS_2="108" I2="7.638799832295391" ID="CMP-002.02.01" LOG_CI_END="0.04234184363952736" LOG_CI_START="-0.14279276254540346" LOG_EFFECT_SIZE="-0.05022545945293805" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3685712647450484" P_Z="0.2875809157354857" STUDIES="14" TAU2="0.0" TOTAL_1="461" TOTAL_2="458" WEIGHT="45.031586638199784" Z="1.0634434443488505">
<NAME>High risk of bias</NAME>
<DICH_DATA CI_END="5.355895422334702" CI_START="0.3319291430456687" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7288320885142859" LOG_CI_START="-0.4789546152976862" LOG_EFFECT_SIZE="0.12493873660829992" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="283" O_E="0.0" SE="0.7094598884597586" STUDY_ID="STD-Bromley-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.5033333333333332" WEIGHT="1.2368186230561349"/>
<DICH_DATA CI_END="1.892323407364669" CI_START="0.23486706485515438" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.2769953614690809" LOG_CI_START="-0.6291778795804434" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="275" O_E="0.0" SE="0.5322906474223771" STUDY_ID="STD-Csontos-2011" TOTAL_1="15" TOTAL_2="15" VAR="0.2833333333333333" WEIGHT="2.4736372461122698"/>
<DICH_DATA CI_END="3.373800796086585" CI_START="0.48012162206574754" EFFECT_SIZE="1.2727272727272727" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5281194363697701" LOG_CI_START="-0.3186487353297442" LOG_EFFECT_SIZE="0.10473535052001297" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="285" O_E="0.0" SE="0.49739581562634544" STUDY_ID="STD-Domenighetti-1997" TOTAL_1="22" TOTAL_2="20" VAR="0.2474025974025974" WEIGHT="2.159524579939283"/>
<DICH_DATA CI_END="132.1011207444225" CI_START="0.37092796581794973" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1209065021796567" LOG_CI_START="-0.43071042215114297" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="286" O_E="0.0" SE="1.4988324120593923" STUDY_ID="STD-El_x002d_Hamamsy-2007" TOTAL_1="50" TOTAL_2="50" VAR="2.246498599439776" WEIGHT="0.20613643717602248"/>
<DICH_DATA CI_END="1.9904147370272371" CI_START="0.3566906252675075" EFFECT_SIZE="0.8425925925925926" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.2989435785382142" LOG_CI_START="-0.4477083048699264" LOG_EFFECT_SIZE="-0.07438236316585613" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="287" O_E="0.0" SE="0.4385870123003728" STUDY_ID="STD-Emet-2004" TOTAL_1="27" TOTAL_2="26" VAR="0.19235856735856735" WEIGHT="3.3604128626430834"/>
<DICH_DATA CI_END="1.6963845355930864" CI_START="0.6654778007660358" EFFECT_SIZE="1.0625" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" LOG_CI_END="0.22952430473485386" LOG_CI_START="-0.1768664272901555" LOG_EFFECT_SIZE="0.026328938722349145" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="289" O_E="0.0" SE="0.23871592765805774" STUDY_ID="STD-Jepsen-1992" TOTAL_1="32" TOTAL_2="34" VAR="0.05698529411764706" WEIGHT="6.796255868106438"/>
<DICH_DATA CI_END="0.9937985996092608" CI_START="0.42513644129315287" EFFECT_SIZE="0.65" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="20" LOG_CI_END="-0.00270161956714033" LOG_CI_START="-0.3714716671471485" LOG_EFFECT_SIZE="-0.1870866433571444" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="290" O_E="0.0" SE="0.21661735138967264" STUDY_ID="STD-Keays-1991" TOTAL_1="25" TOTAL_2="25" VAR="0.04692307692307691" WEIGHT="8.245457487040898"/>
<DICH_DATA CI_END="6.055139337673937" CI_START="0.660595863601809" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.7821241413496992" LOG_CI_START="-0.18006415002173679" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="291" O_E="0.0" SE="0.565194165260439" STUDY_ID="STD-Macedo-2006" TOTAL_1="18" TOTAL_2="24" VAR="0.31944444444444436" WEIGHT="1.4135069977784398"/>
<DICH_DATA CI_END="0.9960030761728802" CI_START="0.21642626378031393" EFFECT_SIZE="0.4642857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="-0.0017393202481444689" LOG_CI_START="-0.6646900378226205" LOG_EFFECT_SIZE="-0.33321467903538243" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="292" O_E="0.0" SE="0.38942053316222514" STUDY_ID="STD-Moradi-2009" TOTAL_1="14" TOTAL_2="13" VAR="0.1516483516483517" WEIGHT="4.275422400687874"/>
<DICH_DATA CI_END="1.6261635848009508" CI_START="0.3137470832586035" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.21116423154273745" LOG_CI_START="-0.5034203028992135" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="294" O_E="0.0" SE="0.4197504927816955" STUDY_ID="STD-Ortolani-2000b" TOTAL_1="12" TOTAL_2="12" VAR="0.17619047619047623" WEIGHT="2.885910120464315"/>
<DICH_DATA CI_END="1.3470381291495137" CI_START="0.37875994048868034" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.129379889000542" LOG_CI_START="-0.421635960357018" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="296" O_E="0.0" SE="0.3236694374850749" STUDY_ID="STD-Rank-2000" TOTAL_1="30" TOTAL_2="30" VAR="0.10476190476190478" WEIGHT="5.77182024092863"/>
<DICH_DATA CI_END="4.407079247591173" CI_START="0.3328969156973013" EFFECT_SIZE="1.2112403100775193" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6441508600134609" LOG_CI_START="-0.4776902285797333" LOG_EFFECT_SIZE="0.08323031571686385" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="297" O_E="0.0" SE="0.6589750086425917" STUDY_ID="STD-Sisillo-2008" TOTAL_1="129" TOTAL_2="125" VAR="0.43424806201550387" WEIGHT="1.6750614422492536"/>
<DICH_DATA CI_END="129.92776744614594" CI_START="0.3771326250203609" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1137019760147355" LOG_CI_START="-0.423505895986222" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="298" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Steib-1998" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="0.20613643717602248"/>
<DICH_DATA CI_END="1.4473847741421566" CI_START="0.27804053753675506" EFFECT_SIZE="0.634375" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.16058399972514328" LOG_CI_START="-0.5558918805385293" LOG_EFFECT_SIZE="-0.19765394040669304" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="300" O_E="0.0" SE="0.4208614786796877" STUDY_ID="STD-Suter-1994" TOTAL_1="32" TOTAL_2="29" VAR="0.17712438423645321" WEIGHT="4.325485894841127"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="12.42926963338218" CI_END="1.19295508971713" CI_START="0.7986832415393943" DF="16" EFFECT_SIZE="0.9761112836486403" ESTIMABLE="YES" EVENTS_1="127" EVENTS_2="133" I2="0.0" ID="CMP-002.02.02" LOG_CI_END="0.07662409442041881" LOG_CI_START="-0.09762542810455441" LOG_EFFECT_SIZE="-0.010500666842067782" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7139390963810194" P_Z="0.8132591314575346" STUDIES="17" TAU2="0.0" TOTAL_1="767" TOTAL_2="775" WEIGHT="54.96841336180023" Z="0.23622364670935797">
<NAME>Low risk of bias</NAME>
<DICH_DATA CI_END="2.278946616108553" CI_START="0.3498080525081715" EFFECT_SIZE="0.8928571428571429" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.35773415203381126" LOG_CI_START="-0.45617019737417447" LOG_EFFECT_SIZE="-0.049218022670181584" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="266" O_E="0.0" SE="0.47809144373375756" STUDY_ID="STD-Bernard-1997" TOTAL_1="14" TOTAL_2="15" VAR="0.22857142857142865" WEIGHT="2.388339410039433"/>
<DICH_DATA CI_END="4.532109560681806" CI_START="0.34011897737665486" EFFECT_SIZE="1.241554054054054" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6563004000934802" LOG_CI_START="-0.46836913537093017" LOG_EFFECT_SIZE="0.09396563236127509" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="267" O_E="0.0" SE="0.6606364523357819" STUDY_ID="STD-Burns-2005" TOTAL_1="148" TOTAL_2="147" VAR="0.4364405221548079" WEIGHT="1.6546816380773601"/>
<DICH_DATA CI_END="1.5402163575984629" CI_START="0.2885597482794114" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.1875817314281723" LOG_CI_START="-0.539764249539535" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="280" O_E="0.0" SE="0.4272466296411038" STUDY_ID="STD-Burns-2010" TOTAL_1="21" TOTAL_2="21" VAR="0.18253968253968256" WEIGHT="3.7104558691684044"/>
<DICH_DATA CI_END="1.921993645698558" CI_START="0.6845724737859185" EFFECT_SIZE="1.1470588235294117" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="17" LOG_CI_END="0.2837519475143089" LOG_CI_START="-0.1645805675458208" LOG_EFFECT_SIZE="0.059585689984244045" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="268" O_E="0.0" SE="0.2633527386280618" STUDY_ID="STD-Charunwatthana-2009" TOTAL_1="56" TOTAL_2="52" VAR="0.06935466494290023" WEIGHT="7.268218081169385"/>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363438" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.4771212547196625" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="269" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Haase-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.6184093115280674"/>
<DICH_DATA CI_END="2.690131744379176" CI_START="0.555298885868718" EFFECT_SIZE="1.2222222222222223" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="9" LOG_CI_END="0.4297735493168515" LOG_CI_START="-0.2554731978790511" LOG_EFFECT_SIZE="0.0871501757189002" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="279" O_E="0.0" SE="0.4025173313289777" STUDY_ID="STD-Hilmi-2010" TOTAL_1="50" TOTAL_2="50" VAR="0.16202020202020204" WEIGHT="3.7104558691684044"/>
<DICH_DATA CI_END="73.21457045001645" CI_START="0.13005106216612491" EFFECT_SIZE="3.085714285714286" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.864597518713366" LOG_CI_START="-0.8858860964400181" LOG_EFFECT_SIZE="0.4893557111366741" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="270" O_E="0.0" SE="1.6156476906545747" STUDY_ID="STD-Hynninen-2006" TOTAL_1="34" TOTAL_2="35" VAR="2.6103174603174604" WEIGHT="0.20323310707495174"/>
<DICH_DATA CI_END="1.3672012569998246" CI_START="0.5655516368553801" EFFECT_SIZE="0.8793309438470729" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="31" LOG_CI_END="0.13583244900161887" LOG_CI_START="-0.24752773631314112" LOG_EFFECT_SIZE="-0.05584764365576113" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="271" O_E="0.0" SE="0.22518767051741245" STUDY_ID="STD-Lee-2009" TOTAL_1="81" TOTAL_2="92" VAR="0.050709486953058706" WEIGHT="11.967828757202138"/>
<DICH_DATA CI_END="2.454270482634857" CI_START="0.7435122882479992" EFFECT_SIZE="1.3508442776735459" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="13" LOG_CI_END="0.38992242417845724" LOG_CI_START="-0.1287118493690649" LOG_EFFECT_SIZE="0.13060528740469618" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="272" O_E="0.0" SE="0.3046483395628732" STUDY_ID="STD-Molnar-1999" TOTAL_1="41" TOTAL_2="45" VAR="0.09281061079841568" WEIGHT="5.110266093712558"/>
<DICH_DATA CI_END="4.007329751896776" CI_START="0.00964621359876602" EFFECT_SIZE="0.19661016949152543" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6028550807748148" LOG_CI_START="-2.0156431256052665" LOG_EFFECT_SIZE="-0.7063940224152256" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="273" O_E="0.0" SE="1.538118808202826" STUDY_ID="STD-Ozaydin-2008" TOTAL_1="58" TOTAL_2="57" VAR="2.3658094681472823" WEIGHT="1.0394914353320792"/>
<DICH_DATA CI_END="2.1315266092423184" CI_START="0.3002542859305412" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.3286907585993715" LOG_CI_START="-0.5225107846154844" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="274" O_E="0.0" SE="0.49999999999999994" STUDY_ID="STD-Paterson-2003" TOTAL_1="10" TOTAL_2="10" VAR="0.24999999999999997" WEIGHT="2.0613643717602246"/>
<DICH_DATA CI_END="3.4594443824994294" CI_START="0.9365665817292654" EFFECT_SIZE="1.8" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.5390063528415914" LOG_CI_START="-0.02846134263497925" LOG_EFFECT_SIZE="0.25527250510330607" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="275" O_E="0.0" SE="0.3333333333333333" STUDY_ID="STD-Peake-1996" TOTAL_1="10" TOTAL_2="10" VAR="0.1111111111111111" WEIGHT="2.0613643717602246"/>
<DICH_DATA CI_END="5.426771668614656" CI_START="0.0485244342329168" EFFECT_SIZE="0.5131578947368421" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7345415490261662" LOG_CI_START="-1.3140395195347503" LOG_EFFECT_SIZE="-0.2897489852542921" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="281" O_E="0.0" SE="1.2033466603125178" STUDY_ID="STD-Ristikankare-2006" TOTAL_1="38" TOTAL_2="39" VAR="1.4480431848852902" WEIGHT="0.8138373623572835"/>
<DICH_DATA CI_END="2.8660736990473508" CI_START="0.3785909081141594" EFFECT_SIZE="1.0416666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.45728735377872365" LOG_CI_START="-0.42182981985786044" LOG_EFFECT_SIZE="0.017728766960431616" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="276" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Spapen-1998" TOTAL_1="12" TOTAL_2="10" VAR="0.2666666666666667" WEIGHT="1.7990089062634689"/>
<DICH_DATA CI_END="2.0605010693751504" CI_START="0.5775695350592529" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.3139728442542525" LOG_CI_START="-0.23839572247545296" LOG_EFFECT_SIZE="0.037788560889399754" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="277" O_E="0.0" SE="0.32446403036553206" STUDY_ID="STD-Spies-1994" TOTAL_1="29" TOTAL_2="29" VAR="0.10527690700104493" WEIGHT="4.535001617872495"/>
<DICH_DATA CI_END="2.5703939747908535" CI_START="0.3726664127879707" EFFECT_SIZE="0.9787234042553191" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.40999969452363927" LOG_CI_START="-0.428679747031926" LOG_EFFECT_SIZE="-0.009340026254143404" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="278" O_E="0.0" SE="0.49264445549992975" STUDY_ID="STD-Szakmany-2003" TOTAL_1="47" TOTAL_2="46" VAR="0.24269855953482228" WEIGHT="2.9169414120822106"/>
<DICH_DATA CI_END="1.1367318594230087" CI_START="0.003822476117610868" EFFECT_SIZE="0.06591760299625468" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.055658032228059366" LOG_CI_START="-2.41765521932891" LOG_EFFECT_SIZE="-1.1809985935504255" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="280" O_E="0.0" SE="1.4528364470626132" STUDY_ID="STD-Wijeysundera-2007" TOTAL_1="88" TOTAL_2="87" VAR="2.1107337419135175" WEIGHT="3.1095157472315256"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="28.178866790127692" CI_END="1.0854401327634595" CI_START="0.8100499318714529" CI_STUDY="95" CI_TOTAL="95" DF="30" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9376890239282858" ESTIMABLE="YES" EVENTS_1="223" EVENTS_2="241" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="0.035605875024454635" LOG_CI_START="-0.09148821017334013" LOG_EFFECT_SIZE="-0.027941167574442715" METHOD="MH" MODIFIED="2012-08-06 10:45:48 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.5609587458902372" P_Q="0.9699711346102194" P_Z="0.3888076335982169" Q="0.0014171080581078857" RANDOM="NO" SCALE="401.0927257502627" SORT_BY="STUDY" STUDIES="32" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1247" TOTAL_2="1254" WEIGHT="100.0" Z="0.8617817587132892">
<NAME>Mortality - adequate sequence generation</NAME>
<GROUP_LABEL_1>N-acetylcysteine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="16.220485820862503" CI_END="1.1191388989113944" CI_START="0.7826787344322266" DF="19" EFFECT_SIZE="0.9359092995872227" ESTIMABLE="YES" EVENTS_1="152" EVENTS_2="165" I2="0.0" ID="CMP-002.03.01" LOG_CI_END="0.04888399116390929" LOG_CI_START="-0.10641646590440837" LOG_EFFECT_SIZE="-0.028766237370249536" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6425200702473886" P_Z="0.4677856982067753" STUDIES="20" TAU2="0.0" TOTAL_1="948" TOTAL_2="951" WEIGHT="68.24934515373344" Z="0.7260865844279778">
<NAME>Adequate sequence generation</NAME>
<DICH_DATA CI_END="2.278946616108553" CI_START="0.3498080525081715" EFFECT_SIZE="0.8928571428571429" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.35773415203381126" LOG_CI_START="-0.45617019737417447" LOG_EFFECT_SIZE="-0.049218022670181584" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="354" O_E="0.0" SE="0.47809144373375756" STUDY_ID="STD-Bernard-1997" TOTAL_1="14" TOTAL_2="15" VAR="0.22857142857142865" WEIGHT="2.3883394100394324"/>
<DICH_DATA CI_END="4.532109560681806" CI_START="0.34011897737665486" EFFECT_SIZE="1.241554054054054" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6563004000934802" LOG_CI_START="-0.46836913537093017" LOG_EFFECT_SIZE="0.09396563236127509" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="355" O_E="0.0" SE="0.6606364523357819" STUDY_ID="STD-Burns-2005" TOTAL_1="148" TOTAL_2="147" VAR="0.4364405221548079" WEIGHT="1.65468163807736"/>
<DICH_DATA CI_END="1.5402163575984629" CI_START="0.2885597482794114" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.1875817314281723" LOG_CI_START="-0.539764249539535" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="277" O_E="0.0" SE="0.4272466296411038" STUDY_ID="STD-Burns-2010" TOTAL_1="21" TOTAL_2="21" VAR="0.18253968253968256" WEIGHT="3.710455869168404"/>
<DICH_DATA CI_END="1.921993645698558" CI_START="0.6845724737859185" EFFECT_SIZE="1.1470588235294117" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="17" LOG_CI_END="0.2837519475143089" LOG_CI_START="-0.1645805675458208" LOG_EFFECT_SIZE="0.059585689984244045" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="356" O_E="0.0" SE="0.2633527386280618" STUDY_ID="STD-Charunwatthana-2009" TOTAL_1="56" TOTAL_2="52" VAR="0.06935466494290023" WEIGHT="7.268218081169384"/>
<DICH_DATA CI_END="1.9904147370272371" CI_START="0.3566906252675075" EFFECT_SIZE="0.8425925925925926" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.2989435785382142" LOG_CI_START="-0.4477083048699264" LOG_EFFECT_SIZE="-0.07438236316585613" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="357" O_E="0.0" SE="0.4385870123003728" STUDY_ID="STD-Emet-2004" TOTAL_1="27" TOTAL_2="26" VAR="0.19235856735856735" WEIGHT="3.360412862643083"/>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363438" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.4771212547196625" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="359" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Haase-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.6184093115280673"/>
<DICH_DATA CI_END="2.690131744379176" CI_START="0.555298885868718" EFFECT_SIZE="1.2222222222222223" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="9" LOG_CI_END="0.4297735493168515" LOG_CI_START="-0.2554731978790511" LOG_EFFECT_SIZE="0.0871501757189002" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="278" O_E="0.0" SE="0.4025173313289777" STUDY_ID="STD-Hilmi-2010" TOTAL_1="50" TOTAL_2="50" VAR="0.16202020202020204" WEIGHT="3.710455869168404"/>
<DICH_DATA CI_END="73.21457045001645" CI_START="0.13005106216612491" EFFECT_SIZE="3.085714285714286" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.864597518713366" LOG_CI_START="-0.8858860964400181" LOG_EFFECT_SIZE="0.4893557111366741" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="360" O_E="0.0" SE="1.6156476906545747" STUDY_ID="STD-Hynninen-2006" TOTAL_1="34" TOTAL_2="35" VAR="2.6103174603174604" WEIGHT="0.2032331070749517"/>
<DICH_DATA CI_END="0.9937985996092608" CI_START="0.42513644129315287" EFFECT_SIZE="0.65" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="20" LOG_CI_END="-0.00270161956714033" LOG_CI_START="-0.3714716671471485" LOG_EFFECT_SIZE="-0.1870866433571444" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="361" O_E="0.0" SE="0.21661735138967264" STUDY_ID="STD-Keays-1991" TOTAL_1="25" TOTAL_2="25" VAR="0.04692307692307691" WEIGHT="8.245457487040898"/>
<DICH_DATA CI_END="1.3672012569998246" CI_START="0.5655516368553801" EFFECT_SIZE="0.8793309438470729" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="31" LOG_CI_END="0.13583244900161887" LOG_CI_START="-0.24752773631314112" LOG_EFFECT_SIZE="-0.05584764365576113" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="362" O_E="0.0" SE="0.22518767051741245" STUDY_ID="STD-Lee-2009" TOTAL_1="81" TOTAL_2="92" VAR="0.050709486953058706" WEIGHT="11.967828757202136"/>
<DICH_DATA CI_END="2.454270482634857" CI_START="0.7435122882479992" EFFECT_SIZE="1.3508442776735459" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="13" LOG_CI_END="0.38992242417845724" LOG_CI_START="-0.1287118493690649" LOG_EFFECT_SIZE="0.13060528740469618" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="363" O_E="0.0" SE="0.3046483395628732" STUDY_ID="STD-Molnar-1999" TOTAL_1="41" TOTAL_2="45" VAR="0.09281061079841568" WEIGHT="5.110266093712557"/>
<DICH_DATA CI_END="4.007329751896776" CI_START="0.00964621359876602" EFFECT_SIZE="0.19661016949152543" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6028550807748148" LOG_CI_START="-2.0156431256052665" LOG_EFFECT_SIZE="-0.7063940224152256" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="364" O_E="0.0" SE="1.538118808202826" STUDY_ID="STD-Ozaydin-2008" TOTAL_1="58" TOTAL_2="57" VAR="2.3658094681472823" WEIGHT="1.039491435332079"/>
<DICH_DATA CI_END="2.1315266092423184" CI_START="0.3002542859305412" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.3286907585993715" LOG_CI_START="-0.5225107846154844" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="365" O_E="0.0" SE="0.49999999999999994" STUDY_ID="STD-Paterson-2003" TOTAL_1="10" TOTAL_2="10" VAR="0.24999999999999997" WEIGHT="2.0613643717602246"/>
<DICH_DATA CI_END="3.4594443824994294" CI_START="0.9365665817292654" EFFECT_SIZE="1.8" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.5390063528415914" LOG_CI_START="-0.02846134263497925" LOG_EFFECT_SIZE="0.25527250510330607" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="366" O_E="0.0" SE="0.3333333333333333" STUDY_ID="STD-Peake-1996" TOTAL_1="10" TOTAL_2="10" VAR="0.1111111111111111" WEIGHT="2.0613643717602246"/>
<DICH_DATA CI_END="5.426771668614656" CI_START="0.0485244342329168" EFFECT_SIZE="0.5131578947368421" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7345415490261662" LOG_CI_START="-1.3140395195347503" LOG_EFFECT_SIZE="-0.2897489852542921" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="367" O_E="0.0" SE="1.2033466603125178" STUDY_ID="STD-Ristikankare-2006" TOTAL_1="38" TOTAL_2="39" VAR="1.4480431848852902" WEIGHT="0.8138373623572834"/>
<DICH_DATA CI_END="4.407079247591173" CI_START="0.3328969156973013" EFFECT_SIZE="1.2112403100775193" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6441508600134609" LOG_CI_START="-0.4776902285797333" LOG_EFFECT_SIZE="0.08323031571686385" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="410" O_E="0.0" SE="0.6589750086425917" STUDY_ID="STD-Sisillo-2008" TOTAL_1="129" TOTAL_2="125" VAR="0.43424806201550387" WEIGHT="1.6750614422492534"/>
<DICH_DATA CI_END="2.8660736990473508" CI_START="0.3785909081141594" EFFECT_SIZE="1.0416666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.45728735377872365" LOG_CI_START="-0.42182981985786044" LOG_EFFECT_SIZE="0.017728766960431616" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="368" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Spapen-1998" TOTAL_1="12" TOTAL_2="10" VAR="0.2666666666666667" WEIGHT="1.7990089062634684"/>
<DICH_DATA CI_END="2.0605010693751504" CI_START="0.5775695350592529" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.3139728442542525" LOG_CI_START="-0.23839572247545296" LOG_EFFECT_SIZE="0.037788560889399754" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="369" O_E="0.0" SE="0.32446403036553206" STUDY_ID="STD-Spies-1994" TOTAL_1="29" TOTAL_2="29" VAR="0.10527690700104493" WEIGHT="4.535001617872494"/>
<DICH_DATA CI_END="2.5703939747908535" CI_START="0.3726664127879707" EFFECT_SIZE="0.9787234042553191" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.40999969452363927" LOG_CI_START="-0.428679747031926" LOG_EFFECT_SIZE="-0.009340026254143404" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="371" O_E="0.0" SE="0.49264445549992975" STUDY_ID="STD-Szakmany-2003" TOTAL_1="47" TOTAL_2="46" VAR="0.24269855953482228" WEIGHT="2.91694141208221"/>
<DICH_DATA CI_END="1.1367318594230087" CI_START="0.003822476117610868" EFFECT_SIZE="0.06591760299625468" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.055658032228059366" LOG_CI_START="-2.41765521932891" LOG_EFFECT_SIZE="-1.1809985935504255" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="373" O_E="0.0" SE="1.4528364470626132" STUDY_ID="STD-Wijeysundera-2007" TOTAL_1="88" TOTAL_2="87" VAR="2.1107337419135175" WEIGHT="3.109515747231525"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="12.002715720996703" CI_END="1.2141858763987115" CI_START="0.730077484376829" DF="10" EFFECT_SIZE="0.941514614972623" ESTIMABLE="YES" EVENTS_1="71" EVENTS_2="76" I2="16.685521573199416" ID="CMP-002.03.02" LOG_CI_END="0.08428517678451804" LOG_CI_START="-0.13663104501446716" LOG_EFFECT_SIZE="-0.026172934114974577" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.2848748892011108" P_Z="0.6423530105575301" STUDIES="12" TAU2="0.0" TOTAL_1="299" TOTAL_2="303" WEIGHT="31.75065484626655" Z="0.4644114209210646">
<NAME>Inadequate or unclear sequence generation</NAME>
<DICH_DATA CI_END="5.355895422334702" CI_START="0.3319291430456687" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7288320885142859" LOG_CI_START="-0.4789546152976862" LOG_EFFECT_SIZE="0.12493873660829992" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="340" O_E="0.0" SE="0.7094598884597586" STUDY_ID="STD-Bromley-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.5033333333333332" WEIGHT="1.2368186230561347"/>
<DICH_DATA CI_END="1.892323407364669" CI_START="0.23486706485515438" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.2769953614690809" LOG_CI_START="-0.6291778795804434" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="276" O_E="0.0" SE="0.5322906474223771" STUDY_ID="STD-Csontos-2011" TOTAL_1="15" TOTAL_2="15" VAR="0.2833333333333333" WEIGHT="2.4736372461122693"/>
<DICH_DATA CI_END="3.373800796086585" CI_START="0.48012162206574754" EFFECT_SIZE="1.2727272727272727" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5281194363697701" LOG_CI_START="-0.3186487353297442" LOG_EFFECT_SIZE="0.10473535052001297" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="342" O_E="0.0" SE="0.49739581562634544" STUDY_ID="STD-Domenighetti-1997" TOTAL_1="22" TOTAL_2="20" VAR="0.2474025974025974" WEIGHT="2.159524579939283"/>
<DICH_DATA CI_END="132.1011207444225" CI_START="0.37092796581794973" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1209065021796567" LOG_CI_START="-0.43071042215114297" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="343" O_E="0.0" SE="1.4988324120593923" STUDY_ID="STD-El_x002d_Hamamsy-2007" TOTAL_1="50" TOTAL_2="50" VAR="2.246498599439776" WEIGHT="0.20613643717602245"/>
<DICH_DATA CI_END="1.6963845355930864" CI_START="0.6654778007660358" EFFECT_SIZE="1.0625" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" LOG_CI_END="0.22952430473485386" LOG_CI_START="-0.1768664272901555" LOG_EFFECT_SIZE="0.026328938722349145" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="344" O_E="0.0" SE="0.23871592765805774" STUDY_ID="STD-Jepsen-1992" TOTAL_1="32" TOTAL_2="34" VAR="0.05698529411764706" WEIGHT="6.796255868106437"/>
<DICH_DATA CI_END="6.055139337673937" CI_START="0.660595863601809" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.7821241413496992" LOG_CI_START="-0.18006415002173679" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="345" O_E="0.0" SE="0.565194165260439" STUDY_ID="STD-Macedo-2006" TOTAL_1="18" TOTAL_2="24" VAR="0.31944444444444436" WEIGHT="1.4135069977784396"/>
<DICH_DATA CI_END="0.9960030761728802" CI_START="0.21642626378031393" EFFECT_SIZE="0.4642857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="-0.0017393202481444689" LOG_CI_START="-0.6646900378226205" LOG_EFFECT_SIZE="-0.33321467903538243" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="346" O_E="0.0" SE="0.38942053316222514" STUDY_ID="STD-Moradi-2009" TOTAL_1="14" TOTAL_2="13" VAR="0.1516483516483517" WEIGHT="4.275422400687873"/>
<DICH_DATA CI_END="1.6261635848009508" CI_START="0.3137470832586035" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.21116423154273745" LOG_CI_START="-0.5034203028992135" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="348" O_E="0.0" SE="0.4197504927816955" STUDY_ID="STD-Ortolani-2000b" TOTAL_1="12" TOTAL_2="12" VAR="0.17619047619047623" WEIGHT="2.8859101204643145"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="349" O_E="0.0" SE="0.0" STUDY_ID="STD-Peker-2008" TOTAL_1="19" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.3470381291495137" CI_START="0.37875994048868034" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.129379889000542" LOG_CI_START="-0.421635960357018" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="350" O_E="0.0" SE="0.3236694374850749" STUDY_ID="STD-Rank-2000" TOTAL_1="30" TOTAL_2="30" VAR="0.10476190476190478" WEIGHT="5.771820240928629"/>
<DICH_DATA CI_END="129.92776744614594" CI_START="0.3771326250203609" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1137019760147355" LOG_CI_START="-0.423505895986222" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="351" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Steib-1998" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="0.20613643717602245"/>
<DICH_DATA CI_END="1.4473847741421566" CI_START="0.27804053753675506" EFFECT_SIZE="0.634375" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.16058399972514328" LOG_CI_START="-0.5558918805385293" LOG_EFFECT_SIZE="-0.19765394040669304" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="353" O_E="0.0" SE="0.4208614786796877" STUDY_ID="STD-Suter-1994" TOTAL_1="32" TOTAL_2="29" VAR="0.17712438423645321" WEIGHT="4.325485894841126"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="28.178866790127692" CI_END="1.0854401327634595" CI_START="0.8100499318714529" CI_STUDY="95" CI_TOTAL="95" DF="30" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9376890239282858" ESTIMABLE="YES" EVENTS_1="223" EVENTS_2="241" I2="0.0" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="0.035605875024454635" LOG_CI_START="-0.09148821017334013" LOG_EFFECT_SIZE="-0.027941167574442715" METHOD="MH" MODIFIED="2012-08-06 10:45:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.5609587458902372" P_Q="0.8993419402727008" P_Z="0.3888076335982169" Q="0.016000400222322856" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="33" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1267" TOTAL_2="1274" WEIGHT="99.99999999999999" Z="0.8617817587132892">
<NAME>Mortality - Allocation concealment</NAME>
<GROUP_LABEL_1>N-acetylcysteine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="19.00666562075365" CI_END="1.12507446616767" CI_START="0.791106611482048" DF="20" EFFECT_SIZE="0.9434266524721884" ESTIMABLE="YES" EVENTS_1="157" EVENTS_2="168" I2="0.0" ID="CMP-002.04.01" LOG_CI_END="0.05118126838108758" LOG_CI_START="-0.10176498596070883" LOG_EFFECT_SIZE="-0.025291858789810648" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5213928739752134" P_Z="0.5168450242536654" STUDIES="22" TAU2="0.0" TOTAL_1="916" TOTAL_2="919" WEIGHT="69.90501776079753" Z="0.6482163625834556">
<NAME>Adequate allocation concealment</NAME>
<DICH_DATA CI_END="2.278946616108553" CI_START="0.3498080525081715" EFFECT_SIZE="0.8928571428571429" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.35773415203381126" LOG_CI_START="-0.45617019737417447" LOG_EFFECT_SIZE="-0.049218022670181584" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="303" O_E="0.0" SE="0.47809144373375756" STUDY_ID="STD-Bernard-1997" TOTAL_1="14" TOTAL_2="15" VAR="0.22857142857142865" WEIGHT="2.3883394100394324"/>
<DICH_DATA CI_END="4.532109560681806" CI_START="0.34011897737665486" EFFECT_SIZE="1.241554054054054" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6563004000934802" LOG_CI_START="-0.46836913537093017" LOG_EFFECT_SIZE="0.09396563236127509" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="304" O_E="0.0" SE="0.6606364523357819" STUDY_ID="STD-Burns-2005" TOTAL_1="148" TOTAL_2="147" VAR="0.4364405221548079" WEIGHT="1.65468163807736"/>
<DICH_DATA CI_END="1.5402163575984629" CI_START="0.2885597482794114" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.1875817314281723" LOG_CI_START="-0.539764249539535" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="281" O_E="0.0" SE="0.4272466296411038" STUDY_ID="STD-Burns-2010" TOTAL_1="21" TOTAL_2="21" VAR="0.18253968253968256" WEIGHT="3.710455869168404"/>
<DICH_DATA CI_END="1.921993645698558" CI_START="0.6845724737859185" EFFECT_SIZE="1.1470588235294117" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="17" LOG_CI_END="0.2837519475143089" LOG_CI_START="-0.1645805675458208" LOG_EFFECT_SIZE="0.059585689984244045" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="305" O_E="0.0" SE="0.2633527386280618" STUDY_ID="STD-Charunwatthana-2009" TOTAL_1="56" TOTAL_2="52" VAR="0.06935466494290023" WEIGHT="7.268218081169384"/>
<DICH_DATA CI_END="3.373800796086585" CI_START="0.48012162206574754" EFFECT_SIZE="1.2727272727272727" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5281194363697701" LOG_CI_START="-0.3186487353297442" LOG_EFFECT_SIZE="0.10473535052001297" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="306" O_E="0.0" SE="0.49739581562634544" STUDY_ID="STD-Domenighetti-1997" TOTAL_1="22" TOTAL_2="20" VAR="0.2474025974025974" WEIGHT="2.159524579939283"/>
<DICH_DATA CI_END="132.1011207444225" CI_START="0.37092796581794973" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1209065021796567" LOG_CI_START="-0.43071042215114297" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="307" O_E="0.0" SE="1.4988324120593923" STUDY_ID="STD-El_x002d_Hamamsy-2007" TOTAL_1="50" TOTAL_2="50" VAR="2.246498599439776" WEIGHT="0.20613643717602245"/>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363438" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.4771212547196625" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="308" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Haase-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.6184093115280673"/>
<DICH_DATA CI_END="2.690131744379176" CI_START="0.555298885868718" EFFECT_SIZE="1.2222222222222223" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="9" LOG_CI_END="0.4297735493168515" LOG_CI_START="-0.2554731978790511" LOG_EFFECT_SIZE="0.0871501757189002" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="282" O_E="0.0" SE="0.4025173313289777" STUDY_ID="STD-Hilmi-2010" TOTAL_1="50" TOTAL_2="50" VAR="0.16202020202020204" WEIGHT="3.710455869168404"/>
<DICH_DATA CI_END="73.21457045001645" CI_START="0.13005106216612491" EFFECT_SIZE="3.085714285714286" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.864597518713366" LOG_CI_START="-0.8858860964400181" LOG_EFFECT_SIZE="0.4893557111366741" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="309" O_E="0.0" SE="1.6156476906545747" STUDY_ID="STD-Hynninen-2006" TOTAL_1="34" TOTAL_2="35" VAR="2.6103174603174604" WEIGHT="0.2032331070749517"/>
<DICH_DATA CI_END="0.9937985996092608" CI_START="0.42513644129315287" EFFECT_SIZE="0.65" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="20" LOG_CI_END="-0.00270161956714033" LOG_CI_START="-0.3714716671471485" LOG_EFFECT_SIZE="-0.1870866433571444" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="310" O_E="0.0" SE="0.21661735138967264" STUDY_ID="STD-Keays-1991" TOTAL_1="25" TOTAL_2="25" VAR="0.04692307692307691" WEIGHT="8.245457487040898"/>
<DICH_DATA CI_END="1.3672012569998246" CI_START="0.5655516368553801" EFFECT_SIZE="0.8793309438470729" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="31" LOG_CI_END="0.13583244900161887" LOG_CI_START="-0.24752773631314112" LOG_EFFECT_SIZE="-0.05584764365576113" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="311" O_E="0.0" SE="0.22518767051741245" STUDY_ID="STD-Lee-2009" TOTAL_1="81" TOTAL_2="92" VAR="0.050709486953058706" WEIGHT="11.967828757202136"/>
<DICH_DATA CI_END="2.454270482634857" CI_START="0.7435122882479992" EFFECT_SIZE="1.3508442776735459" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="13" LOG_CI_END="0.38992242417845724" LOG_CI_START="-0.1287118493690649" LOG_EFFECT_SIZE="0.13060528740469618" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="312" O_E="0.0" SE="0.3046483395628732" STUDY_ID="STD-Molnar-1999" TOTAL_1="41" TOTAL_2="45" VAR="0.09281061079841568" WEIGHT="5.110266093712557"/>
<DICH_DATA CI_END="4.007329751896776" CI_START="0.00964621359876602" EFFECT_SIZE="0.19661016949152543" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6028550807748148" LOG_CI_START="-2.0156431256052665" LOG_EFFECT_SIZE="-0.7063940224152256" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="313" O_E="0.0" SE="1.538118808202826" STUDY_ID="STD-Ozaydin-2008" TOTAL_1="58" TOTAL_2="57" VAR="2.3658094681472823" WEIGHT="1.039491435332079"/>
<DICH_DATA CI_END="2.1315266092423184" CI_START="0.3002542859305412" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.3286907585993715" LOG_CI_START="-0.5225107846154844" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="314" O_E="0.0" SE="0.49999999999999994" STUDY_ID="STD-Paterson-2003" TOTAL_1="10" TOTAL_2="10" VAR="0.24999999999999997" WEIGHT="2.0613643717602246"/>
<DICH_DATA CI_END="3.4594443824994294" CI_START="0.9365665817292654" EFFECT_SIZE="1.8" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.5390063528415914" LOG_CI_START="-0.02846134263497925" LOG_EFFECT_SIZE="0.25527250510330607" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="315" O_E="0.0" SE="0.3333333333333333" STUDY_ID="STD-Peake-1996" TOTAL_1="10" TOTAL_2="10" VAR="0.1111111111111111" WEIGHT="2.0613643717602246"/>
<DICH_DATA CI_END="5.426771668614656" CI_START="0.0485244342329168" EFFECT_SIZE="0.5131578947368421" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7345415490261662" LOG_CI_START="-1.3140395195347503" LOG_EFFECT_SIZE="-0.2897489852542921" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="316" O_E="0.0" SE="1.2033466603125178" STUDY_ID="STD-Ristikankare-2006" TOTAL_1="38" TOTAL_2="39" VAR="1.4480431848852902" WEIGHT="0.8138373623572834"/>
<DICH_DATA CI_END="2.8660736990473508" CI_START="0.3785909081141594" EFFECT_SIZE="1.0416666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.45728735377872365" LOG_CI_START="-0.42182981985786044" LOG_EFFECT_SIZE="0.017728766960431616" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="317" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Spapen-1998" TOTAL_1="12" TOTAL_2="10" VAR="0.2666666666666667" WEIGHT="1.7990089062634684"/>
<DICH_DATA CI_END="2.0605010693751504" CI_START="0.5775695350592529" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.3139728442542525" LOG_CI_START="-0.23839572247545296" LOG_EFFECT_SIZE="0.037788560889399754" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="318" O_E="0.0" SE="0.32446403036553206" STUDY_ID="STD-Spies-1994" TOTAL_1="29" TOTAL_2="29" VAR="0.10527690700104493" WEIGHT="4.535001617872494"/>
<DICH_DATA CI_END="1.4473847741421566" CI_START="0.27804053753675506" EFFECT_SIZE="0.634375" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.16058399972514328" LOG_CI_START="-0.5558918805385293" LOG_EFFECT_SIZE="-0.19765394040669304" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="320" O_E="0.0" SE="0.4208614786796877" STUDY_ID="STD-Suter-1994" TOTAL_1="32" TOTAL_2="29" VAR="0.17712438423645321" WEIGHT="4.325485894841126"/>
<DICH_DATA CI_END="2.5703939747908535" CI_START="0.3726664127879707" EFFECT_SIZE="0.9787234042553191" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.40999969452363927" LOG_CI_START="-0.428679747031926" LOG_EFFECT_SIZE="-0.009340026254143404" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="321" O_E="0.0" SE="0.49264445549992975" STUDY_ID="STD-Szakmany-2003" TOTAL_1="47" TOTAL_2="46" VAR="0.24269855953482228" WEIGHT="2.91694141208221"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="322" O_E="0.0" SE="0.0" STUDY_ID="STD-Tossios-2003" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.1367318594230087" CI_START="0.003822476117610868" EFFECT_SIZE="0.06591760299625468" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.055658032228059366" LOG_CI_START="-2.41765521932891" LOG_EFFECT_SIZE="-1.1809985935504255" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="323" O_E="0.0" SE="1.4528364470626132" STUDY_ID="STD-Wijeysundera-2007" TOTAL_1="88" TOTAL_2="87" VAR="2.1107337419135175" WEIGHT="3.109515747231525"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="9.045455964476375" CI_END="1.2021793754269146" CI_START="0.7107461316184437" DF="9" EFFECT_SIZE="0.9243615854178256" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="73" I2="0.5025281716575816" ID="CMP-002.04.02" LOG_CI_END="0.07996927294625919" LOG_CI_START="-0.1482854953678554" LOG_EFFECT_SIZE="-0.03415811121079812" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4330889864242644" P_Z="0.5574632962807877" STUDIES="11" TAU2="0.0" TOTAL_1="351" TOTAL_2="355" WEIGHT="30.09498223920245" Z="0.5866135305523718">
<NAME>Inadequate or unclear allocation concealment</NAME>
<DICH_DATA CI_END="5.355895422334702" CI_START="0.3319291430456687" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7288320885142859" LOG_CI_START="-0.4789546152976862" LOG_EFFECT_SIZE="0.12493873660829992" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="325" O_E="0.0" SE="0.7094598884597586" STUDY_ID="STD-Bromley-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.5033333333333332" WEIGHT="1.2368186230561347"/>
<DICH_DATA CI_END="1.892323407364669" CI_START="0.23486706485515438" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.2769953614690809" LOG_CI_START="-0.6291778795804434" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="283" O_E="0.0" SE="0.5322906474223771" STUDY_ID="STD-Csontos-2011" TOTAL_1="15" TOTAL_2="15" VAR="0.2833333333333333" WEIGHT="2.4736372461122693"/>
<DICH_DATA CI_END="1.9904147370272371" CI_START="0.3566906252675075" EFFECT_SIZE="0.8425925925925926" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.2989435785382142" LOG_CI_START="-0.4477083048699264" LOG_EFFECT_SIZE="-0.07438236316585613" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="327" O_E="0.0" SE="0.4385870123003728" STUDY_ID="STD-Emet-2004" TOTAL_1="27" TOTAL_2="26" VAR="0.19235856735856735" WEIGHT="3.360412862643083"/>
<DICH_DATA CI_END="1.6963845355930864" CI_START="0.6654778007660358" EFFECT_SIZE="1.0625" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" LOG_CI_END="0.22952430473485386" LOG_CI_START="-0.1768664272901555" LOG_EFFECT_SIZE="0.026328938722349145" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="329" O_E="0.0" SE="0.23871592765805774" STUDY_ID="STD-Jepsen-1992" TOTAL_1="32" TOTAL_2="34" VAR="0.05698529411764706" WEIGHT="6.796255868106437"/>
<DICH_DATA CI_END="6.055139337673937" CI_START="0.660595863601809" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.7821241413496992" LOG_CI_START="-0.18006415002173679" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="330" O_E="0.0" SE="0.565194165260439" STUDY_ID="STD-Macedo-2006" TOTAL_1="18" TOTAL_2="24" VAR="0.31944444444444436" WEIGHT="1.4135069977784396"/>
<DICH_DATA CI_END="0.9960030761728802" CI_START="0.21642626378031393" EFFECT_SIZE="0.4642857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="-0.0017393202481444689" LOG_CI_START="-0.6646900378226205" LOG_EFFECT_SIZE="-0.33321467903538243" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="331" O_E="0.0" SE="0.38942053316222514" STUDY_ID="STD-Moradi-2009" TOTAL_1="14" TOTAL_2="13" VAR="0.1516483516483517" WEIGHT="4.275422400687873"/>
<DICH_DATA CI_END="1.6261635848009508" CI_START="0.3137470832586035" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.21116423154273745" LOG_CI_START="-0.5034203028992135" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="333" O_E="0.0" SE="0.4197504927816955" STUDY_ID="STD-Ortolani-2000b" TOTAL_1="12" TOTAL_2="12" VAR="0.17619047619047623" WEIGHT="2.8859101204643145"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="334" O_E="0.0" SE="0.0" STUDY_ID="STD-Peker-2008" TOTAL_1="19" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.3470381291495137" CI_START="0.37875994048868034" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.129379889000542" LOG_CI_START="-0.421635960357018" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="335" O_E="0.0" SE="0.3236694374850749" STUDY_ID="STD-Rank-2000" TOTAL_1="30" TOTAL_2="30" VAR="0.10476190476190478" WEIGHT="5.771820240928629"/>
<DICH_DATA CI_END="4.407079247591173" CI_START="0.3328969156973013" EFFECT_SIZE="1.2112403100775193" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6441508600134609" LOG_CI_START="-0.4776902285797333" LOG_EFFECT_SIZE="0.08323031571686385" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="336" O_E="0.0" SE="0.6589750086425917" STUDY_ID="STD-Sisillo-2008" TOTAL_1="129" TOTAL_2="125" VAR="0.43424806201550387" WEIGHT="1.6750614422492534"/>
<DICH_DATA CI_END="129.92776744614594" CI_START="0.3771326250203609" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1137019760147355" LOG_CI_START="-0.423505895986222" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="337" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Steib-1998" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="0.20613643717602245"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="28.178866790127692" CI_END="1.0854401327634597" CI_START="0.810049931871453" CI_STUDY="95" CI_TOTAL="95" DF="30" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9376890239282859" ESTIMABLE="YES" EVENTS_1="223" EVENTS_2="241" I2="0.0" I2_Q="30.399110126842" ID="CMP-002.05" LOG_CI_END="0.03560587502445472" LOG_CI_START="-0.09148821017334006" LOG_EFFECT_SIZE="-0.02794116757444266" METHOD="MH" MODIFIED="2012-08-06 10:45:48 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.5609587458902372" P_Q="0.2306641032721679" P_Z="0.3888076335982178" Q="1.4367632394103282" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="31" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1228" TOTAL_2="1233" WEIGHT="99.99999999999999" Z="0.8617817587132877">
<NAME>Mortality - Blinding</NAME>
<GROUP_LABEL_1>N-acetylcysteine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="16.97831878192984" CI_END="1.1492848031300413" CI_START="0.8262278535436568" DF="24" EFFECT_SIZE="0.9744593967941806" ESTIMABLE="YES" EVENTS_1="187" EVENTS_2="194" I2="0.0" ID="CMP-002.05.01" LOG_CI_END="0.060427664111249633" LOG_CI_START="-0.08290016830834315" LOG_EFFECT_SIZE="-0.011236252098546748" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8495853026641542" P_Z="0.7586115528807382" STUDIES="25" TAU2="0.0" TOTAL_1="1114" TOTAL_2="1114" WEIGHT="80.49992931074017" Z="0.3073045766839316">
<NAME>Adequate blinding</NAME>
<DICH_DATA CI_END="2.278946616108553" CI_START="0.3498080525081715" EFFECT_SIZE="0.8928571428571429" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.35773415203381126" LOG_CI_START="-0.45617019737417447" LOG_EFFECT_SIZE="-0.049218022670181584" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="383" O_E="0.0" SE="0.47809144373375756" STUDY_ID="STD-Bernard-1997" TOTAL_1="14" TOTAL_2="15" VAR="0.22857142857142865" WEIGHT="2.3883394100394324"/>
<DICH_DATA CI_END="5.355895422334702" CI_START="0.3319291430456687" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7288320885142859" LOG_CI_START="-0.4789546152976862" LOG_EFFECT_SIZE="0.12493873660829992" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="384" O_E="0.0" SE="0.7094598884597586" STUDY_ID="STD-Bromley-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.5033333333333332" WEIGHT="1.2368186230561347"/>
<DICH_DATA CI_END="4.532109560681806" CI_START="0.34011897737665486" EFFECT_SIZE="1.241554054054054" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6563004000934802" LOG_CI_START="-0.46836913537093017" LOG_EFFECT_SIZE="0.09396563236127509" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="385" O_E="0.0" SE="0.6606364523357819" STUDY_ID="STD-Burns-2005" TOTAL_1="148" TOTAL_2="147" VAR="0.4364405221548079" WEIGHT="1.65468163807736"/>
<DICH_DATA CI_END="1.5402163575984629" CI_START="0.2885597482794114" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.1875817314281723" LOG_CI_START="-0.539764249539535" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="284" O_E="0.0" SE="0.4272466296411038" STUDY_ID="STD-Burns-2010" TOTAL_1="21" TOTAL_2="21" VAR="0.18253968253968256" WEIGHT="3.710455869168404"/>
<DICH_DATA CI_END="1.921993645698558" CI_START="0.6845724737859185" EFFECT_SIZE="1.1470588235294117" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="17" LOG_CI_END="0.2837519475143089" LOG_CI_START="-0.1645805675458208" LOG_EFFECT_SIZE="0.059585689984244045" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="386" O_E="0.0" SE="0.2633527386280618" STUDY_ID="STD-Charunwatthana-2009" TOTAL_1="56" TOTAL_2="52" VAR="0.06935466494290023" WEIGHT="7.268218081169384"/>
<DICH_DATA CI_END="3.373800796086585" CI_START="0.48012162206574754" EFFECT_SIZE="1.2727272727272727" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5281194363697701" LOG_CI_START="-0.3186487353297442" LOG_EFFECT_SIZE="0.10473535052001297" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="387" O_E="0.0" SE="0.49739581562634544" STUDY_ID="STD-Domenighetti-1997" TOTAL_1="22" TOTAL_2="20" VAR="0.2474025974025974" WEIGHT="2.159524579939283"/>
<DICH_DATA CI_END="132.1011207444225" CI_START="0.37092796581794973" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1209065021796567" LOG_CI_START="-0.43071042215114297" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="388" O_E="0.0" SE="1.4988324120593923" STUDY_ID="STD-El_x002d_Hamamsy-2007" TOTAL_1="50" TOTAL_2="50" VAR="2.246498599439776" WEIGHT="0.20613643717602245"/>
<DICH_DATA CI_END="1.9904147370272371" CI_START="0.3566906252675075" EFFECT_SIZE="0.8425925925925926" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.2989435785382142" LOG_CI_START="-0.4477083048699264" LOG_EFFECT_SIZE="-0.07438236316585613" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="389" O_E="0.0" SE="0.4385870123003728" STUDY_ID="STD-Emet-2004" TOTAL_1="27" TOTAL_2="26" VAR="0.19235856735856735" WEIGHT="3.360412862643083"/>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363438" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.4771212547196625" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="391" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Haase-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.6184093115280673"/>
<DICH_DATA CI_END="2.690131744379176" CI_START="0.555298885868718" EFFECT_SIZE="1.2222222222222223" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="9" LOG_CI_END="0.4297735493168515" LOG_CI_START="-0.2554731978790511" LOG_EFFECT_SIZE="0.0871501757189002" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="285" O_E="0.0" SE="0.4025173313289777" STUDY_ID="STD-Hilmi-2010" TOTAL_1="50" TOTAL_2="50" VAR="0.16202020202020204" WEIGHT="3.710455869168404"/>
<DICH_DATA CI_END="73.21457045001645" CI_START="0.13005106216612491" EFFECT_SIZE="3.085714285714286" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.864597518713366" LOG_CI_START="-0.8858860964400181" LOG_EFFECT_SIZE="0.4893557111366741" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="392" O_E="0.0" SE="1.6156476906545747" STUDY_ID="STD-Hynninen-2006" TOTAL_1="34" TOTAL_2="35" VAR="2.6103174603174604" WEIGHT="0.2032331070749517"/>
<DICH_DATA CI_END="1.6963845355930864" CI_START="0.6654778007660358" EFFECT_SIZE="1.0625" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" LOG_CI_END="0.22952430473485386" LOG_CI_START="-0.1768664272901555" LOG_EFFECT_SIZE="0.026328938722349145" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="393" O_E="0.0" SE="0.23871592765805774" STUDY_ID="STD-Jepsen-1992" TOTAL_1="32" TOTAL_2="34" VAR="0.05698529411764706" WEIGHT="6.796255868106437"/>
<DICH_DATA CI_END="1.3672012569998246" CI_START="0.5655516368553801" EFFECT_SIZE="0.8793309438470729" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="31" LOG_CI_END="0.13583244900161887" LOG_CI_START="-0.24752773631314112" LOG_EFFECT_SIZE="-0.05584764365576113" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="394" O_E="0.0" SE="0.22518767051741245" STUDY_ID="STD-Lee-2009" TOTAL_1="81" TOTAL_2="92" VAR="0.050709486953058706" WEIGHT="11.967828757202136"/>
<DICH_DATA CI_END="2.454270482634857" CI_START="0.7435122882479992" EFFECT_SIZE="1.3508442776735459" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="13" LOG_CI_END="0.38992242417845724" LOG_CI_START="-0.1287118493690649" LOG_EFFECT_SIZE="0.13060528740469618" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="395" O_E="0.0" SE="0.3046483395628732" STUDY_ID="STD-Molnar-1999" TOTAL_1="41" TOTAL_2="45" VAR="0.09281061079841568" WEIGHT="5.110266093712557"/>
<DICH_DATA CI_END="4.007329751896776" CI_START="0.00964621359876602" EFFECT_SIZE="0.19661016949152543" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6028550807748148" LOG_CI_START="-2.0156431256052665" LOG_EFFECT_SIZE="-0.7063940224152256" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="396" O_E="0.0" SE="1.538118808202826" STUDY_ID="STD-Ozaydin-2008" TOTAL_1="58" TOTAL_2="57" VAR="2.3658094681472823" WEIGHT="1.039491435332079"/>
<DICH_DATA CI_END="2.1315266092423184" CI_START="0.3002542859305412" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.3286907585993715" LOG_CI_START="-0.5225107846154844" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="397" O_E="0.0" SE="0.49999999999999994" STUDY_ID="STD-Paterson-2003" TOTAL_1="10" TOTAL_2="10" VAR="0.24999999999999997" WEIGHT="2.0613643717602246"/>
<DICH_DATA CI_END="3.4594443824994294" CI_START="0.9365665817292654" EFFECT_SIZE="1.8" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.5390063528415914" LOG_CI_START="-0.02846134263497925" LOG_EFFECT_SIZE="0.25527250510330607" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="398" O_E="0.0" SE="0.3333333333333333" STUDY_ID="STD-Peake-1996" TOTAL_1="10" TOTAL_2="10" VAR="0.1111111111111111" WEIGHT="2.0613643717602246"/>
<DICH_DATA CI_END="1.3470381291495137" CI_START="0.37875994048868034" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.129379889000542" LOG_CI_START="-0.421635960357018" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="400" O_E="0.0" SE="0.3236694374850749" STUDY_ID="STD-Rank-2000" TOTAL_1="30" TOTAL_2="30" VAR="0.10476190476190478" WEIGHT="5.771820240928629"/>
<DICH_DATA CI_END="5.426771668614656" CI_START="0.0485244342329168" EFFECT_SIZE="0.5131578947368421" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7345415490261662" LOG_CI_START="-1.3140395195347503" LOG_EFFECT_SIZE="-0.2897489852542921" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="401" O_E="0.0" SE="1.2033466603125178" STUDY_ID="STD-Ristikankare-2006" TOTAL_1="38" TOTAL_2="39" VAR="1.4480431848852902" WEIGHT="0.8138373623572834"/>
<DICH_DATA CI_END="4.407079247591173" CI_START="0.3328969156973013" EFFECT_SIZE="1.2112403100775193" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6441508600134609" LOG_CI_START="-0.4776902285797333" LOG_EFFECT_SIZE="0.08323031571686385" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="402" O_E="0.0" SE="0.6589750086425917" STUDY_ID="STD-Sisillo-2008" TOTAL_1="129" TOTAL_2="125" VAR="0.43424806201550387" WEIGHT="1.6750614422492534"/>
<DICH_DATA CI_END="2.8660736990473508" CI_START="0.3785909081141594" EFFECT_SIZE="1.0416666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.45728735377872365" LOG_CI_START="-0.42182981985786044" LOG_EFFECT_SIZE="0.017728766960431616" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="403" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Spapen-1998" TOTAL_1="12" TOTAL_2="10" VAR="0.2666666666666667" WEIGHT="1.7990089062634684"/>
<DICH_DATA CI_END="2.0605010693751504" CI_START="0.5775695350592529" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.3139728442542525" LOG_CI_START="-0.23839572247545296" LOG_EFFECT_SIZE="0.037788560889399754" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="404" O_E="0.0" SE="0.32446403036553206" STUDY_ID="STD-Spies-1994" TOTAL_1="29" TOTAL_2="29" VAR="0.10527690700104493" WEIGHT="4.535001617872494"/>
<DICH_DATA CI_END="1.4473847741421566" CI_START="0.27804053753675506" EFFECT_SIZE="0.634375" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.16058399972514328" LOG_CI_START="-0.5558918805385293" LOG_EFFECT_SIZE="-0.19765394040669304" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="406" O_E="0.0" SE="0.4208614786796877" STUDY_ID="STD-Suter-1994" TOTAL_1="32" TOTAL_2="29" VAR="0.17712438423645321" WEIGHT="4.325485894841126"/>
<DICH_DATA CI_END="2.5703939747908535" CI_START="0.3726664127879707" EFFECT_SIZE="0.9787234042553191" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.40999969452363927" LOG_CI_START="-0.428679747031926" LOG_EFFECT_SIZE="-0.009340026254143404" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="407" O_E="0.0" SE="0.49264445549992975" STUDY_ID="STD-Szakmany-2003" TOTAL_1="47" TOTAL_2="46" VAR="0.24269855953482228" WEIGHT="2.91694141208221"/>
<DICH_DATA CI_END="1.1367318594230087" CI_START="0.003822476117610868" EFFECT_SIZE="0.06591760299625468" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.055658032228059366" LOG_CI_START="-2.41765521932891" LOG_EFFECT_SIZE="-1.1809985935504255" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="409" O_E="0.0" SE="1.4528364470626132" STUDY_ID="STD-Wijeysundera-2007" TOTAL_1="88" TOTAL_2="87" VAR="2.1107337419135175" WEIGHT="3.109515747231525"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.626512040843803" CI_END="1.0720815089681648" CI_START="0.5761031015633783" DF="5" EFFECT_SIZE="0.7858940656636277" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="47" I2="34.439230237591076" ID="CMP-002.05.02" LOG_CI_END="0.030227805458802916" LOG_CI_START="-0.23949978665815558" LOG_EFFECT_SIZE="-0.10463599059967635" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.17805614247676294" P_Z="0.12834370526945876" STUDIES="6" TAU2="0.0" TOTAL_1="114" TOTAL_2="119" WEIGHT="19.500070689259815" Z="1.5206658796190933">
<NAME>Inadequate or unclear blinding</NAME>
<DICH_DATA CI_END="1.892323407364669" CI_START="0.23486706485515438" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.2769953614690809" LOG_CI_START="-0.6291778795804434" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="286" O_E="0.0" SE="0.5322906474223771" STUDY_ID="STD-Csontos-2011" TOTAL_1="15" TOTAL_2="15" VAR="0.2833333333333333" WEIGHT="2.4736372461122693"/>
<DICH_DATA CI_END="0.9937985996092608" CI_START="0.42513644129315287" EFFECT_SIZE="0.65" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="20" LOG_CI_END="-0.00270161956714033" LOG_CI_START="-0.3714716671471485" LOG_EFFECT_SIZE="-0.1870866433571444" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="376" O_E="0.0" SE="0.21661735138967264" STUDY_ID="STD-Keays-1991" TOTAL_1="25" TOTAL_2="25" VAR="0.04692307692307691" WEIGHT="8.245457487040898"/>
<DICH_DATA CI_END="6.055139337673937" CI_START="0.660595863601809" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.7821241413496992" LOG_CI_START="-0.18006415002173679" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="377" O_E="0.0" SE="0.565194165260439" STUDY_ID="STD-Macedo-2006" TOTAL_1="18" TOTAL_2="24" VAR="0.31944444444444436" WEIGHT="1.4135069977784396"/>
<DICH_DATA CI_END="0.9960030761728802" CI_START="0.21642626378031393" EFFECT_SIZE="0.4642857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="-0.0017393202481444689" LOG_CI_START="-0.6646900378226205" LOG_EFFECT_SIZE="-0.33321467903538243" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="378" O_E="0.0" SE="0.38942053316222514" STUDY_ID="STD-Moradi-2009" TOTAL_1="14" TOTAL_2="13" VAR="0.1516483516483517" WEIGHT="4.275422400687873"/>
<DICH_DATA CI_END="1.6261635848009508" CI_START="0.3137470832586035" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.21116423154273745" LOG_CI_START="-0.5034203028992135" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="380" O_E="0.0" SE="0.4197504927816955" STUDY_ID="STD-Ortolani-2000b" TOTAL_1="12" TOTAL_2="12" VAR="0.17619047619047623" WEIGHT="2.8859101204643145"/>
<DICH_DATA CI_END="129.92776744614594" CI_START="0.3771326250203609" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1137019760147355" LOG_CI_START="-0.423505895986222" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2012-06-27 10:54:17 +0100" MODIFIED_BY="[Empty name]" ORDER="381" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Steib-1998" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="0.20613643717602245"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="30.918266292325413" CI_END="1.0975930661055655" CI_START="0.8246107650384318" CI_STUDY="95" CI_TOTAL="95" DF="31" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9513606350602217" ESTIMABLE="YES" EVENTS_1="233" EVENTS_2="248" I2="0.0" I2_Q="0.0" ID="CMP-002.06" LOG_CI_END="0.040441354775210284" LOG_CI_START="-0.08375099991754702" LOG_EFFECT_SIZE="-0.021654822571168367" METHOD="MH" MODIFIED="2012-06-27 11:38:21 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.47033685268115444" P_Q="0.35314918662179007" P_Z="0.4942916148519675" Q="0.8621092762102387" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="31" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1238" TOTAL_2="1243" WEIGHT="100.0" Z="0.6834989550861662">
<NAME>Mortality - short and long timescales</NAME>
<GROUP_LABEL_1>N-acetylcysteine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="16.806242194104897" CI_END="1.0914280663987421" CI_START="0.721060341436218" DF="13" EFFECT_SIZE="0.887122028928686" ESTIMABLE="YES" EVENTS_1="108" EVENTS_2="124" I2="22.64778854275947" ID="CMP-002.06.01" LOG_CI_END="0.03799511760305199" LOG_CI_START="-0.1420283901262915" LOG_EFFECT_SIZE="-0.052016636261619724" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.20831379453753773" P_Z="0.2573663189468586" STUDIES="14" TAU2="0.0" TOTAL_1="761" TOTAL_2="763" WEIGHT="50.16917864568442" Z="1.1326380088424095">
<NAME>Short timescale</NAME>
<DICH_DATA CI_END="4.532109560681806" CI_START="0.34011897737665486" EFFECT_SIZE="1.241554054054054" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6563004000934802" LOG_CI_START="-0.46836913537093017" LOG_EFFECT_SIZE="0.09396563236127509" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="292" O_E="0.0" SE="0.6606364523357819" STUDY_ID="STD-Burns-2005" TOTAL_1="148" TOTAL_2="147" VAR="0.4364405221548079" WEIGHT="1.6114971612434206"/>
<DICH_DATA CI_END="1.921993645698558" CI_START="0.6845724737859185" EFFECT_SIZE="1.1470588235294117" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="17" LOG_CI_END="0.2837519475143089" LOG_CI_START="-0.1645805675458208" LOG_EFFECT_SIZE="0.059585689984244045" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="327" O_E="0.0" SE="0.2633527386280618" STUDY_ID="STD-Charunwatthana-2009" TOTAL_1="56" TOTAL_2="52" VAR="0.06935466494290023" WEIGHT="7.078529510191477"/>
<DICH_DATA CI_END="3.373800796086585" CI_START="0.48012162206574754" EFFECT_SIZE="1.2727272727272727" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5281194363697701" LOG_CI_START="-0.3186487353297442" LOG_EFFECT_SIZE="0.10473535052001297" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="322" O_E="0.0" SE="0.49739581562634544" STUDY_ID="STD-Domenighetti-1997" TOTAL_1="22" TOTAL_2="20" VAR="0.2474025974025974" WEIGHT="2.1031645303390043"/>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363438" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.4771212547196625" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="296" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Haase-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.6022698427788967"/>
<DICH_DATA CI_END="73.21457045001645" CI_START="0.13005106216612491" EFFECT_SIZE="3.085714285714286" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.864597518713366" LOG_CI_START="-0.8858860964400181" LOG_EFFECT_SIZE="0.4893557111366741" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="298" O_E="0.0" SE="1.6156476906545747" STUDY_ID="STD-Hynninen-2006" TOTAL_1="34" TOTAL_2="35" VAR="2.6103174603174604" WEIGHT="0.19792905631231347"/>
<DICH_DATA CI_END="0.9937985996092608" CI_START="0.42513644129315287" EFFECT_SIZE="0.65" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="20" LOG_CI_END="-0.00270161956714033" LOG_CI_START="-0.3714716671471485" LOG_EFFECT_SIZE="-0.1870866433571444" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="301" O_E="0.0" SE="0.21661735138967264" STUDY_ID="STD-Keays-1991" TOTAL_1="25" TOTAL_2="25" VAR="0.04692307692307691" WEIGHT="8.03026457038529"/>
<DICH_DATA CI_END="1.3672012569998246" CI_START="0.5655516368553801" EFFECT_SIZE="0.8793309438470729" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="31" LOG_CI_END="0.13583244900161887" LOG_CI_START="-0.24752773631314112" LOG_EFFECT_SIZE="-0.05584764365576113" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="305" O_E="0.0" SE="0.22518767051741245" STUDY_ID="STD-Lee-2009" TOTAL_1="81" TOTAL_2="92" VAR="0.050709486953058706" WEIGHT="11.65548805562859"/>
<DICH_DATA CI_END="6.055139337673937" CI_START="0.660595863601809" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.7821241413496992" LOG_CI_START="-0.18006415002173679" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="302" O_E="0.0" SE="0.565194165260439" STUDY_ID="STD-Macedo-2006" TOTAL_1="18" TOTAL_2="24" VAR="0.31944444444444436" WEIGHT="1.376616783494621"/>
<DICH_DATA CI_END="4.007329751896776" CI_START="0.00964621359876602" EFFECT_SIZE="0.19661016949152543" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6028550807748148" LOG_CI_START="-2.0156431256052665" LOG_EFFECT_SIZE="-0.7063940224152256" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="310" O_E="0.0" SE="1.538118808202826" STUDY_ID="STD-Ozaydin-2008" TOTAL_1="58" TOTAL_2="57" VAR="2.3658094681472823" WEIGHT="1.012362413787889"/>
<DICH_DATA CI_END="3.4594443824994294" CI_START="0.9365665817292654" EFFECT_SIZE="1.8" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.5390063528415914" LOG_CI_START="-0.02846134263497925" LOG_EFFECT_SIZE="0.25527250510330607" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="313" O_E="0.0" SE="0.3333333333333333" STUDY_ID="STD-Peake-1996" TOTAL_1="10" TOTAL_2="10" VAR="0.1111111111111111" WEIGHT="2.0075661425963225"/>
<DICH_DATA CI_END="1.3470381291495137" CI_START="0.37875994048868034" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.129379889000542" LOG_CI_START="-0.421635960357018" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="312" O_E="0.0" SE="0.3236694374850749" STUDY_ID="STD-Rank-2000" TOTAL_1="30" TOTAL_2="30" VAR="0.10476190476190478" WEIGHT="5.621185199269703"/>
<DICH_DATA CI_END="4.407079247591173" CI_START="0.3328969156973013" EFFECT_SIZE="1.2112403100775193" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6441508600134609" LOG_CI_START="-0.4776902285797333" LOG_EFFECT_SIZE="0.08323031571686385" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="315" O_E="0.0" SE="0.6589750086425917" STUDY_ID="STD-Sisillo-2008" TOTAL_1="129" TOTAL_2="125" VAR="0.43424806201550387" WEIGHT="1.631345085952287"/>
<DICH_DATA CI_END="1.4473847741421566" CI_START="0.27804053753675506" EFFECT_SIZE="0.634375" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.16058399972514328" LOG_CI_START="-0.5558918805385293" LOG_EFFECT_SIZE="-0.19765394040669304" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="318" O_E="0.0" SE="0.4208614786796877" STUDY_ID="STD-Suter-1994" TOTAL_1="32" TOTAL_2="29" VAR="0.17712438423645321" WEIGHT="4.212597807415233"/>
<DICH_DATA CI_END="1.1367318594230087" CI_START="0.003822476117610868" EFFECT_SIZE="0.06591760299625468" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.055658032228059366" LOG_CI_START="-2.41765521932891" LOG_EFFECT_SIZE="-1.1809985935504255" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="320" O_E="0.0" SE="1.4528364470626132" STUDY_ID="STD-Wijeysundera-2007" TOTAL_1="88" TOTAL_2="87" VAR="2.1107337419135175" WEIGHT="3.028362486289368"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="13.750084286535206" CI_END="1.2380996260286652" CI_START="0.8338004240083251" DF="17" EFFECT_SIZE="1.0160354290807234" ESTIMABLE="YES" EVENTS_1="125" EVENTS_2="124" I2="0.0" ID="CMP-002.06.02" LOG_CI_END="0.09275559241727739" LOG_CI_START="-0.07893788836008236" LOG_EFFECT_SIZE="0.006908852028597512" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6847069475179814" P_Z="0.8746650180042775" STUDIES="18" TAU2="0.0" TOTAL_1="477" TOTAL_2="480" WEIGHT="49.830821354315574" Z="0.1577357636324792">
<NAME>Long term timescale</NAME>
<DICH_DATA CI_END="2.278946616108553" CI_START="0.3498080525081715" EFFECT_SIZE="0.8928571428571429" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.35773415203381126" LOG_CI_START="-0.45617019737417447" LOG_EFFECT_SIZE="-0.049218022670181584" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="325" O_E="0.0" SE="0.47809144373375756" STUDY_ID="STD-Bernard-1997" TOTAL_1="14" TOTAL_2="15" VAR="0.22857142857142865" WEIGHT="2.3260076686633253"/>
<DICH_DATA CI_END="5.355895422334702" CI_START="0.3319291430456687" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7288320885142859" LOG_CI_START="-0.4789546152976862" LOG_EFFECT_SIZE="0.12493873660829992" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="291" O_E="0.0" SE="0.7094598884597586" STUDY_ID="STD-Bromley-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.5033333333333332" WEIGHT="1.2045396855577934"/>
<DICH_DATA CI_END="1.5402163575984629" CI_START="0.2885597482794114" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.1875817314281723" LOG_CI_START="-0.539764249539535" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="326" O_E="0.0" SE="0.4272466296411038" STUDY_ID="STD-Burns-2010" TOTAL_1="21" TOTAL_2="21" VAR="0.18253968253968256" WEIGHT="3.61361905667338"/>
<DICH_DATA CI_END="1.892323407364669" CI_START="0.23486706485515438" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.2769953614690809" LOG_CI_START="-0.6291778795804434" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="321" O_E="0.0" SE="0.5322906474223771" STUDY_ID="STD-Csontos-2011" TOTAL_1="15" TOTAL_2="15" VAR="0.2833333333333333" WEIGHT="2.409079371115587"/>
<DICH_DATA CI_END="132.1011207444225" CI_START="0.37092796581794973" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1209065021796567" LOG_CI_START="-0.43071042215114297" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="293" O_E="0.0" SE="1.4988324120593923" STUDY_ID="STD-El_x002d_Hamamsy-2007" TOTAL_1="50" TOTAL_2="50" VAR="2.246498599439776" WEIGHT="0.20075661425963223"/>
<DICH_DATA CI_END="1.9904147370272371" CI_START="0.3566906252675075" EFFECT_SIZE="0.8425925925925926" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.2989435785382142" LOG_CI_START="-0.4477083048699264" LOG_EFFECT_SIZE="-0.07438236316585613" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="294" O_E="0.0" SE="0.4385870123003728" STUDY_ID="STD-Emet-2004" TOTAL_1="27" TOTAL_2="26" VAR="0.19235856735856735" WEIGHT="3.272711598496646"/>
<DICH_DATA CI_END="2.690131744379176" CI_START="0.555298885868718" EFFECT_SIZE="1.2222222222222223" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="9" LOG_CI_END="0.4297735493168515" LOG_CI_START="-0.2554731978790511" LOG_EFFECT_SIZE="0.0871501757189002" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="297" O_E="0.0" SE="0.4025173313289777" STUDY_ID="STD-Hilmi-2010" TOTAL_1="50" TOTAL_2="50" VAR="0.16202020202020204" WEIGHT="3.61361905667338"/>
<DICH_DATA CI_END="1.6963845355930864" CI_START="0.6654778007660358" EFFECT_SIZE="1.0625" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" LOG_CI_END="0.22952430473485386" LOG_CI_START="-0.1768664272901555" LOG_EFFECT_SIZE="0.026328938722349145" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="300" O_E="0.0" SE="0.23871592765805774" STUDY_ID="STD-Jepsen-1992" TOTAL_1="32" TOTAL_2="34" VAR="0.05698529411764706" WEIGHT="6.61888473680242"/>
<DICH_DATA CI_END="2.454270482634857" CI_START="0.7435122882479992" EFFECT_SIZE="1.3508442776735459" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="13" LOG_CI_END="0.38992242417845724" LOG_CI_START="-0.1287118493690649" LOG_EFFECT_SIZE="0.13060528740469618" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="304" O_E="0.0" SE="0.3046483395628732" STUDY_ID="STD-Molnar-1999" TOTAL_1="41" TOTAL_2="45" VAR="0.09281061079841568" WEIGHT="4.976896530250418"/>
<DICH_DATA CI_END="0.9960030761728802" CI_START="0.21642626378031393" EFFECT_SIZE="0.4642857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="-0.0017393202481444689" LOG_CI_START="-0.6646900378226205" LOG_EFFECT_SIZE="-0.33321467903538243" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="303" O_E="0.0" SE="0.38942053316222514" STUDY_ID="STD-Moradi-2009" TOTAL_1="14" TOTAL_2="13" VAR="0.1516483516483517" WEIGHT="4.163840888347928"/>
<DICH_DATA CI_END="1.6261635848009508" CI_START="0.3137470832586035" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.21116423154273745" LOG_CI_START="-0.5034203028992135" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="308" O_E="0.0" SE="0.4197504927816955" STUDY_ID="STD-Ortolani-2000b" TOTAL_1="12" TOTAL_2="12" VAR="0.17619047619047623" WEIGHT="2.8105925996348513"/>
<DICH_DATA CI_END="2.1315266092423184" CI_START="0.3002542859305412" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.3286907585993715" LOG_CI_START="-0.5225107846154844" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="311" O_E="0.0" SE="0.49999999999999994" STUDY_ID="STD-Paterson-2003" TOTAL_1="10" TOTAL_2="10" VAR="0.24999999999999997" WEIGHT="2.0075661425963225"/>
<DICH_DATA CI_END="3.4594443824994294" CI_START="0.9365665817292654" EFFECT_SIZE="1.8" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.5390063528415914" LOG_CI_START="-0.02846134263497925" LOG_EFFECT_SIZE="0.25527250510330607" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="323" O_E="0.0" SE="0.3333333333333333" STUDY_ID="STD-Peake-1996" TOTAL_1="10" TOTAL_2="10" VAR="0.1111111111111111" WEIGHT="2.0075661425963225"/>
<DICH_DATA CI_END="5.426771668614656" CI_START="0.0485244342329168" EFFECT_SIZE="0.5131578947368421" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7345415490261662" LOG_CI_START="-1.3140395195347503" LOG_EFFECT_SIZE="-0.2897489852542921" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="314" O_E="0.0" SE="1.2033466603125178" STUDY_ID="STD-Ristikankare-2006" TOTAL_1="38" TOTAL_2="39" VAR="1.4480431848852902" WEIGHT="0.7925975420120546"/>
<DICH_DATA CI_END="2.8660736990473508" CI_START="0.3785909081141594" EFFECT_SIZE="1.0416666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.45728735377872365" LOG_CI_START="-0.42182981985786044" LOG_EFFECT_SIZE="0.017728766960431616" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="316" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Spapen-1998" TOTAL_1="12" TOTAL_2="10" VAR="0.2666666666666667" WEIGHT="1.7520577244476994"/>
<DICH_DATA CI_END="2.0605010693751504" CI_START="0.5775695350592529" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.3139728442542525" LOG_CI_START="-0.23839572247545296" LOG_EFFECT_SIZE="0.037788560889399754" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="324" O_E="0.0" SE="0.32446403036553206" STUDY_ID="STD-Spies-1994" TOTAL_1="29" TOTAL_2="29" VAR="0.10527690700104493" WEIGHT="4.416645513711909"/>
<DICH_DATA CI_END="10.108042421948712" CI_START="0.39572449669526094" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0046670559209654" LOG_CI_START="-0.402607064593003" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="317" O_E="0.0" SE="0.8266397845091497" STUDY_ID="STD-Steib-1998" TOTAL_1="30" TOTAL_2="30" VAR="0.6833333333333333" WEIGHT="0.8030264570385289"/>
<DICH_DATA CI_END="2.5703939747908535" CI_START="0.3726664127879707" EFFECT_SIZE="0.9787234042553191" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.40999969452363927" LOG_CI_START="-0.428679747031926" LOG_EFFECT_SIZE="-0.009340026254143404" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="319" O_E="0.0" SE="0.49264445549992975" STUDY_ID="STD-Szakmany-2003" TOTAL_1="47" TOTAL_2="46" VAR="0.24269855953482228" WEIGHT="2.8408140254373766"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="21.625355652521833" CI_END="1.120235920818814" CI_START="0.811710568329791" CI_STUDY="95" CI_TOTAL="95" DF="16" EFFECT_MEASURE="RR" EFFECT_SIZE="0.953576077694531" ESTIMABLE="YES" EVENTS_1="167" EVENTS_2="182" I2="26.01277751409297" I2_Q="36.26096468786516" ID="CMP-002.07" LOG_CI_END="0.049309494384569906" LOG_CI_START="-0.09059879955780259" LOG_EFFECT_SIZE="-0.020644652586616352" METHOD="MH" MODIFIED="2012-06-27 11:38:21 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.1557055773053453" P_Q="0.21036726901670222" P_Z="0.5629815827890425" Q="1.5688972936332108" RANDOM="NO" SCALE="14.056698458655632" SORT_BY="STUDY" STUDIES="16" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="440" TOTAL_2="456" WEIGHT="100.00000000000001" Z="0.5784185397868712">
<NAME>Mortality - sepsis or other critical illness (SIRS)</NAME>
<GROUP_LABEL_1>N-acetylcysteine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="10.984270330732596" CI_END="1.4050276127551498" CI_START="0.8352056395401253" DF="7" EFFECT_SIZE="1.0832760432515345" ESTIMABLE="YES" EVENTS_1="71" EVENTS_2="67" I2="36.27250796609687" ID="CMP-002.07.01" LOG_CI_END="0.147684859436367" LOG_CI_START="-0.07820658185511771" LOG_EFFECT_SIZE="0.034739138790624645" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.1393066587232814" P_Z="0.5466194805874431" STUDIES="8" TAU2="0.0" TOTAL_1="184" TOTAL_2="185" WEIGHT="37.27800138343787" Z="0.6028334716383016">
<NAME>Mortality in sepsis</NAME>
<DICH_DATA CI_END="1.921993645698558" CI_START="0.6845724737859185" EFFECT_SIZE="1.1470588235294117" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="17" LOG_CI_END="0.2837519475143089" LOG_CI_START="-0.1645805675458208" LOG_EFFECT_SIZE="0.059585689984244045" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="311" O_E="0.0" SE="0.2633527386280618" STUDY_ID="STD-Charunwatthana-2009" TOTAL_1="56" TOTAL_2="52" VAR="0.06935466494290023" WEIGHT="9.845597251086888"/>
<DICH_DATA CI_END="3.967340316212217" CI_START="0.36296356884625103" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.5984994556074743" LOG_CI_START="-0.44013696351222464" LOG_EFFECT_SIZE="0.07918124604762482" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="312" O_E="0.0" SE="0.6101001739241042" STUDY_ID="STD-Domenighetti-1997" TOTAL_1="10" TOTAL_2="9" VAR="0.3722222222222222" WEIGHT="1.7635855314861522"/>
<DICH_DATA CI_END="1.9904147370272371" CI_START="0.3566906252675075" EFFECT_SIZE="0.8425925925925926" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.2989435785382142" LOG_CI_START="-0.4477083048699264" LOG_EFFECT_SIZE="-0.07438236316585613" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="313" O_E="0.0" SE="0.4385870123003728" STUDY_ID="STD-Emet-2004" TOTAL_1="27" TOTAL_2="26" VAR="0.19235856735856735" WEIGHT="4.552047183156709"/>
<DICH_DATA CI_END="2.1315266092423184" CI_START="0.3002542859305412" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.3286907585993715" LOG_CI_START="-0.5225107846154844" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="314" O_E="0.0" SE="0.49999999999999994" STUDY_ID="STD-Paterson-2003" TOTAL_1="10" TOTAL_2="10" VAR="0.24999999999999997" WEIGHT="2.7923437581864077"/>
<DICH_DATA CI_END="7.462512658947491" CI_START="1.567354125151951" EFFECT_SIZE="3.42" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.872885080848498" LOG_CI_START="0.19516713126377214" LOG_EFFECT_SIZE="0.534026106056135" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="315" O_E="0.0" SE="0.3980948783440233" STUDY_ID="STD-Peake-1996" TOTAL_1="10" TOTAL_2="19" VAR="0.1584795321637427" WEIGHT="1.9257543159906256"/>
<DICH_DATA CI_END="1.3470381291495137" CI_START="0.37875994048868034" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.129379889000542" LOG_CI_START="-0.421635960357018" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="316" O_E="0.0" SE="0.3236694374850749" STUDY_ID="STD-Rank-2000" TOTAL_1="30" TOTAL_2="30" VAR="0.10476190476190478" WEIGHT="7.81856252292194"/>
<DICH_DATA CI_END="2.510826009765055" CI_START="0.2765800743435127" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.39981661887899633" LOG_CI_START="-0.558179110974246" LOG_EFFECT_SIZE="-0.07918124604762482" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="317" O_E="0.0" SE="0.5627314338711378" STUDY_ID="STD-Spapen-1998" TOTAL_1="12" TOTAL_2="10" VAR="0.31666666666666665" WEIGHT="2.436954552599046"/>
<DICH_DATA CI_END="2.0605010693751504" CI_START="0.5775695350592529" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.3139728442542525" LOG_CI_START="-0.23839572247545296" LOG_EFFECT_SIZE="0.037788560889399754" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="318" O_E="0.0" SE="0.32446403036553206" STUDY_ID="STD-Spies-1994" TOTAL_1="29" TOTAL_2="29" VAR="0.10527690700104493" WEIGHT="6.143156268010096"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="8.29916669723606" CI_END="1.0764337219161473" CI_START="0.7136860808954377" DF="8" EFFECT_SIZE="0.87649059569286" ESTIMABLE="YES" EVENTS_1="96" EVENTS_2="115" I2="3.604779951409994" ID="CMP-002.07.02" LOG_CI_END="0.03198729464049114" LOG_CI_START="-0.14649277325743607" LOG_EFFECT_SIZE="-0.05725273930847247" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.40480575545603836" P_Z="0.20859713994353668" STUDIES="9" TAU2="0.0" TOTAL_1="256" TOTAL_2="271" WEIGHT="62.721998616562146" Z="1.2574323663417866">
<NAME>Mortality in other critical illness (SIRS)</NAME>
<DICH_DATA CI_END="2.278946616108553" CI_START="0.3498080525081715" EFFECT_SIZE="0.8928571428571429" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.35773415203381126" LOG_CI_START="-0.45617019737417447" LOG_EFFECT_SIZE="-0.049218022670181584" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="303" O_E="0.0" SE="0.47809144373375756" STUDY_ID="STD-Bernard-1997" TOTAL_1="14" TOTAL_2="15" VAR="0.22857142857142865" WEIGHT="3.2352672508642515"/>
<DICH_DATA CI_END="1.892323407364669" CI_START="0.23486706485515438" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.2769953614690809" LOG_CI_START="-0.6291778795804434" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="287" O_E="0.0" SE="0.5322906474223771" STUDY_ID="STD-Csontos-2011" TOTAL_1="15" TOTAL_2="15" VAR="0.2833333333333333" WEIGHT="3.350812509823689"/>
<DICH_DATA CI_END="3.373800796086585" CI_START="0.48012162206574754" EFFECT_SIZE="1.2727272727272727" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5281194363697701" LOG_CI_START="-0.3186487353297442" LOG_EFFECT_SIZE="0.10473535052001297" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="304" O_E="0.0" SE="0.49739581562634544" STUDY_ID="STD-Domenighetti-1997" TOTAL_1="22" TOTAL_2="20" VAR="0.2474025974025974" WEIGHT="2.9253125085762366"/>
<DICH_DATA CI_END="1.6963845355930864" CI_START="0.6654778007660358" EFFECT_SIZE="1.0625" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" LOG_CI_END="0.22952430473485386" LOG_CI_START="-0.1768664272901555" LOG_EFFECT_SIZE="0.026328938722349145" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="305" O_E="0.0" SE="0.23871592765805774" STUDY_ID="STD-Jepsen-1992" TOTAL_1="32" TOTAL_2="34" VAR="0.05698529411764706" WEIGHT="9.206272754263065"/>
<DICH_DATA CI_END="0.9937985996092608" CI_START="0.42513644129315287" EFFECT_SIZE="0.65" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="20" LOG_CI_END="-0.00270161956714033" LOG_CI_START="-0.3714716671471485" LOG_EFFECT_SIZE="-0.1870866433571444" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="306" O_E="0.0" SE="0.21661735138967264" STUDY_ID="STD-Keays-1991" TOTAL_1="25" TOTAL_2="25" VAR="0.04692307692307691" WEIGHT="11.16937503274563"/>
<DICH_DATA CI_END="1.3672012569998246" CI_START="0.5655516368553801" EFFECT_SIZE="0.8793309438470729" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="31" LOG_CI_END="0.13583244900161887" LOG_CI_START="-0.24752773631314112" LOG_EFFECT_SIZE="-0.05584764365576113" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="307" O_E="0.0" SE="0.22518767051741245" STUDY_ID="STD-Lee-2009" TOTAL_1="81" TOTAL_2="92" VAR="0.050709486953058706" WEIGHT="16.2117345128464"/>
<DICH_DATA CI_END="2.454270482634857" CI_START="0.7435122882479992" EFFECT_SIZE="1.3508442776735459" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="13" LOG_CI_END="0.38992242417845724" LOG_CI_START="-0.1287118493690649" LOG_EFFECT_SIZE="0.13060528740469618" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="308" O_E="0.0" SE="0.3046483395628732" STUDY_ID="STD-Molnar-1999" TOTAL_1="41" TOTAL_2="45" VAR="0.09281061079841568" WEIGHT="6.922414991224908"/>
<DICH_DATA CI_END="0.9960030761728802" CI_START="0.21642626378031393" EFFECT_SIZE="0.4642857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="-0.0017393202481444689" LOG_CI_START="-0.6646900378226205" LOG_EFFECT_SIZE="-0.33321467903538243" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="309" O_E="0.0" SE="0.38942053316222514" STUDY_ID="STD-Moradi-2009" TOTAL_1="14" TOTAL_2="13" VAR="0.1516483516483517" WEIGHT="5.791527794756993"/>
<DICH_DATA CI_END="1.6261635848009508" CI_START="0.3137470832586035" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.21116423154273745" LOG_CI_START="-0.5034203028992135" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="310" O_E="0.0" SE="0.4197504927816955" STUDY_ID="STD-Ortolani-2000b" TOTAL_1="12" TOTAL_2="12" VAR="0.17619047619047623" WEIGHT="3.90928126146097"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="32.706612078639914" CI_END="1.1004613868503634" CI_START="0.8151096616446318" CI_STUDY="95" CI_TOTAL="95" DF="28" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9470991018307334" ESTIMABLE="YES" EVENTS_1="212" EVENTS_2="230" I2="14.3903993092385" I2_Q="0.0" ID="CMP-002.08" LOG_CI_END="0.041574808568587515" LOG_CI_START="-0.08878395905962302" LOG_EFFECT_SIZE="-0.023604575245517775" METHOD="MH" MODIFIED="2012-08-06 10:45:48 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.2467159763493013" P_Q="0.695993699263177" P_Z="0.47783016561647973" Q="0.15267341136169377" RANDOM="NO" SCALE="62.81831458281831" SORT_BY="STUDY" STUDIES="29" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1198" TOTAL_2="1206" WEIGHT="100.00000000000001" Z="0.7097967891738289">
<NAME>Mortality - medical or surgical patients</NAME>
<GROUP_LABEL_1>N-acetylcysteine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="22.457805438428903" CI_END="1.092540903178752" CI_START="0.7945024026952695" DF="16" EFFECT_SIZE="0.9316793292857679" ESTIMABLE="YES" EVENTS_1="172" EVENTS_2="191" I2="28.75528268393742" ID="CMP-002.08.01" LOG_CI_END="0.03843770531503634" LOG_CI_START="-0.09990478508250544" LOG_EFFECT_SIZE="-0.030733539883734548" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.12901517512927496" P_Z="0.38384512952942773" STUDIES="17" TAU2="0.0" TOTAL_1="471" TOTAL_2="485" WEIGHT="81.70569799753837" Z="0.8708334094094838">
<NAME>Mortality in medical patients</NAME>
<DICH_DATA CI_END="2.278946616108553" CI_START="0.3498080525081715" EFFECT_SIZE="0.8928571428571429" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.35773415203381126" LOG_CI_START="-0.45617019737417447" LOG_EFFECT_SIZE="-0.049218022670181584" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="273" O_E="0.0" SE="0.47809144373375756" STUDY_ID="STD-Bernard-1997" TOTAL_1="14" TOTAL_2="15" VAR="0.22857142857142865" WEIGHT="2.5124322287983483"/>
<DICH_DATA CI_END="1.5402163575984629" CI_START="0.2885597482794114" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.1875817314281723" LOG_CI_START="-0.539764249539535" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="266" O_E="0.0" SE="0.4272466296411038" STUDY_ID="STD-Burns-2010" TOTAL_1="21" TOTAL_2="21" VAR="0.18253968253968256" WEIGHT="3.903242926883148"/>
<DICH_DATA CI_END="1.921993645698558" CI_START="0.6845724737859185" EFFECT_SIZE="1.1470588235294117" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="17" LOG_CI_END="0.2837519475143089" LOG_CI_START="-0.1645805675458208" LOG_EFFECT_SIZE="0.059585689984244045" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="274" O_E="0.0" SE="0.2633527386280618" STUDY_ID="STD-Charunwatthana-2009" TOTAL_1="56" TOTAL_2="52" VAR="0.06935466494290023" WEIGHT="7.645858572824603"/>
<DICH_DATA CI_END="1.892323407364669" CI_START="0.23486706485515438" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.2769953614690809" LOG_CI_START="-0.6291778795804434" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="288" O_E="0.0" SE="0.5322906474223771" STUDY_ID="STD-Csontos-2011" TOTAL_1="15" TOTAL_2="15" VAR="0.2833333333333333" WEIGHT="2.6021619512554324"/>
<DICH_DATA CI_END="3.373800796086585" CI_START="0.48012162206574754" EFFECT_SIZE="1.2727272727272727" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5281194363697701" LOG_CI_START="-0.3186487353297442" LOG_EFFECT_SIZE="0.10473535052001297" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="275" O_E="0.0" SE="0.49739581562634544" STUDY_ID="STD-Domenighetti-1997" TOTAL_1="22" TOTAL_2="20" VAR="0.2474025974025974" WEIGHT="2.271728687603949"/>
<DICH_DATA CI_END="1.9904147370272371" CI_START="0.3566906252675075" EFFECT_SIZE="0.8425925925925926" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.2989435785382142" LOG_CI_START="-0.4477083048699264" LOG_EFFECT_SIZE="-0.07438236316585613" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="269" O_E="0.0" SE="0.4385870123003728" STUDY_ID="STD-Emet-2004" TOTAL_1="27" TOTAL_2="26" VAR="0.19235856735856735" WEIGHT="3.535012462082851"/>
<DICH_DATA CI_END="1.6963845355930864" CI_START="0.6654778007660358" EFFECT_SIZE="1.0625" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" LOG_CI_END="0.22952430473485386" LOG_CI_START="-0.1768664272901555" LOG_EFFECT_SIZE="0.026328938722349145" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="271" O_E="0.0" SE="0.23871592765805774" STUDY_ID="STD-Jepsen-1992" TOTAL_1="32" TOTAL_2="34" VAR="0.05698529411764706" WEIGHT="7.149374249913914"/>
<DICH_DATA CI_END="0.9937985996092608" CI_START="0.42513644129315287" EFFECT_SIZE="0.65" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="20" LOG_CI_END="-0.00270161956714033" LOG_CI_START="-0.3714716671471485" LOG_EFFECT_SIZE="-0.1870866433571444" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="272" O_E="0.0" SE="0.21661735138967264" STUDY_ID="STD-Keays-1991" TOTAL_1="25" TOTAL_2="25" VAR="0.04692307692307691" WEIGHT="8.67387317085144"/>
<DICH_DATA CI_END="1.3672012569998246" CI_START="0.5655516368553801" EFFECT_SIZE="0.8793309438470729" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="31" LOG_CI_END="0.13583244900161887" LOG_CI_START="-0.24752773631314112" LOG_EFFECT_SIZE="-0.05584764365576113" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="226" O_E="0.0" SE="0.22518767051741245" STUDY_ID="STD-Lee-2009" TOTAL_1="81" TOTAL_2="92" VAR="0.050709486953058706" WEIGHT="12.589650596536398"/>
<DICH_DATA CI_END="2.454270482634857" CI_START="0.7435122882479992" EFFECT_SIZE="1.3508442776735459" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="13" LOG_CI_END="0.38992242417845724" LOG_CI_START="-0.1287118493690649" LOG_EFFECT_SIZE="0.13060528740469618" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="282" O_E="0.0" SE="0.3046483395628732" STUDY_ID="STD-Molnar-1999" TOTAL_1="41" TOTAL_2="45" VAR="0.09281061079841568" WEIGHT="5.375784186120718"/>
<DICH_DATA CI_END="0.9960030761728802" CI_START="0.21642626378031393" EFFECT_SIZE="0.4642857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="-0.0017393202481444689" LOG_CI_START="-0.6646900378226205" LOG_EFFECT_SIZE="-0.33321467903538243" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="283" O_E="0.0" SE="0.38942053316222514" STUDY_ID="STD-Moradi-2009" TOTAL_1="14" TOTAL_2="13" VAR="0.1516483516483517" WEIGHT="4.497563866367414"/>
<DICH_DATA CI_END="2.1315266092423184" CI_START="0.3002542859305412" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.3286907585993715" LOG_CI_START="-0.5225107846154844" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="278" O_E="0.0" SE="0.49999999999999994" STUDY_ID="STD-Paterson-2003" TOTAL_1="10" TOTAL_2="10" VAR="0.24999999999999997" WEIGHT="2.16846829271286"/>
<DICH_DATA CI_END="7.462512658947491" CI_START="1.567354125151951" EFFECT_SIZE="3.42" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.872885080848498" LOG_CI_START="0.19516713126377214" LOG_EFFECT_SIZE="0.534026106056135" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="279" O_E="0.0" SE="0.3980948783440233" STUDY_ID="STD-Peake-1996" TOTAL_1="10" TOTAL_2="19" VAR="0.1584795321637427" WEIGHT="1.495495374284731"/>
<DICH_DATA CI_END="1.3470381291495137" CI_START="0.37875994048868034" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.129379889000542" LOG_CI_START="-0.421635960357018" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="266" O_E="0.0" SE="0.3236694374850749" STUDY_ID="STD-Rank-2000" TOTAL_1="30" TOTAL_2="30" VAR="0.10476190476190478" WEIGHT="6.071711219596009"/>
<DICH_DATA CI_END="2.8660736990473508" CI_START="0.3785909081141594" EFFECT_SIZE="1.0416666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.45728735377872365" LOG_CI_START="-0.42182981985786044" LOG_EFFECT_SIZE="0.017728766960431616" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="265" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Spapen-1998" TOTAL_1="12" TOTAL_2="10" VAR="0.2666666666666667" WEIGHT="1.8924814190948596"/>
<DICH_DATA CI_END="2.0605010693751504" CI_START="0.5775695350592529" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.3139728442542525" LOG_CI_START="-0.23839572247545296" LOG_EFFECT_SIZE="0.037788560889399754" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="267" O_E="0.0" SE="0.32446403036553206" STUDY_ID="STD-Spies-1994" TOTAL_1="29" TOTAL_2="29" VAR="0.10527690700104493" WEIGHT="4.770630243968292"/>
<DICH_DATA CI_END="1.4473847741421566" CI_START="0.27804053753675506" EFFECT_SIZE="0.634375" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.16058399972514328" LOG_CI_START="-0.5558918805385293" LOG_EFFECT_SIZE="-0.19765394040669304" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="264" O_E="0.0" SE="0.4208614786796877" STUDY_ID="STD-Suter-1994" TOTAL_1="32" TOTAL_2="29" VAR="0.17712438423645321" WEIGHT="4.5502285486433784"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="9.81885158453449" CI_END="1.5219931146594587" CI_START="0.678181901399493" DF="11" EFFECT_SIZE="1.0159666256411617" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="39" I2="0.0" ID="CMP-002.08.02" LOG_CI_END="0.1824126877353642" LOG_CI_START="-0.16865380439457472" LOG_EFFECT_SIZE="0.006879441670394769" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5467516951494631" P_Z="0.9387712995941899" STUDIES="12" TAU2="0.0" TOTAL_1="727" TOTAL_2="721" WEIGHT="18.29430200246165" Z="0.07681426857865568">
<NAME>Mortality in surgical patients</NAME>
<DICH_DATA CI_END="5.355895422334702" CI_START="0.3319291430456687" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7288320885142859" LOG_CI_START="-0.4789546152976862" LOG_EFFECT_SIZE="0.12493873660829992" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="319" O_E="0.0" SE="0.7094598884597586" STUDY_ID="STD-Bromley-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.5033333333333332" WEIGHT="1.3010809756277162"/>
<DICH_DATA CI_END="4.532109560681806" CI_START="0.34011897737665486" EFFECT_SIZE="1.241554054054054" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6563004000934802" LOG_CI_START="-0.46836913537093017" LOG_EFFECT_SIZE="0.09396563236127509" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="320" O_E="0.0" SE="0.6606364523357819" STUDY_ID="STD-Burns-2005" TOTAL_1="148" TOTAL_2="147" VAR="0.4364405221548079" WEIGHT="1.7406552261505264"/>
<DICH_DATA CI_END="132.1011207444225" CI_START="0.37092796581794973" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1209065021796567" LOG_CI_START="-0.43071042215114297" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="322" O_E="0.0" SE="1.4988324120593923" STUDY_ID="STD-El_x002d_Hamamsy-2007" TOTAL_1="50" TOTAL_2="50" VAR="2.246498599439776" WEIGHT="0.216846829271286"/>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363438" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.4771212547196625" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="323" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Haase-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.6505404878138581"/>
<DICH_DATA CI_END="2.690131744379176" CI_START="0.555298885868718" EFFECT_SIZE="1.2222222222222223" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="9" LOG_CI_END="0.4297735493168515" LOG_CI_START="-0.2554731978790511" LOG_EFFECT_SIZE="0.0871501757189002" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="269" O_E="0.0" SE="0.4025173313289777" STUDY_ID="STD-Hilmi-2010" TOTAL_1="50" TOTAL_2="50" VAR="0.16202020202020204" WEIGHT="3.903242926883148"/>
<DICH_DATA CI_END="73.21457045001645" CI_START="0.13005106216612491" EFFECT_SIZE="3.085714285714286" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.864597518713366" LOG_CI_START="-0.8858860964400181" LOG_EFFECT_SIZE="0.4893557111366741" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="299" O_E="0.0" SE="1.6156476906545747" STUDY_ID="STD-Hynninen-2006" TOTAL_1="34" TOTAL_2="35" VAR="2.6103174603174604" WEIGHT="0.21379264857732425"/>
<DICH_DATA CI_END="4.007329751896776" CI_START="0.00964621359876602" EFFECT_SIZE="0.19661016949152543" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6028550807748148" LOG_CI_START="-2.0156431256052665" LOG_EFFECT_SIZE="-0.7063940224152256" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="324" O_E="0.0" SE="1.538118808202826" STUDY_ID="STD-Ozaydin-2008" TOTAL_1="58" TOTAL_2="57" VAR="2.3658094681472823" WEIGHT="1.093501104872297"/>
<DICH_DATA CI_END="5.426771668614656" CI_START="0.0485244342329168" EFFECT_SIZE="0.5131578947368421" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7345415490261662" LOG_CI_START="-1.3140395195347503" LOG_EFFECT_SIZE="-0.2897489852542921" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="325" O_E="0.0" SE="1.2033466603125178" STUDY_ID="STD-Ristikankare-2006" TOTAL_1="38" TOTAL_2="39" VAR="1.4480431848852902" WEIGHT="0.856122546733389"/>
<DICH_DATA CI_END="4.407079247591173" CI_START="0.3328969156973013" EFFECT_SIZE="1.2112403100775193" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6441508600134609" LOG_CI_START="-0.4776902285797333" LOG_EFFECT_SIZE="0.08323031571686385" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="326" O_E="0.0" SE="0.6589750086425917" STUDY_ID="STD-Sisillo-2008" TOTAL_1="129" TOTAL_2="125" VAR="0.43424806201550387" WEIGHT="1.762093919747773"/>
<DICH_DATA CI_END="129.92776744614594" CI_START="0.3771326250203609" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1137019760147355" LOG_CI_START="-0.423505895986222" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="327" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Steib-1998" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="0.216846829271286"/>
<DICH_DATA CI_END="2.5703939747908535" CI_START="0.3726664127879707" EFFECT_SIZE="0.9787234042553191" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.40999969452363927" LOG_CI_START="-0.428679747031926" LOG_EFFECT_SIZE="-0.009340026254143404" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="328" O_E="0.0" SE="0.49264445549992975" STUDY_ID="STD-Szakmany-2003" TOTAL_1="47" TOTAL_2="46" VAR="0.24269855953482228" WEIGHT="3.0684992185055098"/>
<DICH_DATA CI_END="1.1367318594230087" CI_START="0.003822476117610868" EFFECT_SIZE="0.06591760299625468" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.055658032228059366" LOG_CI_START="-2.41765521932891" LOG_EFFECT_SIZE="-1.1809985935504255" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="329" O_E="0.0" SE="1.4528364470626132" STUDY_ID="STD-Wijeysundera-2007" TOTAL_1="88" TOTAL_2="87" VAR="2.1107337419135175" WEIGHT="3.271079289007535"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="31.894187267240095" CI_END="1.0816438814362357" CI_START="0.8069137727705508" CI_STUDY="95" CI_TOTAL="95" DF="31" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9342340954835117" ESTIMABLE="YES" EVENTS_1="223" EVENTS_2="241" I2="2.80360574717812" I2_Q="53.00474809013581" ID="CMP-002.09" LOG_CI_END="0.034084297938386125" LOG_CI_START="-0.09317287173483832" LOG_EFFECT_SIZE="-0.029544286898226108" METHOD="MH" MODIFIED="2012-08-06 10:45:48 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.4218817735979583" P_Q="0.14464125924952698" P_Z="0.3627916379883672" Q="2.127874539151268" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="31" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1228" TOTAL_2="1233" WEIGHT="100.0" Z="0.9100585596573335">
<NAME>Mortality - early or late administration</NAME>
<GROUP_LABEL_1>N-acetylcysteine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="20.571510393754767" CI_END="1.0437326339891535" CI_START="0.7215729291983464" DF="23" EFFECT_SIZE="0.8678301757875553" ESTIMABLE="YES" EVENTS_1="143" EVENTS_2="167" I2="0.0" ID="CMP-002.09.01" LOG_CI_END="0.018589262599034838" LOG_CI_START="-0.14171976831576893" LOG_EFFECT_SIZE="-0.061565252858367024" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6072369166993279" P_Z="0.1322178368096446" STUDIES="24" TAU2="0.0" TOTAL_1="1047" TOTAL_2="1052" WEIGHT="69.6307648281321" Z="1.505413358348212">
<NAME>Mortality in early administration</NAME>
<DICH_DATA CI_END="5.355895422334702" CI_START="0.3319291430456687" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7288320885142859" LOG_CI_START="-0.4789546152976862" LOG_EFFECT_SIZE="0.12493873660829992" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="288" O_E="0.0" SE="0.7094598884597586" STUDY_ID="STD-Bromley-1995" TOTAL_1="25" TOTAL_2="25" VAR="0.5033333333333332" WEIGHT="1.2366733197524369"/>
<DICH_DATA CI_END="4.532109560681806" CI_START="0.34011897737665486" EFFECT_SIZE="1.241554054054054" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6563004000934802" LOG_CI_START="-0.46836913537093017" LOG_EFFECT_SIZE="0.09396563236127509" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="291" O_E="0.0" SE="0.6606364523357819" STUDY_ID="STD-Burns-2005" TOTAL_1="148" TOTAL_2="147" VAR="0.4364405221548079" WEIGHT="1.6544872436010003"/>
<DICH_DATA CI_END="1.921993645698558" CI_START="0.6845724737859185" EFFECT_SIZE="1.1470588235294117" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="17" LOG_CI_END="0.2837519475143089" LOG_CI_START="-0.1645805675458208" LOG_EFFECT_SIZE="0.059585689984244045" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="290" O_E="0.0" SE="0.2633527386280618" STUDY_ID="STD-Charunwatthana-2009" TOTAL_1="56" TOTAL_2="52" VAR="0.06935466494290023" WEIGHT="7.267364200026667"/>
<DICH_DATA CI_END="1.892323407364669" CI_START="0.23486706485515438" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.2769953614690809" LOG_CI_START="-0.6291778795804434" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="289" O_E="0.0" SE="0.5322906474223771" STUDY_ID="STD-Csontos-2011" TOTAL_1="15" TOTAL_2="15" VAR="0.2833333333333333" WEIGHT="2.4733466395048738"/>
<DICH_DATA CI_END="132.1011207444225" CI_START="0.37092796581794973" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1209065021796567" LOG_CI_START="-0.43071042215114297" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="284" O_E="0.0" SE="1.4988324120593923" STUDY_ID="STD-El_x002d_Hamamsy-2007" TOTAL_1="50" TOTAL_2="50" VAR="2.246498599439776" WEIGHT="0.2061122199587395"/>
<DICH_DATA CI_END="1.9904147370272371" CI_START="0.3566906252675075" EFFECT_SIZE="0.8425925925925926" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.2989435785382142" LOG_CI_START="-0.4477083048699264" LOG_EFFECT_SIZE="-0.07438236316585613" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="287" O_E="0.0" SE="0.4385870123003728" STUDY_ID="STD-Emet-2004" TOTAL_1="27" TOTAL_2="26" VAR="0.19235856735856735" WEIGHT="3.3600180763085077"/>
<DICH_DATA CI_END="7.8698689779204765" CI_START="0.01411854649967386" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8959675020363438" LOG_CI_START="-1.850210011475669" LOG_EFFECT_SIZE="-0.4771212547196625" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="302" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Haase-2007" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.6183366598762184"/>
<DICH_DATA CI_END="2.690131744379176" CI_START="0.555298885868718" EFFECT_SIZE="1.2222222222222223" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="9" LOG_CI_END="0.4297735493168515" LOG_CI_START="-0.2554731978790511" LOG_EFFECT_SIZE="0.0871501757189002" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="270" O_E="0.0" SE="0.4025173313289777" STUDY_ID="STD-Hilmi-2010" TOTAL_1="50" TOTAL_2="50" VAR="0.16202020202020204" WEIGHT="3.710019959257311"/>
<DICH_DATA CI_END="73.21457045001645" CI_START="0.13005106216612491" EFFECT_SIZE="3.085714285714286" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.864597518713366" LOG_CI_START="-0.8858860964400181" LOG_EFFECT_SIZE="0.4893557111366741" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="300" O_E="0.0" SE="1.6156476906545747" STUDY_ID="STD-Hynninen-2006" TOTAL_1="34" TOTAL_2="35" VAR="2.6103174603174604" WEIGHT="0.20320923094523613"/>
<DICH_DATA CI_END="0.9937985996092608" CI_START="0.42513644129315287" EFFECT_SIZE="0.65" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="20" LOG_CI_END="-0.00270161956714033" LOG_CI_START="-0.3714716671471485" LOG_EFFECT_SIZE="-0.1870866433571444" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="301" O_E="0.0" SE="0.21661735138967264" STUDY_ID="STD-Keays-1991" TOTAL_1="25" TOTAL_2="25" VAR="0.04692307692307691" WEIGHT="8.244488798349579"/>
<DICH_DATA CI_END="1.3672012569998246" CI_START="0.5655516368553801" EFFECT_SIZE="0.8793309438470729" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="31" LOG_CI_END="0.13583244900161887" LOG_CI_START="-0.24752773631314112" LOG_EFFECT_SIZE="-0.05584764365576113" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="421" O_E="0.0" SE="0.22518767051741245" STUDY_ID="STD-Lee-2009" TOTAL_1="81" TOTAL_2="92" VAR="0.050709486953058706" WEIGHT="11.966422758760574"/>
<DICH_DATA CI_END="6.055139337673937" CI_START="0.660595863601809" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.7821241413496992" LOG_CI_START="-0.18006415002173679" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="306" O_E="0.0" SE="0.565194165260439" STUDY_ID="STD-Macedo-2006" TOTAL_1="18" TOTAL_2="24" VAR="0.31944444444444436" WEIGHT="1.413340936859928"/>
<DICH_DATA CI_END="1.8648390111169084" CI_START="0.09728072680504668" EFFECT_SIZE="0.42592592592592593" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.270641345741818" LOG_CI_START="-1.011973193352569" LOG_EFFECT_SIZE="-0.3706659238053756" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="304" O_E="0.0" SE="0.7534141293084076" STUDY_ID="STD-Molnar-1999" TOTAL_1="18" TOTAL_2="23" VAR="0.5676328502415459" WEIGHT="2.171719000540865"/>
<DICH_DATA CI_END="0.9960030761728802" CI_START="0.21642626378031393" EFFECT_SIZE="0.4642857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="10" LOG_CI_END="-0.0017393202481444689" LOG_CI_START="-0.6646900378226205" LOG_EFFECT_SIZE="-0.33321467903538243" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="305" O_E="0.0" SE="0.38942053316222514" STUDY_ID="STD-Moradi-2009" TOTAL_1="14" TOTAL_2="13" VAR="0.1516483516483517" WEIGHT="4.274920117662745"/>
<DICH_DATA CI_END="1.6261635848009508" CI_START="0.3137470832586035" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.21116423154273745" LOG_CI_START="-0.5034203028992135" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="309" O_E="0.0" SE="0.4197504927816955" STUDY_ID="STD-Ortolani-2000b" TOTAL_1="12" TOTAL_2="12" VAR="0.17619047619047623" WEIGHT="2.885571079422353"/>
<DICH_DATA CI_END="4.007329751896776" CI_START="0.00964621359876602" EFFECT_SIZE="0.19661016949152543" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6028550807748148" LOG_CI_START="-2.0156431256052665" LOG_EFFECT_SIZE="-0.7063940224152256" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="309" O_E="0.0" SE="1.538118808202826" STUDY_ID="STD-Ozaydin-2008" TOTAL_1="58" TOTAL_2="57" VAR="2.3658094681472823" WEIGHT="1.0393693143218488"/>
<DICH_DATA CI_END="2.1315266092423184" CI_START="0.3002542859305412" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.3286907585993715" LOG_CI_START="-0.5225107846154844" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="420" O_E="0.0" SE="0.49999999999999994" STUDY_ID="STD-Paterson-2003" TOTAL_1="10" TOTAL_2="10" VAR="0.24999999999999997" WEIGHT="2.0611221995873947"/>
<DICH_DATA CI_END="5.426771668614656" CI_START="0.0485244342329168" EFFECT_SIZE="0.5131578947368421" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7345415490261662" LOG_CI_START="-1.3140395195347503" LOG_EFFECT_SIZE="-0.2897489852542921" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="315" O_E="0.0" SE="1.2033466603125178" STUDY_ID="STD-Ristikankare-2006" TOTAL_1="38" TOTAL_2="39" VAR="1.4480431848852902" WEIGHT="0.8137417515254131"/>
<DICH_DATA CI_END="4.407079247591173" CI_START="0.3328969156973013" EFFECT_SIZE="1.2112403100775193" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6441508600134609" LOG_CI_START="-0.4776902285797333" LOG_EFFECT_SIZE="0.08323031571686385" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="312" O_E="0.0" SE="0.6589750086425917" STUDY_ID="STD-Sisillo-2008" TOTAL_1="129" TOTAL_2="125" VAR="0.43424806201550387" WEIGHT="1.6748646535229854"/>
<DICH_DATA CI_END="2.8660736990473508" CI_START="0.3785909081141594" EFFECT_SIZE="1.0416666666666667" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.45728735377872365" LOG_CI_START="-0.42182981985786044" LOG_EFFECT_SIZE="0.017728766960431616" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="313" O_E="0.0" SE="0.5163977794943223" STUDY_ID="STD-Spapen-1998" TOTAL_1="12" TOTAL_2="10" VAR="0.2666666666666667" WEIGHT="1.7987975560035445"/>
<DICH_DATA CI_END="129.92776744614594" CI_START="0.3771326250203609" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1137019760147355" LOG_CI_START="-0.423505895986222" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="293" O_E="0.0" SE="1.490368463394884" STUDY_ID="STD-Steib-1998" TOTAL_1="30" TOTAL_2="30" VAR="2.2211981566820276" WEIGHT="0.2061122199587395"/>
<DICH_DATA CI_END="1.4473847741421566" CI_START="0.27804053753675506" EFFECT_SIZE="0.634375" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.16058399972514328" LOG_CI_START="-0.5558918805385293" LOG_EFFECT_SIZE="-0.19765394040669304" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="299" O_E="0.0" SE="0.4208614786796877" STUDY_ID="STD-Suter-1994" TOTAL_1="32" TOTAL_2="29" VAR="0.17712438423645321" WEIGHT="4.324977730281747"/>
<DICH_DATA CI_END="2.5703939747908535" CI_START="0.3726664127879707" EFFECT_SIZE="0.9787234042553191" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.40999969452363927" LOG_CI_START="-0.428679747031926" LOG_EFFECT_SIZE="-0.009340026254143404" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="298" O_E="0.0" SE="0.49264445549992975" STUDY_ID="STD-Szakmany-2003" TOTAL_1="47" TOTAL_2="46" VAR="0.24269855953482228" WEIGHT="2.916598725437647"/>
<DICH_DATA CI_END="1.1367318594230087" CI_START="0.003822476117610868" EFFECT_SIZE="0.06591760299625468" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.055658032228059366" LOG_CI_START="-2.41765521932891" LOG_EFFECT_SIZE="-1.1809985935504255" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="296" O_E="0.0" SE="1.4528364470626132" STUDY_ID="STD-Wijeysundera-2007" TOTAL_1="88" TOTAL_2="87" VAR="2.1107337419135175" WEIGHT="3.109150436665731"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="8.111732746610596" CI_END="1.3797308922446674" CI_START="0.8555657731458014" DF="7" EFFECT_SIZE="1.0864854014465428" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="74" I2="13.705243766507492" ID="CMP-002.09.02" LOG_CI_END="0.13979438827804108" LOG_CI_START="-0.0677465976760528" LOG_EFFECT_SIZE="0.03602389530099415" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.3228448152670341" P_Z="0.4962506524619873" STUDIES="8" TAU2="0.0" TOTAL_1="181" TOTAL_2="181" WEIGHT="30.3692351718679" Z="0.6804009053749751">
<NAME>Mortality in late administration</NAME>
<DICH_DATA CI_END="2.278946616108553" CI_START="0.3498080525081715" EFFECT_SIZE="0.8928571428571429" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.35773415203381126" LOG_CI_START="-0.45617019737417447" LOG_EFFECT_SIZE="-0.049218022670181584" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="330" O_E="0.0" SE="0.47809144373375756" STUDY_ID="STD-Bernard-1997" TOTAL_1="14" TOTAL_2="15" VAR="0.22857142857142865" WEIGHT="2.3880588243495335"/>
<DICH_DATA CI_END="1.5402163575984629" CI_START="0.2885597482794114" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.1875817314281723" LOG_CI_START="-0.539764249539535" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="290" O_E="0.0" SE="0.4272466296411038" STUDY_ID="STD-Burns-2010" TOTAL_1="21" TOTAL_2="21" VAR="0.18253968253968256" WEIGHT="3.710019959257311"/>
<DICH_DATA CI_END="3.373800796086585" CI_START="0.48012162206574754" EFFECT_SIZE="1.2727272727272727" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.5281194363697701" LOG_CI_START="-0.3186487353297442" LOG_EFFECT_SIZE="0.10473535052001297" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="331" O_E="0.0" SE="0.49739581562634544" STUDY_ID="STD-Domenighetti-1997" TOTAL_1="22" TOTAL_2="20" VAR="0.2474025974025974" WEIGHT="2.159270875758223"/>
<DICH_DATA CI_END="1.6963845355930864" CI_START="0.6654778007660358" EFFECT_SIZE="1.0625" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" LOG_CI_END="0.22952430473485386" LOG_CI_START="-0.1768664272901555" LOG_EFFECT_SIZE="0.026328938722349145" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="332" O_E="0.0" SE="0.23871592765805774" STUDY_ID="STD-Jepsen-1992" TOTAL_1="32" TOTAL_2="34" VAR="0.05698529411764706" WEIGHT="6.795457433791168"/>
<DICH_DATA CI_END="3.829081027110395" CI_START="0.9557738067711392" EFFECT_SIZE="1.9130434782608696" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="7" LOG_CI_END="0.5830945565421517" LOG_CI_START="-0.019644875604962603" LOG_EFFECT_SIZE="0.28172484046859453" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="333" O_E="0.0" SE="0.3540521260515231" STUDY_ID="STD-Molnar-1999" TOTAL_1="23" TOTAL_2="22" VAR="0.1253529079616036" WEIGHT="2.9496948811872943"/>
<DICH_DATA CI_END="3.4594443824994294" CI_START="0.9365665817292654" EFFECT_SIZE="1.8" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.5390063528415914" LOG_CI_START="-0.02846134263497925" LOG_EFFECT_SIZE="0.25527250510330607" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="334" O_E="0.0" SE="0.3333333333333333" STUDY_ID="STD-Peake-1996" TOTAL_1="10" TOTAL_2="10" VAR="0.1111111111111111" WEIGHT="2.0611221995873947"/>
<DICH_DATA CI_END="1.3470381291495137" CI_START="0.37875994048868034" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" LOG_CI_END="0.129379889000542" LOG_CI_START="-0.421635960357018" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="335" O_E="0.0" SE="0.3236694374850749" STUDY_ID="STD-Rank-2000" TOTAL_1="30" TOTAL_2="30" VAR="0.10476190476190478" WEIGHT="5.771142158844706"/>
<DICH_DATA CI_END="2.0605010693751504" CI_START="0.5775695350592529" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.3139728442542525" LOG_CI_START="-0.23839572247545296" LOG_EFFECT_SIZE="0.037788560889399754" MODIFIED="2012-06-27 10:55:05 +0100" MODIFIED_BY="[Empty name]" ORDER="336" O_E="0.0" SE="0.32446403036553206" STUDY_ID="STD-Spies-1994" TOTAL_1="29" TOTAL_2="29" VAR="0.10527690700104493" WEIGHT="4.534468839092269"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2012-07-29 15:16:49 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>N-acetylcysteine versus placebo</NAME>
<CONT_OUTCOME CHI2="25.94755046281276" CI_END="0.17015910440416684" CI_START="-0.25963756109286645" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.0447392283443498" ESTIMABLE="YES" I2="65.31464496851629" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2012-06-27 11:38:05 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.002083749638456145" P_Q="1.0" P_Z="0.6832437611217907" Q="0.0" RANDOM="YES" SCALE="20.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.028963018326969625" TOTALS="YES" TOTAL_1="259" TOTAL_2="257" UNITS="" WEIGHT="100.0" Z="0.40804074712694316">
<NAME>Duration of mechanical ventilation</NAME>
<GROUP_LABEL_1>N-acetylcysteine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.767876556150694" CI_START="-5.167876556150697" EFFECT_SIZE="-1.200000000000001" ESTIMABLE="YES" MEAN_1="8.1" MEAN_2="9.3" MODIFIED="2012-06-27 11:02:38 +0100" MODIFIED_BY="[Empty name]" ORDER="152" SD_1="6.5" SD_2="6.6" SE="2.0244640143639367" STUDY_ID="STD-Domenighetti-1997" TOTAL_1="22" TOTAL_2="20" WEIGHT="0.291267147257966"/>
<CONT_DATA CI_END="1.3779843090899453" CI_START="-1.3779843090899453" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="8.0" MEAN_2="8.0" MODIFIED="2012-06-27 11:02:38 +0100" MODIFIED_BY="[Empty name]" ORDER="153" SD_1="2.0" SD_2="3.0" SE="0.7030661379287118" STUDY_ID="STD-Emet-2004" TOTAL_1="27" TOTAL_2="26" WEIGHT="2.2974613443102623"/>
<CONT_DATA CI_END="0.1113333154455861" CI_START="-0.1113333154455861" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.72" MEAN_2="0.72" MODIFIED="2012-06-27 11:02:38 +0100" MODIFIED_BY="[Empty name]" ORDER="154" SD_1="0.22" SD_2="0.22" SE="0.05680375574437545" STUDY_ID="STD-Haase-2007" TOTAL_1="30" TOTAL_2="30" WEIGHT="37.34678172783393"/>
<CONT_DATA CI_END="5.176133592517474" CI_START="-2.616133592517474" EFFECT_SIZE="1.2800000000000002" ESTIMABLE="YES" MEAN_1="5.58" MEAN_2="4.3" MODIFIED="2012-06-27 11:02:38 +0100" MODIFIED_BY="[Empty name]" ORDER="271" SD_1="9.79" SD_2="9.37" SE="1.9878597888786114" STUDY_ID="STD-Hilmi-2010" TOTAL_1="46" TOTAL_2="47" WEIGHT="0.30201386056293816"/>
<CONT_DATA CI_END="1.7360861917920434" CI_START="-1.7360861917920434" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="5.0" MEAN_2="5.0" MODIFIED="2012-06-27 11:02:38 +0100" MODIFIED_BY="[Empty name]" ORDER="156" SD_1="3.33" SD_2="4.81" SE="0.8857745374333762" STUDY_ID="STD-Molnar-1999" TOTAL_1="41" TOTAL_2="45" WEIGHT="1.477680570642078"/>
<CONT_DATA CI_END="-1.1570764663653303" CI_START="-15.042923533634665" EFFECT_SIZE="-8.099999999999998" ESTIMABLE="YES" MEAN_1="24.8" MEAN_2="32.9" MODIFIED="2012-06-27 11:02:38 +0100" MODIFIED_BY="[Empty name]" ORDER="157" SD_1="8.5" SD_2="9.8" SE="3.542373017259277" STUDY_ID="STD-Moradi-2009" TOTAL_1="14" TOTAL_2="13" WEIGHT="0.09558287435741239"/>
<CONT_DATA CI_END="0.04382612702882909" CI_START="-0.04382612702882909" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.48" MEAN_2="0.48" MODIFIED="2012-06-27 11:02:38 +0100" MODIFIED_BY="[Empty name]" ORDER="419" SD_1="0.05" SD_2="0.05" SE="0.0223606797749979" STUDY_ID="STD-Orhan-2006" TOTAL_1="10" TOTAL_2="10" WEIGHT="40.80305439190603"/>
<CONT_DATA CI_END="2.227614377200722" CI_START="-6.827614377200724" EFFECT_SIZE="-2.3000000000000007" ESTIMABLE="YES" MEAN_1="7.83" MEAN_2="10.13" MODIFIED="2012-06-27 11:02:38 +0100" MODIFIED_BY="[Empty name]" ORDER="418" SD_1="4.48" SD_2="5.77" SE="2.3100497830133446" STUDY_ID="STD-Peake-1996" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.22406625979953199"/>
<CONT_DATA CI_END="-3.84979863816192" CI_START="-10.15020136183808" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="14.0" MODIFIED="2012-06-27 11:02:38 +0100" MODIFIED_BY="[Empty name]" ORDER="417" SD_1="1.0" SD_2="5.0" SE="1.6072751268321592" STUDY_ID="STD-Spapen-1998" TOTAL_1="12" TOTAL_2="10" WEIGHT="0.46020090277314546"/>
<CONT_DATA CI_END="0.4065010956450956" CI_START="-0.4065010956450956" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.0" MEAN_2="1.0" MODIFIED="2012-06-27 11:02:38 +0100" MODIFIED_BY="[Empty name]" ORDER="159" SD_1="1.0" SD_2="1.0" SE="0.2074023292527436" STUDY_ID="STD-Szakmany-2003" TOTAL_1="47" TOTAL_2="46" WEIGHT="16.701890920556707"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2012-07-29 15:17:02 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>N-acetylcysteine versus placebo</NAME>
<CONT_OUTCOME CHI2="111.87193989208743" CI_END="0.49035059229426753" CI_START="-0.8029967892739271" CI_STUDY="95" CI_TOTAL="95" DF="20" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.15632309848982978" ESTIMABLE="YES" I2="82.12241602381066" I2_Q="0.0" ID="CMP-004.01" MODIFIED="2012-06-27 11:38:10 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="8.770761894538737E-15" P_Q="1.0" P_Z="0.6356495410452241" Q="0.0" RANDOM="YES" SCALE="24.79262217592013" SORT_BY="STUDY" STUDIES="21" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.95274996173135" TOTALS="YES" TOTAL_1="725" TOTAL_2="726" UNITS="" WEIGHT="99.99999999999999" Z="0.47379017788751626">
<NAME>Length of stay on the intensive care unit</NAME>
<GROUP_LABEL_1>N-acetylcysteine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.503764708551201" CI_START="-2.503764708551201" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="2.0" MODIFIED="2012-06-27 11:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="132" SD_1="9.74" SD_2="12.11" SE="1.2774544472758569" STUDY_ID="STD-Burns-2005" TOTAL_1="148" TOTAL_2="148" WEIGHT="4.211862365156295"/>
<CONT_DATA CI_END="21.903663065922643" CI_START="0.6963369340773564" EFFECT_SIZE="11.299999999999999" ESTIMABLE="YES" MEAN_1="24.4" MEAN_2="13.1" MODIFIED="2012-06-27 11:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="267" SD_1="23.5" SD_2="7.9" SE="5.410131588928666" STUDY_ID="STD-Burns-2010" TOTAL_1="21" TOTAL_2="21" WEIGHT="0.3602027860484363"/>
<CONT_DATA CI_END="0.02261221690059312" CI_START="-9.622612216900595" EFFECT_SIZE="-4.800000000000001" ESTIMABLE="YES" MEAN_1="13.8" MEAN_2="18.6" MODIFIED="2012-06-27 11:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="133" SD_1="7.2" SD_2="8.6" SE="2.4605616505919206" STUDY_ID="STD-Domenighetti-1997" TOTAL_1="22" TOTAL_2="20" WEIGHT="1.553585090454976"/>
<CONT_DATA CI_END="1.0452192613453573" CI_START="-3.0452192613453573" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="10.0" MEAN_2="11.0" MODIFIED="2012-06-27 11:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="134" SD_1="2.0" SD_2="4.0" SE="1.043498389499902" STUDY_ID="STD-Emet-2004" TOTAL_1="20" TOTAL_2="18" WEIGHT="5.332063116754237"/>
<CONT_DATA CI_END="0.7560821992152895" CI_START="-0.7560821992152895" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.8" MEAN_2="1.8" MODIFIED="2012-06-27 11:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="135" SD_1="1.38" SD_2="1.6" SE="0.3857633125808277" STUDY_ID="STD-Haase-2007" TOTAL_1="30" TOTAL_2="30" WEIGHT="9.882452748650689"/>
<CONT_DATA CI_END="6.379582611644399" CI_START="-3.399582611644399" EFFECT_SIZE="1.4900000000000002" ESTIMABLE="YES" MEAN_1="10.33" MEAN_2="8.84" MODIFIED="2012-06-27 11:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="272" SD_1="11.6" SD_2="13.29" SE="2.494730847205766" STUDY_ID="STD-Hilmi-2010" TOTAL_1="50" TOTAL_2="50" WEIGHT="1.5169303173464985"/>
<CONT_DATA CI_END="2.259767198619063" CI_START="-2.4597671986190632" EFFECT_SIZE="-0.10000000000000009" ESTIMABLE="YES" MEAN_1="2.5" MEAN_2="2.6" MODIFIED="2012-06-27 11:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="137" SD_1="5.0" SD_2="5.0" SE="1.2039849799448386" STUDY_ID="STD-Hynninen-2006" TOTAL_1="34" TOTAL_2="35" WEIGHT="4.531495734613827"/>
<CONT_DATA CI_END="1.301981023385269" CI_START="-0.4819810233852688" EFFECT_SIZE="0.41000000000000014" ESTIMABLE="YES" MEAN_1="2.93" MEAN_2="2.52" MODIFIED="2012-06-27 11:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="138" SD_1="1.53" SD_2="1.36" SE="0.4551007214525886" STUDY_ID="STD-Macedo-2006" TOTAL_1="18" TOTAL_2="24" WEIGHT="9.385688790926254"/>
<CONT_DATA CI_END="0.4653420836354756" CI_START="-4.465342083635475" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="6.0" MEAN_2="8.0" MODIFIED="2012-06-27 11:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="140" SD_1="4.44" SD_2="7.04" SE="1.2578507069934852" STUDY_ID="STD-Molnar-1999" TOTAL_1="41" TOTAL_2="45" WEIGHT="4.294442568234395"/>
<CONT_DATA CI_END="-2.418230805779711" CI_START="-15.981769194220295" EFFECT_SIZE="-9.200000000000003" ESTIMABLE="YES" MEAN_1="32.9" MEAN_2="42.1" MODIFIED="2012-06-27 11:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="141" SD_1="7.6" SD_2="10.1" SE="3.4601499046482598" STUDY_ID="STD-Moradi-2009" TOTAL_1="14" TOTAL_2="13" WEIGHT="0.8422298643693744"/>
<CONT_DATA CI_END="0.37202183381731324" CI_START="-0.5720218338173132" EFFECT_SIZE="-0.09999999999999998" ESTIMABLE="YES" MEAN_1="0.9" MEAN_2="1.0" MODIFIED="2012-06-27 11:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="142" SD_1="0.7" SD_2="0.3" SE="0.2408318915758459" STUDY_ID="STD-Orhan-2006" TOTAL_1="10" TOTAL_2="10" WEIGHT="10.770366188762864"/>
<CONT_DATA CI_END="1.0138621679627384" CI_START="-9.013862167962738" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="8.0" MODIFIED="2012-06-27 11:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="144" SD_1="5.22" SD_2="6.18" SE="2.5581399492600085" STUDY_ID="STD-Paterson-2003" TOTAL_1="10" TOTAL_2="10" WEIGHT="1.4521000567832807"/>
<CONT_DATA CI_END="9.880438099326039" CI_START="-9.880438099326039" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="19.0" MEAN_2="19.0" MODIFIED="2012-06-27 11:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="145" SD_1="23.51" SD_2="14.48" SE="5.041132478587195" STUDY_ID="STD-Rank-2000" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.4128894625578399"/>
<CONT_DATA CI_END="2.702075228052353" CI_START="1.6979247719476478" EFFECT_SIZE="2.2" ESTIMABLE="YES" MEAN_1="5.4" MEAN_2="3.2" MODIFIED="2012-06-27 11:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="146" SD_1="1.5" SD_2="0.5" SE="0.2561655377408247" STUDY_ID="STD-Ristikankare-2006" TOTAL_1="38" TOTAL_2="39" WEIGHT="10.689768212975329"/>
<CONT_DATA CI_END="-11.647802137763048" CI_START="-26.352197862236952" EFFECT_SIZE="-19.0" ESTIMABLE="YES" MEAN_1="13.0" MEAN_2="32.0" MODIFIED="2012-06-27 11:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="148" SD_1="2.0" SD_2="9.0" SE="3.7511902872859664" STUDY_ID="STD-Spapen-1998" TOTAL_1="7" TOTAL_2="6" WEIGHT="0.724575203169866"/>
<CONT_DATA CI_END="8.236367143052966" CI_START="-14.236367143052966" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="16.0" MEAN_2="19.0" MODIFIED="2012-06-27 11:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="155" SD_1="13.0" SD_2="18.0" SE="5.732945723331651" STUDY_ID="STD-Spies-1994" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.3218904492865687"/>
<CONT_DATA CI_END="6.0675824311514726" CI_START="-4.667582431151472" EFFECT_SIZE="0.7000000000000002" ESTIMABLE="YES" MEAN_1="6.4" MEAN_2="5.7" MODIFIED="2012-06-27 11:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="150" SD_1="12.0" SD_2="9.0" SE="2.7386127875258306" STUDY_ID="STD-Steib-1998" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.2878823178740895"/>
<CONT_DATA CI_END="0.6197950323045617" CI_START="-0.6197950323045617" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.0" MEAN_2="1.0" MODIFIED="2012-06-27 11:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="151" SD_1="1.0" SD_2="1.0" SE="0.31622776601683794" STUDY_ID="STD-Sucu-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="10.34067690225451"/>
<CONT_DATA CI_END="4.144097272767858" CI_START="-5.944097272767856" EFFECT_SIZE="-0.8999999999999986" ESTIMABLE="YES" MEAN_1="11.3" MEAN_2="12.2" MODIFIED="2012-06-27 11:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="152" SD_1="10.5" SD_2="9.6" SE="2.5735663066031074" STUDY_ID="STD-Suter-1994" TOTAL_1="32" TOTAL_2="29" WEIGHT="1.4369266840797499"/>
<CONT_DATA CI_END="0.9024324323321123" CI_START="-0.9024324323321123" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="3.0" MODIFIED="2012-06-27 11:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="153" SD_1="2.22" SD_2="2.22" SE="0.4604331709410908" STUDY_ID="STD-Szakmany-2003" TOTAL_1="47" TOTAL_2="46" WEIGHT="9.346348723096172"/>
<CONT_DATA CI_END="0.3974297696914343" CI_START="0.002570230308565624" EFFECT_SIZE="0.19999999999999996" ESTIMABLE="YES" MEAN_1="1.9" MEAN_2="1.7" MODIFIED="2012-06-27 11:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="154" SD_1="0.71" SD_2="0.62" SE="0.10073132529410497" STUDY_ID="STD-Wijeysundera-2007" TOTAL_1="88" TOTAL_2="87" WEIGHT="11.305622416604727"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2012-07-29 15:17:16 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>N-acetylcysteine versus placebo</NAME>
<DICH_OUTCOME CHI2="14.521860821063513" CI_END="1.2680165454418282" CI_START="0.826276252923408" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RR" EFFECT_SIZE="1.023587788034108" ESTIMABLE="YES" EVENTS_1="110" EVENTS_2="112" I2="24.252131765063893" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="0.1031249203810503" LOG_CI_START="-0.08287472863351604" LOG_EFFECT_SIZE="0.010125095873767108" METHOD="MH" MODIFIED="2012-06-27 11:38:13 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2054490701622611" P_Q="1.0" P_Z="0.8310262123800299" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="13" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="661" TOTAL_2="663" WEIGHT="100.0" Z="0.21338559892706593">
<NAME>Incidence of new organ failure</NAME>
<GROUP_LABEL_1>N-acetylcysteine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1506618776336486" CI_START="0.2968218396269404" EFFECT_SIZE="0.5844155844155844" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="11" LOG_CI_END="0.0609477248018338" LOG_CI_START="-0.5275041475961103" LOG_EFFECT_SIZE="-0.23327821139713822" MODIFIED="2012-06-27 11:03:38 +0100" MODIFIED_BY="[Empty name]" ORDER="162" O_E="0.0" SE="0.34565954273029914" STUDY_ID="STD-Bernard-1997" TOTAL_1="14" TOTAL_2="15" VAR="0.11948051948051948" WEIGHT="9.510744167203985"/>
<DICH_DATA CI_END="1.4644174664635545" CI_START="0.7193735170173217" EFFECT_SIZE="1.0263835263835264" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="42" LOG_CI_END="0.16566490017637567" LOG_CI_START="-0.1430455543197668" LOG_EFFECT_SIZE="0.011309672928304466" MODIFIED="2012-06-27 11:03:38 +0100" MODIFIED_BY="[Empty name]" ORDER="163" O_E="0.0" SE="0.18133804911242937" STUDY_ID="STD-Burns-2005" TOTAL_1="148" TOTAL_2="145" VAR="0.03288348805590185" WEIGHT="37.99576230124683"/>
<DICH_DATA CI_END="101.58460526662178" CI_START="0.24610028197072092" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.006827897373713" LOG_CI_START="-0.6088878887016753" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2012-06-27 11:03:38 +0100" MODIFIED_BY="[Empty name]" ORDER="164" O_E="0.0" SE="1.5364844007426468" STUDY_ID="STD-El_x002d_Hamamsy-2007" TOTAL_1="50" TOTAL_2="50" VAR="2.3607843137254902" WEIGHT="0.4477460728066811"/>
<DICH_DATA CI_END="1.9452025119460867" CI_START="0.6506391968072258" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="16" LOG_CI_END="0.28896482172465093" LOG_CI_START="-0.18665977682988838" LOG_EFFECT_SIZE="0.05115252244738129" MODIFIED="2012-06-27 11:03:38 +0100" MODIFIED_BY="[Empty name]" ORDER="273" O_E="0.0" SE="0.27938424357067015" STUDY_ID="STD-Hilmi-2010" TOTAL_1="50" TOTAL_2="50" VAR="0.07805555555555554" WEIGHT="14.327874329813795"/>
<DICH_DATA CI_END="1.0198361669523746" CI_START="0.33929053749849375" EFFECT_SIZE="0.5882352941176471" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="17" LOG_CI_END="0.00853040950370991" LOG_CI_START="-0.46942825226025775" LOG_EFFECT_SIZE="-0.2304489213782739" MODIFIED="2012-06-27 11:03:38 +0100" MODIFIED_BY="[Empty name]" ORDER="165" O_E="0.0" SE="0.2807552838536876" STUDY_ID="STD-Keays-1991" TOTAL_1="25" TOTAL_2="25" VAR="0.07882352941176468" WEIGHT="15.223366475427158"/>
<DICH_DATA CI_END="4.333522421474782" CI_START="0.7756071814593866" EFFECT_SIZE="1.8333333333333333" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.6368410479282809" LOG_CI_START="-0.11035817837911803" LOG_EFFECT_SIZE="0.2632414347745814" MODIFIED="2012-06-27 11:03:38 +0100" MODIFIED_BY="[Empty name]" ORDER="166" O_E="0.0" SE="0.4389085242287881" STUDY_ID="STD-Macedo-2006" TOTAL_1="14" TOTAL_2="22" VAR="0.19264069264069267" WEIGHT="4.17896334619569"/>
<DICH_DATA CI_END="70.91920212209737" CI_START="0.12263957373928792" EFFECT_SIZE="2.9491525423728815" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.850763840917606" LOG_CI_START="-0.9113693676366952" LOG_EFFECT_SIZE="0.4696972366404556" MODIFIED="2012-06-27 11:03:38 +0100" MODIFIED_BY="[Empty name]" ORDER="167" O_E="0.0" SE="1.6224907194846905" STUDY_ID="STD-Ozaydin-2008" TOTAL_1="58" TOTAL_2="57" VAR="2.632476134813949" WEIGHT="0.4515729623178493"/>
<DICH_DATA CI_END="3.682030338251536" CI_START="0.879949294914979" EFFECT_SIZE="1.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5660873625712961" LOG_CI_START="-0.05554235236468391" LOG_EFFECT_SIZE="0.25527250510330607" MODIFIED="2012-06-27 11:03:38 +0100" MODIFIED_BY="[Empty name]" ORDER="168" O_E="0.0" SE="0.3651483716701107" STUDY_ID="STD-Peake-1996" TOTAL_1="4" TOTAL_2="8" VAR="0.1333333333333333" WEIGHT="2.878367610900093"/>
<DICH_DATA CI_END="70.82882080128427" CI_START="0.12706691849706478" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8502100114756685" LOG_CI_START="-0.895967502036344" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2012-06-27 11:03:38 +0100" MODIFIED_BY="[Empty name]" ORDER="169" O_E="0.0" SE="1.613118265234886" STUDY_ID="STD-Ristikankare-2006" TOTAL_1="30" TOTAL_2="30" VAR="2.6021505376344085" WEIGHT="0.4477460728066811"/>
<DICH_DATA CI_END="4.3106993247881125" CI_START="0.6050487571477691" EFFECT_SIZE="1.6149870801033592" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" LOG_CI_END="0.6345477314738477" LOG_CI_START="-0.21820962682351985" LOG_EFFECT_SIZE="0.20816905232516383" MODIFIED="2012-06-27 11:03:38 +0100" MODIFIED_BY="[Empty name]" ORDER="171" O_E="0.0" SE="0.5009138934808761" STUDY_ID="STD-Sisillo-2008" TOTAL_1="129" TOTAL_2="125" VAR="0.2509147286821705" WEIGHT="5.457566304761751"/>
<DICH_DATA CI_END="4.269071591426954" CI_START="0.20499306561131594" EFFECT_SIZE="0.9354838709677419" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6303334378915493" LOG_CI_START="-0.6882608297621826" LOG_EFFECT_SIZE="-0.02896369593531662" MODIFIED="2012-06-27 11:03:38 +0100" MODIFIED_BY="[Empty name]" ORDER="173" O_E="0.0" SE="0.7745487999666955" STUDY_ID="STD-Suter-1994" TOTAL_1="31" TOTAL_2="29" VAR="0.599925843529848" WEIGHT="2.7760256514014228"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-06-27 11:03:38 +0100" MODIFIED_BY="[Empty name]" ORDER="174" O_E="0.0" SE="0.0" STUDY_ID="STD-Tossios-2003" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.8610742268908047" CI_START="0.17148785522992024" EFFECT_SIZE="0.564935064935065" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.2697636948321219" LOG_CI_START="-0.7657666312678111" LOG_EFFECT_SIZE="-0.2480014682178445" MODIFIED="2012-06-27 11:03:38 +0100" MODIFIED_BY="[Empty name]" ORDER="175" O_E="0.0" SE="0.6082756395088852" STUDY_ID="STD-Wijeysundera-2007" TOTAL_1="88" TOTAL_2="87" VAR="0.3699992536199433" WEIGHT="6.30426470511807"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2012-07-29 15:18:26 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2012-07-29 14:53:57 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAiMAAADOCAMAAADbsfL2AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2012-07-29 14:53:57 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Methodological quality summary: review authors' judgements about each methodological quality item for each included study.</P>
<P>+: yes, -: no, ?: unclear</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAASkAAAXoCAIAAABuAKrXAABFiklEQVR42u3dv24UWfrG8ZZICBwQ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</FILE>
</FIGURE>
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2012-03-27 23:53:20 +0100" MODIFIED_BY="Jane Cracknell" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAXwAAAUXCAYAAABam9tAAAA2LUlEQVR42u3di7KjuJJG4Xr/l+6J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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2012-07-29 15:17:59 +0100" MODIFIED_BY="Jane Cracknell" NO="4" REF_ID="CMP-001.01" SETTINGS="SHOW_STUDY_NAMES:NO;DISTINGUISH_SUBGROUPS:NO;SHOW_CI_LINES:YES;SHOW_EFFECT_ESTIMATE:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 N-acetylcysteine versus placebo, outcome: 1.1 30-day all-cause mortality.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2012-07-29 15:18:26 +0100" MODIFIED_BY="[Empty name]" NO="5" REF_ID="CMP-002.01" SETTINGS="SHOW_STUDY_NAMES:NO;DISTINGUISH_SUBGROUPS:YES;SHOW_CI_LINES:YES;SHOW_EFFECT_ESTIMATE:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 2 N-acetylcysteine versus placebo - subgroup analysis, outcome: 2.1 Mortality (all reported time scales).</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2010-02-02 11:51:43 +0000" MODIFIED_BY="Jane Cracknell">
<APPENDIX ID="APP-01" MODIFIED="2010-02-02 11:51:43 +0000" MODIFIED_BY="Jane Cracknell" NO="1">
<TITLE MODIFIED="2010-02-02 11:51:43 +0000" MODIFIED_BY="Jane Cracknell">Search strategy to identify eligible trials in MEDLINE</TITLE>
<APPENDIX_BODY MODIFIED="2010-01-16 15:21:48 +0000" MODIFIED_BY="[Empty name]">
<TABLE COLS="1" ROWS="53">
<TR>
<TH>
<P>Search terms</P>
</TH>
</TR>
<TR>
<TD>
<P>#52 #25 and #51</P>
</TD>
</TR>
<TR>
<TD>
<P>#51 #34 or #50</P>
</TD>
</TR>
<TR>
<TD>
<P>#50 #49 not #34</P>
</TD>
</TR>
<TR>
<TD>
<P>#49 #47 not #48</P>
</TD>
</TR>
<TR>
<TD>
<P>#48 (TG=ANIMALS) not ((TG=HUMAN) and (TG=ANIMALS))</P>
</TD>
</TR>
<TR>
<TD>
<P>#47 #35 or #36 or #37 or #38 or #40 or #41 or #42 or #43 or #44 or #45 or #46</P>
</TD>
</TR>
<TR>
<TD>
<P>#46 RESEARCH-DESIGN</P>
</TD>
</TR>
<TR>
<TD>
<P>#45 random* in AB</P>
</TD>
</TR>
<TR>
<TD>
<P>#44 random* in TI</P>
</TD>
</TR>
<TR>
<TD>
<P>#43 placebo* in AB</P>
</TD>
</TR>
<TR>
<TD>
<P>#42 placebo* in TI</P>
</TD>
</TR>
<TR>
<TD>
<P>#41 PLACEBOS</P>
</TD>
</TR>
<TR>
<TD>
<P>#40 (#39 in TI) or (#39 in AB)</P>
</TD>
</TR>
<TR>
<TD>
<P>#39 (singl* or doubl* or trebl* or tripl*) near (blind* or mask*)</P>
</TD>
</TR>
<TR>
<TD>
<P>#38 (clin* near trial*) in AB</P>
</TD>
</TR>
<TR>
<TD>
<P>#37 (clin* near trial*) in TI</P>
</TD>
</TR>
<TR>
<TD>
<P>#36 explode CLINICAL-TRIALS / all subheadings</P>
</TD>
</TR>
<TR>
<TD>
<P>#35 CLINICAL-TRIAL in PT</P>
</TD>
</TR>
<TR>
<TD>
<P>#34 #32 not #33</P>
</TD>
</TR>
<TR>
<TD>
<P>#33 (TG=ANIMALS) not ((TG=HUMAN) and (TG=ANIMALS))</P>
</TD>
</TR>
<TR>
<TD>
<P>#32 #26 or #27 or #28 or #29 or #30 or #31</P>
</TD>
</TR>
<TR>
<TD>
<P>#31 SINGLE-BLIND-METHOD</P>
</TD>
</TR>
<TR>
<TD>
<P>#30 DOUBLE-BLIND-METHOD</P>
</TD>
</TR>
<TR>
<TD>
<P>#29 RANDOM-ALLOCATION</P>
</TD>
</TR>
<TR>
<TD>
<P>#28 RANDOMIZED-CONTROLLED-TRIALS</P>
</TD>
</TR>
<TR>
<TD>
<P>#27 CONTROLLED-CLINICAL-TRIAL in PT</P>
</TD>
</TR>
<TR>
<TD>
<P>#26 RANDOMIZED-CONTROLLED-TRIAL in PT</P>
</TD>
</TR>
<TR>
<TD>
<P>#25 #15 and #24</P>
</TD>
</TR>
<TR>
<TD>
<P>#24 #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23</P>
</TD>
</TR>
<TR>
<TD>
<P>#23 Free?Radical* Scavenger*</P>
</TD>
</TR>
<TR>
<TD>
<P>#22 explode "Free-Radical-Scavengers" / all SUBHEADINGS in MIME,MJME</P>
</TD>
</TR>
<TR>
<TD>
<P>#21 Antioxidant*</P>
</TD>
</TR>
<TR>
<TD>
<P>#20 explode "Antioxidants-" / all SUBHEADINGS in MIME,MJME</P>
</TD>
</TR>
<TR>
<TD>
<P>#19 NAC</P>
</TD>
</TR>
<TR>
<TD>
<P>#18 N?acetylcystein*</P>
</TD>
</TR>
<TR>
<TD>
<P>#17 acetylcystein*</P>
</TD>
</TR>
<TR>
<TD>
<P>#16 explode Acetylcysteine/ all subheadings</P>
</TD>
</TR>
<TR>
<TD>
<P>#15 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14</P>
</TD>
</TR>
<TR>
<TD>
<P>#14 peri?operat*</P>
</TD>
</TR>
<TR>
<TD>
<P>#13 "Perioperative-Care" / all SUBHEADINGS in MIME,MJME</P>
</TD>
</TR>
<TR>
<TD>
<P>#12 ("Intensive-Care" / all SUBHEADINGS in MIME,MJME) or ("Intensive-Care-Units" / all SUBHEADINGS in MIME,MJME)</P>
</TD>
</TR>
<TR>
<TD>
<P>#11 explode Septicemia/ all subheadings</P>
</TD>
</TR>
<TR>
<TD>
<P>#10 septi* or sepsis</P>
</TD>
</TR>
<TR>
<TD>
<P>#9 septic shock or ARDS or Multiple?Organ* Failure or Sepsis complication* or Sepsis Syndrome or organ dysfunction* or pancreatitis or surgery</P>
</TD>
</TR>
<TR>
<TD>
<P>#8 ("Surgical-Procedures-Operative" / all SUBHEADINGS in MIME,MJME) or ("Specialties-Surgical" / all SUBHEADINGS in MIME,MJME) or ("Surgery-" / all SUBHEADINGS in MIME,MJME)</P>
</TD>
</TR>
<TR>
<TD>
<P>#7 explode "Respiratory-Distress-Syndrome-Adult" / all SUBHEADINGS in MIME,MJME</P>
</TD>
</TR>
<TR>
<TD>
<P>#6 (explode "Pancreatitis-" / all SUBHEADINGS in MIME,MJME) or (explode "Pancreatitis-Acute-Necrotizing" / all SUBHEADINGS in MIME,MJME)</P>
</TD>
</TR>
<TR>
<TD>
<P>#5 explode "Multiple-Organ-Failure" / all SUBHEADINGS in MIME,MJME</P>
</TD>
</TR>
<TR>
<TD>
<P>#4 explode Shock-Septic/ all subheadings</P>
</TD>
</TR>
<TR>
<TD>
<P>#3 system* infla?mator* response syndrome</P>
</TD>
</TR>
<TR>
<TD>
<P>#2 explode "Sepsis-Syndrome" / all SUBHEADINGS in MIME,MJME</P>
</TD>
</TR>
<TR>
<TD>
<P>#1 explode "Sepsis-" / all SUBHEADINGS in MIME,MJME</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2010-02-02 11:51:43 +0000" MODIFIED_BY="Jane Cracknell" NO="2">
<TITLE MODIFIED="2010-02-02 11:51:43 +0000" MODIFIED_BY="Jane Cracknell">Search strategy to identify eligible trials from the CENTRAL database</TITLE>
<APPENDIX_BODY MODIFIED="2010-01-16 15:21:48 +0000" MODIFIED_BY="[Empty name]">
<TABLE COLS="1" ROWS="24">
<TR>
<TH>
<P>Search terms</P>
</TH>
</TR>
<TR>
<TD>
<P>#1 MeSH descriptor Sepsis explode all trees</P>
</TD>
</TR>
<TR>
<TD>
<P>#2 MeSH descriptor Sepsis Syndrome explode all trees</P>
</TD>
</TR>
<TR>
<TD>
<P>#3 system* infla?mator* response syndrome</P>
</TD>
</TR>
<TR>
<TD>
<P>#4 MeSH descriptor Shock, Septic explode all trees</P>
</TD>
</TR>
<TR>
<TD>
<P>#5 MeSH descriptor Multiple Organ Failure explode all trees</P>
</TD>
</TR>
<TR>
<TD>
<P>#6 MeSH descriptor Pancreatitis, this term only</P>
</TD>
</TR>
<TR>
<TD>
<P>#7 MeSH descriptor Respiratory Distress Syndrome, Adult, this term only</P>
</TD>
</TR>
<TR>
<TD>
<P>#8 MeSH descriptor Surgery explode all trees</P>
</TD>
</TR>
<TR>
<TD>
<P>#9 MeSH descriptor Surgical Procedures, Operative, this term only</P>
</TD>
</TR>
<TR>
<TD>
<P>#10 MeSH descriptor Specialties, Surgical explode all trees</P>
</TD>
</TR>
<TR>
<TD>
<P>#11 MeSH descriptor Intensive Care explode all trees</P>
</TD>
</TR>
<TR>
<TD>
<P>#12 MeSH descriptor Intensive Care Units explode all trees</P>
</TD>
</TR>
<TR>
<TD>
<P>#13 MeSH descriptor Perioperative Care explode all trees</P>
</TD>
</TR>
<TR>
<TD>
<P>#14 MeSH descriptor Perioperative Care explode all trees</P>
</TD>
</TR>
<TR>
<TD>
<P>#15 septic shock or ARDS or Multiple?Organ* Failure or Sepsis complication* or Sepsis Syndrome or organ dysfunction* or pancreatitis or surgery</P>
</TD>
</TR>
<TR>
<TD>
<P>#16 peri?operat* or septi* or sepsis</P>
</TD>
</TR>
<TR>
<TD>
<P>#17 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 oR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16)</P>
</TD>
</TR>
<TR>
<TD>
<P>#18 MeSH descriptor Acetylcysteine explode all trees</P>
</TD>
</TR>
<TR>
<TD>
<P>#19 MeSH descriptor Antioxidants explode all trees</P>
</TD>
</TR>
<TR>
<TD>
<P>#20 MeSH descriptor Free Radical Scavengers explode all trees</P>
</TD>
</TR>
<TR>
<TD>
<P>#21 (FreeRadical* Scavenger*) or (Free-Radical* Scavenger*) or (Free Radica</P>
</TD>
</TR>
<TR>
<TD>
<P>#22 (18 OR 19 OR 20 OR 21)</P>
</TD>
</TR>
<TR>
<TD>
<P>#23 (17 AND 22)</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2010-02-02 11:51:43 +0000" MODIFIED_BY="Jane Cracknell" NO="3">
<TITLE MODIFIED="2010-02-02 11:51:43 +0000" MODIFIED_BY="Jane Cracknell">Search strategy to identify eligible trials from the CINAHL database</TITLE>
<APPENDIX_BODY MODIFIED="2010-01-16 15:21:48 +0000" MODIFIED_BY="[Empty name]">
<TABLE COLS="1" ROWS="19">
<TR>
<TH>
<P>Search terms</P>
</TH>
</TR>
<TR>
<TD>
<P>#1 explode Sepsis- / all TOPICAL SUBHEADINGS / all AGE SUBHEADINGS in DE</P>
</TD>
</TR>
<TR>
<TD>
<P>#2 explode Systemic-Inflammatory-Response-Syndrome / all TOPICAL SUBHEADINGS / all AGE SUBHEADINGS in DE</P>
</TD>
</TR>
<TR>
<TD>
<P>#3 explode Shock-Septic / all TOPICAL SUBHEADINGS / all AGE SUBHEADINGS in DE</P>
</TD>
</TR>
<TR>
<TD>
<P>#4 explode Multiple-Organ-Dysfunction-Syndrome / all TOPICAL SUBHEADINGS / all AGE SUBHEADINGS in DE</P>
</TD>
</TR>
<TR>
<TD>
<P>#5 Pancreatitis- / all TOPICAL SUBHEADINGS / all AGE SUBHEADINGS in DE</P>
</TD>
</TR>
<TR>
<TD>
<P>#6 (explode Respiratory-Distress-Syndrome / all TOPICAL SUBHEADINGS / all AGE SUBHEADINGS in DE) or (explode Respiratory-Distress-Syndrome-Acute / all TOPICAL SUBHEADINGS / all AGE SUBHEADINGS in DE)</P>
</TD>
</TR>
<TR>
<TD>
<P>#7 explode Surgery-Operative / all TOPICAL SUBHEADINGS / all AGE SUBHEADINGS in DE</P>
</TD>
</TR>
<TR>
<TD>
<P>#8 (Critical-Care / all TOPICAL SUBHEADINGS / all AGE SUBHEADINGS in DE) or (Intensive-Care-Units / all TOPICAL SUBHEADINGS / all AGE SUBHEADINGS in DE)</P>
</TD>
</TR>
<TR>
<TD>
<P>#9 Perioperative-Care / all TOPICAL SUBHEADINGS / all AGE SUBHEADINGS in DE</P>
</TD>
</TR>
<TR>
<TD>
<P>#10 system* infla?mator* response syndrome</P>
</TD>
</TR>
<TR>
<TD>
<P>#11 septic shock or ARDS or Multiple?Organ* Failure or Sepsis complication* or Sepsis Syndrome or organ dysfunction* or pancreatitis or surgery or septi* or sepsis or peri?operat*</P>
</TD>
</TR>
<TR>
<TD>
<P>#12 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11</P>
</TD>
</TR>
<TR>
<TD>
<P>#13 explode "Acetylcysteine-" / all TOPICAL SUBHEADINGS / all AGE SUBHEADINGS in DE<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>#14 explode "Antioxidants-" / all TOPICAL SUBHEADINGS / all AGE SUBHEADINGS in DE</P>
</TD>
</TR>
<TR>
<TD>
<P>#15 explode "Free-Radical-Scavengers" / all TOPICAL SUBHEADINGS / all AGE SUBHEADINGS in DE</P>
</TD>
</TR>
<TR>
<TD>
<P>#16 (Free?Radical* Scavenger*) or Antioxidant* or NAC or N?acetylcystein* or acetylcystein*</P>
</TD>
</TR>
<TR>
<TD>
<P>#17 #13 or #14 or #15 or #16</P>
</TD>
</TR>
<TR>
<TD>
<P>#18 #12 and #17</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2010-02-02 11:51:43 +0000" MODIFIED_BY="Jane Cracknell" NO="4">
<TITLE MODIFIED="2010-02-02 11:51:43 +0000" MODIFIED_BY="Jane Cracknell">Search strategy to identify eligible trials in the EMBASE database</TITLE>
<APPENDIX_BODY MODIFIED="2010-01-16 15:21:48 +0000" MODIFIED_BY="[Empty name]">
<TABLE COLS="1" ROWS="42">
<TR>
<TH>
<P>Search terms</P>
</TH>
</TR>
<TR>
<TD>
<P>#40 #22 and #39</P>
</TD>
</TR>
<TR>
<TD>
<P>#39 #34 not #38</P>
</TD>
</TR>
<TR>
<TD>
<P>#38 #36 not #37</P>
</TD>
</TR>
<TR>
<TD>
<P>#37 #35 and #36</P>
</TD>
</TR>
<TR>
<TD>
<P>#36 (ANIMAL or NONHUMAN) in DER</P>
</TD>
</TR>
<TR>
<TD>
<P>#35 HUMAN in DER</P>
</TD>
</TR>
<TR>
<TD>
<P>#34 #31 or #32 or #33</P>
</TD>
</TR>
<TR>
<TD>
<P>#33 (SINGL* or DOUBL* or TREBL* or TRIPL*) near ((BLIND* or MASK*) in TI,AB)</P>
</TD>
</TR>
<TR>
<TD>
<P>#33 (SINGL* or DOUBL* or TREBL* or TRIPL*) near ((BLIND* or MASK*) in TI,AB)</P>
</TD>
</TR>
<TR>
<TD>
<P>#32 (RANDOM* or CROSS?OVER* or FACTORIAL* or PLACEBO* or VOLUNTEER*) in TI,AB</P>
</TD>
</TR>
<TR>
<TD>
<P>#31 #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30</P>
</TD>
</TR>
<TR>
<TD>
<P>#30 "SINGLE-BLIND-PROCEDURE"/ all subheadings</P>
</TD>
</TR>
<TR>
<TD>
<P>#29 "DOUBLE-BLIND-PROCEDURE"/ all subheadings</P>
</TD>
</TR>
<TR>
<TD>
<P>#28 "PHASE-4-CLINICAL-TRIAL"/ all subheadings</P>
</TD>
</TR>
<TR>
<TD>
<P>#27 "PHASE-3-CLINICAL-TRIAL"/ all subheadings</P>
</TD>
</TR>
<TR>
<TD>
<P>#26 "MULTICENTER-STUDY"/ all subheadings</P>
</TD>
</TR>
<TR>
<TD>
<P>#25 "CONTROLLED-STUDY"/ all subheadings</P>
</TD>
</TR>
<TR>
<TD>
<P>#24 "RANDOMIZATION"/ all subheadings</P>
</TD>
</TR>
<TR>
<TD>
<P>#23 "RANDOMIZED-CONTROLLED-TRIAL"/ all subheadings</P>
</TD>
</TR>
<TR>
<TD>
<P>#22 #15 and #21</P>
</TD>
</TR>
<TR>
<TD>
<P>#21 #16 or #17 or #18 or #19 or #20</P>
</TD>
</TR>
<TR>
<TD>
<P>#20 acetylcystein* or N?acetylcystein* or NAC or Antioxidant* or (Free?Radical* Scavenger*)</P>
</TD>
</TR>
<TR>
<TD>
<P>#19 explode "scavenger-" / all SUBHEADINGS in DEM,DER,DRM,DRR</P>
</TD>
</TR>
<TR>
<TD>
<P>#18 explode "antioxidant-" / all SUBHEADINGS in DEM,DER,DRM,DRR</P>
</TD>
</TR>
<TR>
<TD>
<P>#17 explode "antioxidant-" / all SUBHEADINGS in DEM,DER,DRM,DRR</P>
</TD>
</TR>
<TR>
<TD>
<P>#16 explode "acetylcysteine-" / all SUBHEADINGS in DEM,DER,DRM,DRR</P>
</TD>
</TR>
<TR>
<TD>
<P>#15 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14</P>
</TD>
</TR>
<TR>
<TD>
<P>#14 peri?operat*<BR/>
</P>
</TD>
</TR>
<TR>
<TD>
<P>#13 "perioperative-period" / all SUBHEADINGS in DEM,DER,DRM,DRR</P>
</TD>
</TR>
<TR>
<TD>
<P>#12 "intensive-care" / all SUBHEADINGS in DEM,DER,DRM,DRR</P>
</TD>
</TR>
<TR>
<TD>
<P>#11 explode "septicemia-" / all SUBHEADINGS in DEM,DER,DRM,DRR</P>
</TD>
</TR>
<TR>
<TD>
<P>#10 septi* or sepsis</P>
</TD>
</TR>
<TR>
<TD>
<P>#9 septic shock or ARDS or (Multiple?Organ* Failure) or (Sepsis complication*) or (Sepsis Syndrome) or (organ dysfunction*) or pancreatit* or surg*</P>
</TD>
</TR>
<TR>
<TD>
<P>#8 explode "surgical-technique" / all SUBHEADINGS in DEM,DER,DRM,DRR</P>
</TD>
</TR>
<TR>
<TD>
<P>#7 explode "surgery-" / all SUBHEADINGS in DEM,DER,DRM,DRR</P>
</TD>
</TR>
<TR>
<TD>
<P>#6 "adult-respiratory-distress-syndrome" / all SUBHEADINGS in DEM,DER,DRM,DRR</P>
</TD>
</TR>
<TR>
<TD>
<P>#5 ("acute-pancreatitis" / all SUBHEADINGS in DEM,DER,DRM,DRR) or ("pancreatitis-" / all SUBHEADINGS in DEM,DER,DRM,DRR)</P>
</TD>
</TR>
<TR>
<TD>
<P>#4 explode "multiple-organ-failure" / all SUBHEADINGS in DEM,DER,DRM,DRR</P>
</TD>
</TR>
<TR>
<TD>
<P>#3 system* infla?mator* response syndrome</P>
</TD>
</TR>
<TR>
<TD>
<P>#2 explode "septic-shock" / all SUBHEADINGS in DEM,DER,DRM,DRR</P>
</TD>
</TR>
<TR>
<TD>
<P>#1 explode "sepsis-" / all SUBHEADINGS in DEM,DER,DRM,DRR</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_3" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="3">
<FLOWCHARTBOX TEXT="&lt;p&gt;&lt;b&gt;Included = 41&lt;/b&gt;&lt;/p&gt;&lt;p&gt;N-acetylcysteine vs placebo = 41&lt;/p&gt;&lt;p&gt;&lt;b&gt;Number of trials by outcome&lt;/b&gt;&lt;/p&gt;&lt;p&gt;30-day mortality 11&lt;/p&gt;&lt;p&gt;Mortality (all timescales)&amp;#160;37&lt;/p&gt;&lt;p&gt;Length of stay on ICU&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 21&lt;/p&gt;&lt;p&gt;Duration of mechanical ventilation&amp;#160;&amp;#160;&amp;#160;10&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/p&gt;&lt;p&gt;Incidence of new organ failure&amp;#160;&amp;#160;&amp;#160;13&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;&lt;b&gt;Full paper review&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;73&lt;/b&gt;&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;&lt;b&gt;Excluded Database Search&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Irrelevant/Review/Non-RCT&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 6152&lt;/p&gt;&lt;p&gt;Duplicates&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 760&lt;/p&gt;&lt;p&gt;&lt;b&gt;Excluded Other Sources&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Outcome not relevant&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;1&lt;/p&gt;" WIDTH="200">
<FLOWCHARTBOX TEXT="&lt;p&gt;&lt;b&gt;Database Search&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 6983&lt;/b&gt;&lt;/p&gt;&lt;p&gt;MEDLINE&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;974&lt;/p&gt;&lt;p&gt;CENTRAL&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2309&lt;/p&gt;&lt;p&gt;EMBASE&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2788&lt;/p&gt;&lt;p&gt;LILACS&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;45&lt;/p&gt;&lt;p&gt;CINAHL&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;867&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;&lt;b&gt;Other Sources&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 1&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Web search&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;1&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;&lt;b&gt;Excluded&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 32&lt;/b&gt;&lt;/p&gt;&lt;p&gt;Intervention not relevant&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;14&lt;/p&gt;&lt;p&gt;Patient group not relevant&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;1&lt;/p&gt;&lt;p&gt;Not RCT&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;4&lt;/p&gt;&lt;p&gt;Outcome not relevant&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 1&lt;/p&gt;&lt;p&gt;Duplicate publication&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;12&lt;/p&gt;"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>